TWI508949B - Electron transport material and organic electroluminescent device using the same - Google Patents
Electron transport material and organic electroluminescent device using the same Download PDFInfo
- Publication number
- TWI508949B TWI508949B TW100140164A TW100140164A TWI508949B TW I508949 B TWI508949 B TW I508949B TW 100140164 A TW100140164 A TW 100140164A TW 100140164 A TW100140164 A TW 100140164A TW I508949 B TWI508949 B TW I508949B
- Authority
- TW
- Taiwan
- Prior art keywords
- compound
- represented
- formula
- group
- added
- Prior art date
Links
- 239000000463 material Substances 0.000 title claims description 52
- 150000001875 compounds Chemical class 0.000 claims description 281
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical group C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 60
- -1 hydroxyquinoline metal complex Chemical class 0.000 claims description 44
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 40
- 125000004432 carbon atom Chemical group C* 0.000 claims description 35
- 125000000217 alkyl group Chemical group 0.000 claims description 32
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 28
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 21
- 125000001624 naphthyl group Chemical group 0.000 claims description 14
- 238000002347 injection Methods 0.000 claims description 13
- 239000007924 injection Substances 0.000 claims description 13
- ROFVEXUMMXZLPA-UHFFFAOYSA-N Bipyridyl Chemical class N1=CC=CC=C1C1=CC=CC=N1 ROFVEXUMMXZLPA-UHFFFAOYSA-N 0.000 claims description 8
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 8
- 239000001257 hydrogen Substances 0.000 claims description 8
- 229910052739 hydrogen Inorganic materials 0.000 claims description 8
- 229910052799 carbon Inorganic materials 0.000 claims description 6
- NSMJMUQZRGZMQC-UHFFFAOYSA-N 2-naphthalen-1-yl-1H-imidazo[4,5-f][1,10]phenanthroline Chemical compound C12=CC=CN=C2C2=NC=CC=C2C2=C1NC(C=1C3=CC=CC=C3C=CC=1)=N2 NSMJMUQZRGZMQC-UHFFFAOYSA-N 0.000 claims description 5
- 229910052761 rare earth metal Inorganic materials 0.000 claims description 5
- 150000002910 rare earth metals Chemical class 0.000 claims description 5
- 229910052783 alkali metal Inorganic materials 0.000 claims description 4
- 150000001340 alkali metals Chemical class 0.000 claims description 4
- 229910052784 alkaline earth metal Inorganic materials 0.000 claims description 4
- 150000001342 alkaline earth metals Chemical class 0.000 claims description 4
- 239000002585 base Substances 0.000 claims description 4
- UORVGPXVDQYIDP-BJUDXGSMSA-N borane Chemical class [10BH3] UORVGPXVDQYIDP-BJUDXGSMSA-N 0.000 claims description 4
- 229910001508 alkali metal halide Inorganic materials 0.000 claims description 2
- 150000008045 alkali metal halides Chemical class 0.000 claims description 2
- 229910001615 alkaline earth metal halide Inorganic materials 0.000 claims description 2
- 229910000287 alkaline earth metal oxide Inorganic materials 0.000 claims description 2
- 229910001404 rare earth metal oxide Inorganic materials 0.000 claims description 2
- 229910044991 metal oxide Inorganic materials 0.000 claims 1
- 150000004706 metal oxides Chemical class 0.000 claims 1
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 253
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 144
- 230000015572 biosynthetic process Effects 0.000 description 103
- 238000003786 synthesis reaction Methods 0.000 description 102
- 239000010410 layer Substances 0.000 description 97
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 81
- 239000002904 solvent Substances 0.000 description 66
- 239000007787 solid Substances 0.000 description 64
- 239000000243 solution Substances 0.000 description 61
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 60
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 58
- 238000006243 chemical reaction Methods 0.000 description 57
- 238000007740 vapor deposition Methods 0.000 description 54
- GWHJZXXIDMPWGX-UHFFFAOYSA-N 1,2,4-trimethylbenzene Chemical compound CC1=CC=C(C)C(C)=C1 GWHJZXXIDMPWGX-UHFFFAOYSA-N 0.000 description 46
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 46
- 238000010992 reflux Methods 0.000 description 45
- 238000000034 method Methods 0.000 description 44
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 41
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 35
- 239000007788 liquid Substances 0.000 description 35
- 229910052749 magnesium Inorganic materials 0.000 description 34
- 239000011777 magnesium Substances 0.000 description 34
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 33
- 238000000926 separation method Methods 0.000 description 33
- 229910052709 silver Inorganic materials 0.000 description 33
- 239000004332 silver Substances 0.000 description 33
- 238000001816 cooling Methods 0.000 description 32
- 239000000203 mixture Substances 0.000 description 32
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 30
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 30
- 229910000160 potassium phosphate Inorganic materials 0.000 description 28
- 235000011009 potassium phosphates Nutrition 0.000 description 28
- 238000010898 silica gel chromatography Methods 0.000 description 26
- 238000005160 1H NMR spectroscopy Methods 0.000 description 24
- 238000005481 NMR spectroscopy Methods 0.000 description 24
- 239000010408 film Substances 0.000 description 24
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 24
- 238000000967 suction filtration Methods 0.000 description 24
- 239000012299 nitrogen atmosphere Substances 0.000 description 23
- 125000001622 2-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C(*)C([H])=C([H])C2=C1[H] 0.000 description 18
- IUYHWZFSGMZEOG-UHFFFAOYSA-M magnesium;propane;chloride Chemical compound [Mg+2].[Cl-].C[CH-]C IUYHWZFSGMZEOG-UHFFFAOYSA-M 0.000 description 18
- 239000003480 eluent Substances 0.000 description 16
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 14
- 239000012295 chemical reaction liquid Substances 0.000 description 14
- 238000010438 heat treatment Methods 0.000 description 14
- 229910052750 molybdenum Inorganic materials 0.000 description 14
- 239000011733 molybdenum Substances 0.000 description 14
- 239000000758 substrate Substances 0.000 description 14
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 13
- 239000007864 aqueous solution Substances 0.000 description 13
- SIKJAQJRHWYJAI-UHFFFAOYSA-N benzopyrrole Natural products C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 13
- 230000000052 comparative effect Effects 0.000 description 12
- WEHCCWCYFYMBQX-UHFFFAOYSA-L zinc;n,n,n',n'-tetramethylethane-1,2-diamine;dichloride Chemical compound Cl[Zn]Cl.CN(C)CCN(C)C WEHCCWCYFYMBQX-UHFFFAOYSA-L 0.000 description 12
- 239000006103 coloring component Substances 0.000 description 11
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 10
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 10
- 238000004440 column chromatography Methods 0.000 description 10
- 230000005525 hole transport Effects 0.000 description 10
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 10
- UKSZBOKPHAQOMP-SVLSSHOZSA-N (1e,4e)-1,5-diphenylpenta-1,4-dien-3-one;palladium Chemical compound [Pd].C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1.C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1 UKSZBOKPHAQOMP-SVLSSHOZSA-N 0.000 description 9
- NIHNNTQXNPWCJQ-UHFFFAOYSA-N o-biphenylenemethane Natural products C1=CC=C2CC3=CC=CC=C3C2=C1 NIHNNTQXNPWCJQ-UHFFFAOYSA-N 0.000 description 9
- 238000010792 warming Methods 0.000 description 9
- ZHXUWDPHUQHFOV-UHFFFAOYSA-N 2,5-dibromopyridine Chemical compound BrC1=CC=C(Br)N=C1 ZHXUWDPHUQHFOV-UHFFFAOYSA-N 0.000 description 8
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- MWPLVEDNUUSJAV-UHFFFAOYSA-N anthracene Chemical compound C1=CC=CC2=CC3=CC=CC=C3C=C21 MWPLVEDNUUSJAV-UHFFFAOYSA-N 0.000 description 8
- 235000011089 carbon dioxide Nutrition 0.000 description 8
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 8
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 8
- 239000002994 raw material Substances 0.000 description 8
- 238000003756 stirring Methods 0.000 description 8
- 238000001308 synthesis method Methods 0.000 description 8
- FYGHSUNMUKGBRK-UHFFFAOYSA-N trimethylbenzene Natural products CC1=CC=CC(C)=C1C FYGHSUNMUKGBRK-UHFFFAOYSA-N 0.000 description 8
- 150000001454 anthracenes Chemical class 0.000 description 7
- 239000004327 boric acid Substances 0.000 description 7
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 7
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 7
- WLPUWLXVBWGYMZ-UHFFFAOYSA-N tricyclohexylphosphine Chemical compound C1CCCCC1P(C1CCCCC1)C1CCCCC1 WLPUWLXVBWGYMZ-UHFFFAOYSA-N 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 6
- 238000004040 coloring Methods 0.000 description 6
- 238000005859 coupling reaction Methods 0.000 description 6
- 238000004821 distillation Methods 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- BMQDAIUNAGXSKR-UHFFFAOYSA-N (3-hydroxy-2,3-dimethylbutan-2-yl)oxyboronic acid Chemical compound CC(C)(O)C(C)(C)OB(O)O BMQDAIUNAGXSKR-UHFFFAOYSA-N 0.000 description 5
- MAIJPIYXFRLIEK-UHFFFAOYSA-N 3-(6-bromonaphthalen-2-yl)pyridine Chemical compound C1=CC2=CC(Br)=CC=C2C=C1C1=CC=CN=C1 MAIJPIYXFRLIEK-UHFFFAOYSA-N 0.000 description 5
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 5
- UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 description 5
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical group [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 description 5
- 239000003054 catalyst Substances 0.000 description 5
- 238000005401 electroluminescence Methods 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 235000011056 potassium acetate Nutrition 0.000 description 5
- 125000004076 pyridyl group Chemical group 0.000 description 5
- 229910052707 ruthenium Inorganic materials 0.000 description 5
- 239000010409 thin film Substances 0.000 description 5
- BSERFWSHIIPTNK-UHFFFAOYSA-N 5-bromo-2-(6-methylpyridin-3-yl)pyridine Chemical compound C1=NC(C)=CC=C1C1=CC=C(Br)C=N1 BSERFWSHIIPTNK-UHFFFAOYSA-N 0.000 description 4
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 4
- 239000007818 Grignard reagent Substances 0.000 description 4
- XYFCBTPGUUZFHI-UHFFFAOYSA-N Phosphine Natural products P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 description 4
- 238000006069 Suzuki reaction reaction Methods 0.000 description 4
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 4
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- 150000004795 grignard reagents Chemical class 0.000 description 4
- OAKJQQAXSVQMHS-UHFFFAOYSA-N hydrazine group Chemical group NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 4
- 229910052751 metal Inorganic materials 0.000 description 4
- 239000002184 metal Substances 0.000 description 4
- SKTCDJAMAYNROS-UHFFFAOYSA-N methoxycyclopentane Chemical compound COC1CCCC1 SKTCDJAMAYNROS-UHFFFAOYSA-N 0.000 description 4
- 150000004866 oxadiazoles Chemical class 0.000 description 4
- XYFCBTPGUUZFHI-UHFFFAOYSA-O phosphonium Chemical compound [PH4+] XYFCBTPGUUZFHI-UHFFFAOYSA-O 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- 229910000027 potassium carbonate Inorganic materials 0.000 description 4
- 150000003222 pyridines Chemical class 0.000 description 4
- 125000005504 styryl group Chemical group 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- VEKIYFGCEAJDDT-UHFFFAOYSA-N 2-pyridin-3-ylpyridine Chemical compound N1=CC=CC=C1C1=CC=CN=C1 VEKIYFGCEAJDDT-UHFFFAOYSA-N 0.000 description 3
- AIPWPTPHMIYYOX-UHFFFAOYSA-N 3-bromo-2-methylpyridine Chemical compound CC1=NC=CC=C1Br AIPWPTPHMIYYOX-UHFFFAOYSA-N 0.000 description 3
- VNDPZWKJILZKED-UHFFFAOYSA-N 4-[3-(6-bromonaphthalen-2-yl)phenyl]pyridine Chemical compound BrC=1C=C2C=CC(=CC2=CC1)C=1C=C(C=CC1)C1=CC=NC=C1 VNDPZWKJILZKED-UHFFFAOYSA-N 0.000 description 3
- OFKWIQJLYCKDNY-UHFFFAOYSA-N 5-bromo-2-methylpyridine Chemical compound CC1=CC=C(Br)C=N1 OFKWIQJLYCKDNY-UHFFFAOYSA-N 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 3
- 229910045601 alloy Inorganic materials 0.000 description 3
- 239000000956 alloy Substances 0.000 description 3
- 229910052782 aluminium Inorganic materials 0.000 description 3
- 125000005577 anthracene group Chemical group 0.000 description 3
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 3
- 229940125782 compound 2 Drugs 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 238000010520 demethylation reaction Methods 0.000 description 3
- 239000002019 doping agent Substances 0.000 description 3
- 238000001704 evaporation Methods 0.000 description 3
- 230000008020 evaporation Effects 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 3
- 229910000073 phosphorus hydride Inorganic materials 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 238000001226 reprecipitation Methods 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 3
- 235000019345 sodium thiosulphate Nutrition 0.000 description 3
- 238000004544 sputter deposition Methods 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- 230000002194 synthesizing effect Effects 0.000 description 3
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 3
- ITMCEJHCFYSIIV-UHFFFAOYSA-M triflate Chemical compound [O-]S(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-M 0.000 description 3
- 229910052725 zinc Inorganic materials 0.000 description 3
- 239000011701 zinc Substances 0.000 description 3
- CYPYTURSJDMMMP-WVCUSYJESA-N (1e,4e)-1,5-diphenylpenta-1,4-dien-3-one;palladium Chemical compound [Pd].[Pd].C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1.C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1.C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1 CYPYTURSJDMMMP-WVCUSYJESA-N 0.000 description 2
- BCMCBBGGLRIHSE-UHFFFAOYSA-N 1,3-benzoxazole Chemical class C1=CC=C2OC=NC2=C1 BCMCBBGGLRIHSE-UHFFFAOYSA-N 0.000 description 2
- KJCVRFUGPWSIIH-UHFFFAOYSA-N 1-naphthol Chemical compound C1=CC=C2C(O)=CC=CC2=C1 KJCVRFUGPWSIIH-UHFFFAOYSA-N 0.000 description 2
- PUUUSJLVYHNFLH-UHFFFAOYSA-N 2-(5-bromopyridin-2-yl)-4-methylpyridine Chemical compound CC1=CC=NC(C=2N=CC(Br)=CC=2)=C1 PUUUSJLVYHNFLH-UHFFFAOYSA-N 0.000 description 2
- LMIGNMKZAPNHIP-UHFFFAOYSA-N 2-(5-bromopyridin-2-yl)-5-methylpyridine Chemical compound N1=CC(C)=CC=C1C1=CC=C(Br)C=N1 LMIGNMKZAPNHIP-UHFFFAOYSA-N 0.000 description 2
- QXEYHCOZNYXWPL-UHFFFAOYSA-N 2-(5-bromopyridin-2-yl)-6-methylpyridine Chemical compound CC1=CC=CC(C=2N=CC(Br)=CC=2)=N1 QXEYHCOZNYXWPL-UHFFFAOYSA-N 0.000 description 2
- AYFJBMBVXWNYLT-UHFFFAOYSA-N 2-bromo-6-methoxynaphthalene Chemical compound C1=C(Br)C=CC2=CC(OC)=CC=C21 AYFJBMBVXWNYLT-UHFFFAOYSA-N 0.000 description 2
- ZWZZYIURSCRVCS-UHFFFAOYSA-N 3-bromo-5-(2-methylpyridin-4-yl)pyridine Chemical compound BrC=1C=C(C=NC1)C1=CC(=NC=C1)C ZWZZYIURSCRVCS-UHFFFAOYSA-N 0.000 description 2
- ADCLTLQMVAEBLB-UHFFFAOYSA-N 3-bromo-5-methylpyridine Chemical compound CC1=CN=CC(Br)=C1 ADCLTLQMVAEBLB-UHFFFAOYSA-N 0.000 description 2
- JFBMFWHEXBLFCR-UHFFFAOYSA-N 4-bromo-2-methylpyridine Chemical compound CC1=CC(Br)=CC=N1 JFBMFWHEXBLFCR-UHFFFAOYSA-N 0.000 description 2
- KQFBHVJLZVHFFX-UHFFFAOYSA-N 4-bromo-3-methylpyridine;hydrochloride Chemical compound Cl.CC1=CN=CC=C1Br KQFBHVJLZVHFFX-UHFFFAOYSA-N 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
- ROUVPFHYROCBLK-UHFFFAOYSA-N 9-(3-tert-butylphenyl)-9h-fluorene Chemical compound CC(C)(C)C1=CC=CC(C2C3=CC=CC=C3C3=CC=CC=C32)=C1 ROUVPFHYROCBLK-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 2
- 101150003085 Pdcl gene Proteins 0.000 description 2
- 229920000265 Polyparaphenylene Polymers 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 2
- RDOXTESZEPMUJZ-UHFFFAOYSA-N anisole Chemical compound COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 description 2
- 239000010405 anode material Substances 0.000 description 2
- 125000006615 aromatic heterocyclic group Chemical group 0.000 description 2
- 125000003785 benzimidazolyl group Chemical class N1=C(NC2=C1C=CC=C2)* 0.000 description 2
- IOJUPLGTWVMSFF-UHFFFAOYSA-N benzothiazole Chemical class C1=CC=C2SC=NC2=C1 IOJUPLGTWVMSFF-UHFFFAOYSA-N 0.000 description 2
- 150000004696 coordination complex Chemical class 0.000 description 2
- 239000012043 crude product Substances 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 2
- 239000007772 electrode material Substances 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 230000000977 initiatory effect Effects 0.000 description 2
- 239000011630 iodine Substances 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- 229910052741 iridium Inorganic materials 0.000 description 2
- GKOZUEZYRPOHIO-UHFFFAOYSA-N iridium atom Chemical compound [Ir] GKOZUEZYRPOHIO-UHFFFAOYSA-N 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- 229910052744 lithium Inorganic materials 0.000 description 2
- PQXKHYXIUOZZFA-UHFFFAOYSA-M lithium fluoride Chemical compound [Li+].[F-] PQXKHYXIUOZZFA-UHFFFAOYSA-M 0.000 description 2
- 238000004768 lowest unoccupied molecular orbital Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 2
- 239000012046 mixed solvent Substances 0.000 description 2
- 125000002524 organometallic group Chemical group 0.000 description 2
- 229910052762 osmium Inorganic materials 0.000 description 2
- SYQBFIAQOQZEGI-UHFFFAOYSA-N osmium atom Chemical compound [Os] SYQBFIAQOQZEGI-UHFFFAOYSA-N 0.000 description 2
- 150000002923 oximes Chemical class 0.000 description 2
- 229910052763 palladium Inorganic materials 0.000 description 2
- GRJHONXDTNBDTC-UHFFFAOYSA-N phenyl trifluoromethanesulfonate Chemical compound FC(F)(F)S(=O)(=O)OC1=CC=CC=C1 GRJHONXDTNBDTC-UHFFFAOYSA-N 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 229920002098 polyfluorene Polymers 0.000 description 2
- NROKBHXJSPEDAR-UHFFFAOYSA-M potassium fluoride Chemical compound [F-].[K+] NROKBHXJSPEDAR-UHFFFAOYSA-M 0.000 description 2
- AOJFQRQNPXYVLM-UHFFFAOYSA-N pyridin-1-ium;chloride Chemical compound [Cl-].C1=CC=[NH+]C=C1 AOJFQRQNPXYVLM-UHFFFAOYSA-N 0.000 description 2
- LISFMEBWQUVKPJ-UHFFFAOYSA-N quinolin-2-ol Chemical class C1=CC=C2NC(=O)C=CC2=C1 LISFMEBWQUVKPJ-UHFFFAOYSA-N 0.000 description 2
- 125000001567 quinoxalinyl group Chemical class N1=C(C=NC2=CC=CC=C12)* 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 150000004867 thiadiazoles Chemical class 0.000 description 2
- 150000003577 thiophenes Chemical class 0.000 description 2
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 2
- 229910052721 tungsten Inorganic materials 0.000 description 2
- 239000010937 tungsten Substances 0.000 description 2
- 239000008096 xylene Substances 0.000 description 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
- HNXRLRRQDUXQEE-YKDNNCFHSA-N (2r,3r,4s,5s,6r)-2-[[(2r,3s,4r)-4-hydroxy-2-(hydroxymethyl)-3,4-dihydro-2h-pyran-3-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC=C[C@H]1O HNXRLRRQDUXQEE-YKDNNCFHSA-N 0.000 description 1
- BJQCPCFFYBKRLM-UHFFFAOYSA-N (3-methylphenyl)boronic acid Chemical compound CC1=CC=CC(B(O)O)=C1 BJQCPCFFYBKRLM-UHFFFAOYSA-N 0.000 description 1
- MNJYZNVROSZZQC-UHFFFAOYSA-N (4-tert-butylphenyl)boronic acid Chemical compound CC(C)(C)C1=CC=C(B(O)O)C=C1 MNJYZNVROSZZQC-UHFFFAOYSA-N 0.000 description 1
- ADYKPXIKPPZOQF-UHFFFAOYSA-N 1,1'-biphenyl;hydrazine Chemical class NN.C1=CC=CC=C1C1=CC=CC=C1 ADYKPXIKPPZOQF-UHFFFAOYSA-N 0.000 description 1
- LVEYOSJUKRVCCF-UHFFFAOYSA-N 1,3-Bis(diphenylphosphino)propane Substances C=1C=CC=CC=1P(C=1C=CC=CC=1)CCCP(C=1C=CC=CC=1)C1=CC=CC=C1 LVEYOSJUKRVCCF-UHFFFAOYSA-N 0.000 description 1
- 125000001989 1,3-phenylene group Chemical group [H]C1=C([H])C([*:1])=C([H])C([*:2])=C1[H] 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- 125000001140 1,4-phenylene group Chemical group [H]C1=C([H])C([*:2])=C([H])C([H])=C1[*:1] 0.000 description 1
- LQBMPJSTUHWGDE-UHFFFAOYSA-N 1-bromo-3-ethoxybenzene Chemical compound CCOC1=CC=CC(Br)=C1 LQBMPJSTUHWGDE-UHFFFAOYSA-N 0.000 description 1
- PLDWAJLZAAHOGG-UHFFFAOYSA-N 1-bromo-3-methoxybenzene Chemical compound COC1=CC=CC(Br)=C1 PLDWAJLZAAHOGG-UHFFFAOYSA-N 0.000 description 1
- WGOBPPNNYVSJTE-UHFFFAOYSA-N 1-diphenylphosphanylpropan-2-yl(diphenyl)phosphane Chemical compound C=1C=CC=CC=1P(C=1C=CC=CC=1)C(C)CP(C=1C=CC=CC=1)C1=CC=CC=C1 WGOBPPNNYVSJTE-UHFFFAOYSA-N 0.000 description 1
- 125000001637 1-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C(*)=C([H])C([H])=C([H])C2=C1[H] 0.000 description 1
- HQBYDNBCRHSMFS-UHFFFAOYSA-N 2-(5-bromopyridin-2-yl)-3-methylpyridine Chemical compound CC1=CC=CN=C1C1=CC=C(Br)C=N1 HQBYDNBCRHSMFS-UHFFFAOYSA-N 0.000 description 1
- ZPRQXVPYQGBZON-UHFFFAOYSA-N 2-bromo-1h-indole Chemical compound C1=CC=C2NC(Br)=CC2=C1 ZPRQXVPYQGBZON-UHFFFAOYSA-N 0.000 description 1
- LSZMVESSGLHDJE-UHFFFAOYSA-N 2-bromo-4-methylpyridine Chemical compound CC1=CC=NC(Br)=C1 LSZMVESSGLHDJE-UHFFFAOYSA-N 0.000 description 1
- YWNJQQNBJQUKME-UHFFFAOYSA-N 2-bromo-5-methylpyridine Chemical compound CC1=CC=C(Br)N=C1 YWNJQQNBJQUKME-UHFFFAOYSA-N 0.000 description 1
- SOHDPICLICFSOP-UHFFFAOYSA-N 2-bromo-6-methylpyridine Chemical compound CC1=CC=CC(Br)=N1 SOHDPICLICFSOP-UHFFFAOYSA-N 0.000 description 1
- JOFOVYQPOOUQHX-UHFFFAOYSA-N 2-bromo-7-methoxynaphthalene Chemical compound C1=CC(Br)=CC2=CC(OC)=CC=C21 JOFOVYQPOOUQHX-UHFFFAOYSA-N 0.000 description 1
- KYGSXEYUWRFVNY-UHFFFAOYSA-N 2-pyran-2-ylidenepropanedinitrile Chemical class N#CC(C#N)=C1OC=CC=C1 KYGSXEYUWRFVNY-UHFFFAOYSA-N 0.000 description 1
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- SOSPMXMEOFGPIM-UHFFFAOYSA-N 3,5-dibromopyridine Chemical compound BrC1=CN=CC(Br)=C1 SOSPMXMEOFGPIM-UHFFFAOYSA-N 0.000 description 1
- ISJCHWPQBBYBRC-UHFFFAOYSA-N 3-(5-bromopyridin-2-yl)-2-methylpyridine Chemical compound BrC=1C=CC(=NC1)C=1C(=NC=CC1)C ISJCHWPQBBYBRC-UHFFFAOYSA-N 0.000 description 1
- HJELNLLGPHYCSO-UHFFFAOYSA-N 3-(5-bromopyridin-2-yl)-4-methylpyridine Chemical compound CC1=CC=NC=C1C1=CC=C(Br)C=N1 HJELNLLGPHYCSO-UHFFFAOYSA-N 0.000 description 1
- QISWUFFRVXNFAT-UHFFFAOYSA-N 3-[4-[10-(4-pyridin-3-ylnaphthalen-1-yl)anthracen-9-yl]naphthalen-1-yl]pyridine Chemical compound N1=CC(=CC=C1)C1=CC=C(C2=CC=CC=C12)C=1C2=CC=CC=C2C(=C2C=CC=CC12)C1=CC=C(C2=CC=CC=C12)C=1C=NC=CC1 QISWUFFRVXNFAT-UHFFFAOYSA-N 0.000 description 1
- GSQZOLXWFQQJHJ-UHFFFAOYSA-N 3-bromo-4-methylpyridine Chemical compound CC1=CC=NC=C1Br GSQZOLXWFQQJHJ-UHFFFAOYSA-N 0.000 description 1
- KFQQGJWQQRRHRB-UHFFFAOYSA-N 3-bromo-4-methylpyridine hydrochloride Chemical compound Cl.BrC=1C=NC=CC1C KFQQGJWQQRRHRB-UHFFFAOYSA-N 0.000 description 1
- NYPYPOZNGOXYSU-UHFFFAOYSA-N 3-bromopyridine Chemical compound BrC1=CC=CN=C1 NYPYPOZNGOXYSU-UHFFFAOYSA-N 0.000 description 1
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 description 1
- LCTYNEHIFPECNL-UHFFFAOYSA-N 4-(3-bromophenyl)pyridine Chemical compound BrC1=CC=CC(C=2C=CN=CC=2)=C1 LCTYNEHIFPECNL-UHFFFAOYSA-N 0.000 description 1
- UKYVKUTVSIQCBN-UHFFFAOYSA-N 4-(5-bromopyridin-2-yl)-3-methylpyridine Chemical compound BrC=1C=CC(=NC1)C1=C(C=NC=C1)C UKYVKUTVSIQCBN-UHFFFAOYSA-N 0.000 description 1
- GYUAOSJIGMDMNJ-UHFFFAOYSA-N 4-bromo-3-methylpyridine Chemical compound CC1=CN=CC=C1Br GYUAOSJIGMDMNJ-UHFFFAOYSA-N 0.000 description 1
- QJPJQTDYNZXKQF-UHFFFAOYSA-N 4-bromoanisole Chemical compound COC1=CC=C(Br)C=C1 QJPJQTDYNZXKQF-UHFFFAOYSA-N 0.000 description 1
- BSDGZUDFPKIYQG-UHFFFAOYSA-N 4-bromopyridine Chemical compound BrC1=CC=NC=C1 BSDGZUDFPKIYQG-UHFFFAOYSA-N 0.000 description 1
- MPZMVUQGXAOJIK-UHFFFAOYSA-N 4-bromopyridine;hydron;chloride Chemical compound Cl.BrC1=CC=NC=C1 MPZMVUQGXAOJIK-UHFFFAOYSA-N 0.000 description 1
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 description 1
- CNGYZEMWVAWWOB-VAWYXSNFSA-N 5-[[4-anilino-6-[bis(2-hydroxyethyl)amino]-1,3,5-triazin-2-yl]amino]-2-[(e)-2-[4-[[4-anilino-6-[bis(2-hydroxyethyl)amino]-1,3,5-triazin-2-yl]amino]-2-sulfophenyl]ethenyl]benzenesulfonic acid Chemical compound N=1C(NC=2C=C(C(\C=C\C=3C(=CC(NC=4N=C(N=C(NC=5C=CC=CC=5)N=4)N(CCO)CCO)=CC=3)S(O)(=O)=O)=CC=2)S(O)(=O)=O)=NC(N(CCO)CCO)=NC=1NC1=CC=CC=C1 CNGYZEMWVAWWOB-VAWYXSNFSA-N 0.000 description 1
- CFNMUZCFSDMZPQ-GHXNOFRVSA-N 7-[(z)-3-methyl-4-(4-methyl-5-oxo-2h-furan-2-yl)but-2-enoxy]chromen-2-one Chemical compound C=1C=C2C=CC(=O)OC2=CC=1OC/C=C(/C)CC1OC(=O)C(C)=C1 CFNMUZCFSDMZPQ-GHXNOFRVSA-N 0.000 description 1
- 150000004325 8-hydroxyquinolines Chemical class 0.000 description 1
- ORLPQINCOCFGFG-UHFFFAOYSA-N 9-(3-ethoxyphenyl)-10-naphthalen-2-ylanthracene Chemical compound C(C)OC=1C=C(C=CC=1)C=1C2=CC=CC=C2C(=C2C=CC=CC=12)C1=CC2=CC=CC=C2C=C1 ORLPQINCOCFGFG-UHFFFAOYSA-N 0.000 description 1
- BOBFSAJVTRDKMP-UHFFFAOYSA-N 9-(4-tert-butylphenyl)-9h-fluorene Chemical compound C1=CC(C(C)(C)C)=CC=C1C1C2=CC=CC=C2C2=CC=CC=C21 BOBFSAJVTRDKMP-UHFFFAOYSA-N 0.000 description 1
- CNRQPOCDGPMSBA-UHFFFAOYSA-N 9-(4-tert-butylphenyl)anthracene Chemical compound C1=CC(C(C)(C)C)=CC=C1C1=C(C=CC=C2)C2=CC2=CC=CC=C12 CNRQPOCDGPMSBA-UHFFFAOYSA-N 0.000 description 1
- RRFSDXVQFGASBQ-UHFFFAOYSA-N 9-phenyl-10-(4-phenylnaphthalen-1-yl)anthracene Chemical compound c1ccc(cc1)-c1ccc(-c2c3ccccc3c(-c3ccccc3)c3ccccc23)c2ccccc12 RRFSDXVQFGASBQ-UHFFFAOYSA-N 0.000 description 1
- 229910000838 Al alloy Inorganic materials 0.000 description 1
- KLZUFWVZNOTSEM-UHFFFAOYSA-K Aluminum fluoride Inorganic materials F[Al](F)F KLZUFWVZNOTSEM-UHFFFAOYSA-K 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- CPLCEXBGPDKYLH-UHFFFAOYSA-N C(CCC)N(CCCC)C[C-]1C(=CC=C1)P(C(C)(C)C)C(C)(C)C.[CH-]1C=CC=C1.[Fe+2] Chemical compound C(CCC)N(CCCC)C[C-]1C(=CC=C1)P(C(C)(C)C)C(C)(C)C.[CH-]1C=CC=C1.[Fe+2] CPLCEXBGPDKYLH-UHFFFAOYSA-N 0.000 description 1
- UXYHZIYEDDINQH-UHFFFAOYSA-N C1=CNC2=C3C=NN=C3C=CC2=C1 Chemical class C1=CNC2=C3C=NN=C3C=CC2=C1 UXYHZIYEDDINQH-UHFFFAOYSA-N 0.000 description 1
- PHQWACKLVCPLDM-UHFFFAOYSA-N CCCCC.[B] Chemical group CCCCC.[B] PHQWACKLVCPLDM-UHFFFAOYSA-N 0.000 description 1
- ZTBALIMGUQNCFO-UHFFFAOYSA-N COC[C-]1C(=CC=C1)P(C(C)(C)C)C(C)(C)C.[CH-]1C=CC=C1.[Fe+2] Chemical compound COC[C-]1C(=CC=C1)P(C(C)(C)C)C(C)(C)C.[CH-]1C=CC=C1.[Fe+2] ZTBALIMGUQNCFO-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- GYHNNYVSQQEPJS-UHFFFAOYSA-N Gallium Chemical compound [Ga] GYHNNYVSQQEPJS-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 239000005909 Kieselgur Substances 0.000 description 1
- 241000254158 Lampyridae Species 0.000 description 1
- 239000004594 Masterbatch (MB) Substances 0.000 description 1
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 1
- 229910000861 Mg alloy Inorganic materials 0.000 description 1
- 238000006411 Negishi coupling reaction Methods 0.000 description 1
- NRCMAYZCPIVABH-UHFFFAOYSA-N Quinacridone Chemical class N1C2=CC=CC=C2C(=O)C2=C1C=C1C(=O)C3=CC=CC=C3NC1=C2 NRCMAYZCPIVABH-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 229910006404 SnO 2 Inorganic materials 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 235000010724 Wisteria floribunda Nutrition 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 229910000272 alkali metal oxide Inorganic materials 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 150000004982 aromatic amines Chemical class 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- RQPZNWPYLFFXCP-UHFFFAOYSA-L barium dihydroxide Chemical compound [OH-].[OH-].[Ba+2] RQPZNWPYLFFXCP-UHFFFAOYSA-L 0.000 description 1
- 229910001863 barium hydroxide Inorganic materials 0.000 description 1
- WZJYKHNJTSNBHV-UHFFFAOYSA-N benzo[h]quinoline Chemical class C1=CN=C2C3=CC=CC=C3C=CC2=C1 WZJYKHNJTSNBHV-UHFFFAOYSA-N 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 125000000319 biphenyl-4-yl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 description 1
- ZADPBFCGQRWHPN-UHFFFAOYSA-N boronic acid Chemical compound OBO ZADPBFCGQRWHPN-UHFFFAOYSA-N 0.000 description 1
- 230000031709 bromination Effects 0.000 description 1
- 238000005893 bromination reaction Methods 0.000 description 1
- 150000004768 bromobenzenes Chemical class 0.000 description 1
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 1
- 229910000024 caesium carbonate Inorganic materials 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 125000000609 carbazolyl group Chemical class C1(=CC=CC=2C3=CC=CC=C3NC12)* 0.000 description 1
- 238000005266 casting Methods 0.000 description 1
- 239000010406 cathode material Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- LNAMMBFJMYMQTO-FNEBRGMMSA-N chloroform;(1e,4e)-1,5-diphenylpenta-1,4-dien-3-one;palladium Chemical compound [Pd].[Pd].ClC(Cl)Cl.C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1.C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1.C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1 LNAMMBFJMYMQTO-FNEBRGMMSA-N 0.000 description 1
- 229940125898 compound 5 Drugs 0.000 description 1
- 150000004775 coumarins Chemical class 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- NXQGGXCHGDYOHB-UHFFFAOYSA-L cyclopenta-1,4-dien-1-yl(diphenyl)phosphane;dichloropalladium;iron(2+) Chemical compound [Fe+2].Cl[Pd]Cl.[CH-]1C=CC(P(C=2C=CC=CC=2)C=2C=CC=CC=2)=C1.[CH-]1C=CC(P(C=2C=CC=CC=2)C=2C=CC=CC=2)=C1 NXQGGXCHGDYOHB-UHFFFAOYSA-L 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 230000017858 demethylation Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 125000004663 dialkyl amino group Chemical group 0.000 description 1
- 125000005266 diarylamine group Chemical group 0.000 description 1
- WDUDHEOUGWAKFD-UHFFFAOYSA-N ditert-butyl(cyclopenta-2,4-dien-1-yl)phosphane;iron(2+) Chemical compound [Fe+2].CC(C)(C)P(C(C)(C)C)C1=CC=C[CH-]1.CC(C)(C)P(C(C)(C)C)C1=CC=C[CH-]1 WDUDHEOUGWAKFD-UHFFFAOYSA-N 0.000 description 1
- NNNFHIWKVLLMKH-UHFFFAOYSA-N ditert-butyl-[1-(2-ditert-butylphosphanylnaphthalen-1-yl)naphthalen-2-yl]phosphane Chemical group C1=CC=C2C(C3=C4C=CC=CC4=CC=C3P(C(C)(C)C)C(C)(C)C)=C(P(C(C)(C)C)C(C)(C)C)C=CC2=C1 NNNFHIWKVLLMKH-UHFFFAOYSA-N 0.000 description 1
- MUPGNOONALUUNP-UHFFFAOYSA-N ditert-butyl-[1-(2-methoxynaphthalen-1-yl)naphthalen-2-yl]phosphane Chemical group C1=CC=C2C(C3=C4C=CC=CC4=CC=C3OC)=C(P(C(C)(C)C)C(C)(C)C)C=CC2=C1 MUPGNOONALUUNP-UHFFFAOYSA-N 0.000 description 1
- 230000005684 electric field Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 150000002220 fluorenes Chemical class 0.000 description 1
- 229910052733 gallium Inorganic materials 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 229940058961 hydroxyquinoline derivative for amoebiasis and other protozoal diseases Drugs 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 125000004857 imidazopyridinyl group Chemical class N1C(=NC2=C1C=CC=N2)* 0.000 description 1
- 229910052738 indium Inorganic materials 0.000 description 1
- APFVFJFRJDLVQX-UHFFFAOYSA-N indium atom Chemical compound [In] APFVFJFRJDLVQX-UHFFFAOYSA-N 0.000 description 1
- AMGQUBHHOARCQH-UHFFFAOYSA-N indium;oxotin Chemical compound [In].[Sn]=O AMGQUBHHOARCQH-UHFFFAOYSA-N 0.000 description 1
- 125000001041 indolyl group Chemical group 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000004491 isohexyl group Chemical group C(CCC(C)C)* 0.000 description 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- 238000004020 luminiscence type Methods 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- IZDROVVXIHRYMH-UHFFFAOYSA-N methanesulfonic anhydride Chemical compound CS(=O)(=O)OS(C)(=O)=O IZDROVVXIHRYMH-UHFFFAOYSA-N 0.000 description 1
- UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 229960005181 morphine Drugs 0.000 description 1
- MESMXXUBQDBBSR-UHFFFAOYSA-N n,9-diphenyl-n-[4-[4-(n-(9-phenylcarbazol-3-yl)anilino)phenyl]phenyl]carbazol-3-amine Chemical compound C1=CC=CC=C1N(C=1C=C2C3=CC=CC=C3N(C=3C=CC=CC=3)C2=CC=1)C1=CC=C(C=2C=CC(=CC=2)N(C=2C=CC=CC=2)C=2C=C3C4=CC=CC=C4N(C=4C=CC=CC=4)C3=CC=2)C=C1 MESMXXUBQDBBSR-UHFFFAOYSA-N 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 150000002790 naphthalenes Chemical class 0.000 description 1
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 150000004893 oxazines Chemical class 0.000 description 1
- 150000004880 oxines Chemical class 0.000 description 1
- 150000002941 palladium compounds Chemical class 0.000 description 1
- 150000002987 phenanthrenes Chemical class 0.000 description 1
- QARVLSVVCXYDNA-UHFFFAOYSA-N phenyl bromide Natural products BrC1=CC=CC=C1 QARVLSVVCXYDNA-UHFFFAOYSA-N 0.000 description 1
- IEQIEDJGQAUEQZ-UHFFFAOYSA-N phthalocyanine Chemical class N1C(N=C2C3=CC=CC=C3C(N=C3C4=CC=CC=C4C(=N4)N3)=N2)=C(C=CC=C2)C2=C1N=C1C2=CC=CC=C2C4=N1 IEQIEDJGQAUEQZ-UHFFFAOYSA-N 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000002985 plastic film Substances 0.000 description 1
- 238000007747 plating Methods 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229920003227 poly(N-vinyl carbazole) Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920000123 polythiophene Polymers 0.000 description 1
- 150000004033 porphyrin derivatives Chemical class 0.000 description 1
- 239000011698 potassium fluoride Substances 0.000 description 1
- 235000003270 potassium fluoride Nutrition 0.000 description 1
- ZLMJMSJWJFRBEC-OUBTZVSYSA-N potassium-40 Chemical compound [40K] ZLMJMSJWJFRBEC-OUBTZVSYSA-N 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 150000003216 pyrazines Chemical class 0.000 description 1
- 150000003217 pyrazoles Chemical class 0.000 description 1
- 150000003233 pyrroles Chemical class 0.000 description 1
- MCJGNVYPOGVAJF-UHFFFAOYSA-N quinolin-8-ol Chemical compound C1=CN=C2C(O)=CC=CC2=C1 MCJGNVYPOGVAJF-UHFFFAOYSA-N 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 229910052703 rhodium Inorganic materials 0.000 description 1
- 239000010948 rhodium Substances 0.000 description 1
- MHOVAHRLVXNVSD-UHFFFAOYSA-N rhodium atom Chemical compound [Rh] MHOVAHRLVXNVSD-UHFFFAOYSA-N 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 1
- SYXYWTXQFUUWLP-UHFFFAOYSA-N sodium;butan-1-olate Chemical compound [Na+].CCCC[O-] SYXYWTXQFUUWLP-UHFFFAOYSA-N 0.000 description 1
- VNFWTIYUKDMAOP-UHFFFAOYSA-N sphos Chemical compound COC1=CC=CC(OC)=C1C1=CC=CC=C1P(C1CCCCC1)C1CCCCC1 VNFWTIYUKDMAOP-UHFFFAOYSA-N 0.000 description 1
- 238000004528 spin coating Methods 0.000 description 1
- 125000003003 spiro group Chemical group 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- KSYNLCYTMRMCGG-UHFFFAOYSA-J tetrasodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate;dihydrate Chemical compound O.O.[Na+].[Na+].[Na+].[Na+].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O KSYNLCYTMRMCGG-UHFFFAOYSA-J 0.000 description 1
- 150000004882 thiopyrans Chemical class 0.000 description 1
- 238000002834 transmittance Methods 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 125000005259 triarylamine group Chemical group 0.000 description 1
- 150000003918 triazines Chemical class 0.000 description 1
- 150000003852 triazoles Chemical class 0.000 description 1
- 125000006617 triphenylamine group Chemical group 0.000 description 1
- 229910000404 tripotassium phosphate Inorganic materials 0.000 description 1
- 235000019798 tripotassium phosphate Nutrition 0.000 description 1
- BWHDROKFUHTORW-UHFFFAOYSA-N tritert-butylphosphane Chemical compound CC(C)(C)P(C(C)(C)C)C(C)(C)C BWHDROKFUHTORW-UHFFFAOYSA-N 0.000 description 1
- 125000001834 xanthenyl group Chemical class C1=CC=CC=2OC3=CC=CC=C3C(C12)* 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
- 235000005074 zinc chloride Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
- C07D213/16—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
- C07D213/22—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing two or more pyridine rings directly linked together, e.g. bipyridyl
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K50/00—Organic light-emitting devices
- H10K50/10—OLEDs or polymer light-emitting diodes [PLED]
- H10K50/11—OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K50/00—Organic light-emitting devices
- H10K50/10—OLEDs or polymer light-emitting diodes [PLED]
- H10K50/14—Carrier transporting layers
- H10K50/16—Electron transporting layers
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K50/00—Organic light-emitting devices
- H10K50/10—OLEDs or polymer light-emitting diodes [PLED]
- H10K50/17—Carrier injection layers
- H10K50/171—Electron injection layers
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
- H10K85/60—Organic compounds having low molecular weight
- H10K85/615—Polycyclic condensed aromatic hydrocarbons, e.g. anthracene
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
- H10K85/60—Organic compounds having low molecular weight
- H10K85/615—Polycyclic condensed aromatic hydrocarbons, e.g. anthracene
- H10K85/626—Polycyclic condensed aromatic hydrocarbons, e.g. anthracene containing more than one polycyclic condensed aromatic rings, e.g. bis-anthracene
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
- H10K85/60—Organic compounds having low molecular weight
- H10K85/649—Aromatic compounds comprising a hetero atom
- H10K85/654—Aromatic compounds comprising a hetero atom comprising only nitrogen as heteroatom
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K2102/00—Constructional details relating to the organic devices covered by this subclass
- H10K2102/10—Transparent electrodes, e.g. using graphene
- H10K2102/101—Transparent electrodes, e.g. using graphene comprising transparent conductive oxides [TCO]
- H10K2102/103—Transparent electrodes, e.g. using graphene comprising transparent conductive oxides [TCO] comprising indium oxides, e.g. ITO
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Physics & Mathematics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Optics & Photonics (AREA)
- Electroluminescent Light Sources (AREA)
- Pyridine Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Description
本發明是有關於一種具有吡啶基的新穎電子傳輸材料、使用該電子傳輸材料的有機電激發光元件(以下,有時簡稱為有機EL元件,或僅簡稱為元件)等。 The present invention relates to a novel electron transporting material having a pyridyl group, an organic electroluminescent device using the electron transporting material (hereinafter sometimes simply referred to as an organic EL device, or simply an element).
近年來,有機EL元件作為次世代的全彩平板顯示器(full color flat panel display)而備受矚目,目前業界正活躍地對其進行研究。為了促進有機EL元件的實用化,元件驅動電壓的降低、壽命延長是不可或缺的要素,為了實現這些要素,業界一直在開發新的電子傳輸材料。尤其必須實現藍色元件的驅動電壓降低、壽命延長。專利文獻1(日本專利特開2003-123983號公報)中記載有如下情況:藉由將作為啡啉(phenanthroline)衍生物或其類似物的2,2'-聯吡啶化合物用於電子傳輸材料,能以低電壓驅動有機EL元件。然而,該文獻的實例所報告的元件特性(驅動電壓、發光效率等)僅為以比較例為基準的相對值,並未記載可判斷為實用值的實測值。此外,將2,2'-聯吡啶化合物用於電子傳輸材料的例子在非專利文獻1(Proceedings of the 10th International Workshop on Inorganic and Organic Electroluminescence,第十屆無機及有機電激發光國際研討會文集)、專利文獻2(日本專利特開2002-158093號公報)及專利文獻3(國際公開2007/86552手冊)中有揭示。非專利文獻1中記載的化合 物之Tg低,並不實用。專利文獻2及專利文獻3中記載的化合物雖然能以相對低電壓來驅動有機EL元件,但實際應用時仍期待能進一步使壽命延長。 In recent years, organic EL elements have attracted attention as next-generation full color flat panel displays, and the industry is actively studying them. In order to promote the practical use of organic EL devices, reduction in device driving voltage and life extension are indispensable factors, and in order to realize these factors, the industry has been developing new electron transport materials. In particular, it is necessary to reduce the driving voltage of the blue element and extend the life. In the case of using a 2,2'-bipyridine compound as a phenanthroline derivative or an analog thereof, an electron transporting material is described in Patent Document 1 (Japanese Laid-Open Patent Publication No. 2003-123983). The organic EL element can be driven at a low voltage. However, the element characteristics (driving voltage, luminous efficiency, and the like) reported by the examples of this document are only relative values based on the comparative example, and the actual measured values which can be judged to be practical values are not described. Further, the compounds 2,2'-bipyridine Examples of electron transport materials for Non-Patent Document 1 (Proceedings of the 10 th International Workshop on Inorganic and Organic Electroluminescence, tenth inorganic and organic electroluminescent light Proceedings International Symposium It is disclosed in Patent Document 2 (Japanese Patent Laid-Open Publication No. 2002-158093) and Patent Document 3 (International Publication No. 2007/86552). The compound described in Non-Patent Document 1 has a low Tg and is not practical. Although the compound described in Patent Document 2 and Patent Document 3 can drive the organic EL element at a relatively low voltage, it is expected to further extend the life in practical use.
[專利文獻1]日本專利特開2003-123983號公報 [Patent Document 1] Japanese Patent Laid-Open Publication No. 2003-123983
[專利文獻2]日本專利特開2002-158093號公報 [Patent Document 2] Japanese Patent Laid-Open Publication No. 2002-158093
[專利文獻3]國際公開2007/86552手冊 [Patent Document 3] International Publication 2007/86552 Manual
[非專利文獻1]Proceedings of the 10th International Workshop on Inorganic and Organic Electroluminescence (2000)(第十屆無機及有機電激發光國際研討會文集(2000)) [Patent Document 1] Proceedings of the 10 th International Workshop on Inorganic and Organic Electroluminescence (2000) ( the tenth inorganic and organic light International Symposium (2000))
本發明是鑒於此種先前技術所存在的課題研究而成。本發明的課題在於提供一種有助於有機EL元件的壽命延長等的電子傳輸材料。此外,本發明的課題在於提供一種使用該電子傳輸材料的有機EL元件。 The present invention has been made in view of the problems of the prior art. An object of the present invention is to provide an electron transporting material which contributes to prolonging the life of an organic EL device. Further, an object of the present invention is to provide an organic EL device using the electron transport material.
本發明者等人經過努力研究,結果發現:藉由將如下化合物用於有機EL元件的電子傳輸層,可獲得能以長壽命驅動的有機EL元件,該化合物是在9-(2-萘基)-10-苯基蒽的萘基或苯基中的任一個上具有吡啶基、聯吡啶基、或吡啶基苯基,且苯環、萘環及吡啶環上的至少一個氫被取代為碳數為1~6的烷基或碳數為3~6的環烷基的化合 物,基於該發現而完成本發明。 As a result of intensive studies, the present inventors have found that an organic EL device capable of driving with a long lifetime can be obtained by using the following compound for an electron transport layer of an organic EL device, which is 9-(2-naphthyl). Any one of a naphthyl group or a phenyl group of -10-phenylindole having a pyridyl group, a bipyridyl group, or a pyridylphenyl group, and at least one hydrogen on the benzene ring, the naphthalene ring, and the pyridine ring is substituted with carbon a combination of an alkyl group having 1 to 6 carbon atoms or a cycloalkyl group having 3 to 6 carbon atoms The present invention was completed based on this finding.
上述的課題是藉由以下所示的各項而解決。 The above problems are solved by the items shown below.
[1]一種化合物,其以下述式(1)表示,
式(1)中,Py獨立為式(2)、(3)或(4)所表示的基;
m及n為0或1,m+n=1;並且,式(1)中的苯環、萘環及吡啶環上的至少一個氫被取代為碳數為1~6的烷基或碳數為3~6的環烷基。 m and n are 0 or 1, m+n=1; and at least one hydrogen on the benzene ring, the naphthalene ring and the pyridine ring in the formula (1) is substituted with an alkyl group having 1 to 6 carbon atoms or a carbon number It is a 3 to 6 cycloalkyl group.
[2]如上述[1]項所述之化合物,其以下述式(1-1)或(1-2)表示,
式(1-1)及(1-2)中,Py為式(2)、(3)或(4)所表示的基;
並且,式(1-1)及(1-2)中的苯環、萘環及吡啶環上的至少一個氫被取代為碳數為1~6的烷基或碳數為3~6的環烷基。 Further, at least one hydrogen on the benzene ring, the naphthalene ring and the pyridine ring in the formulae (1-1) and (1-2) is substituted with an alkyl group having 1 to 6 carbon atoms or a ring having 3 to 6 carbon atoms. alkyl.
[3]如上述[1]項所述之化合物,其以下述式(1-3)、(1-4)、(1-5)、或(1-6)表示,
式(1-3)~(1-6)中,Py為式(2)、(3)或(4)所表示的基;
並且,式(1-3)~(1-6)中的苯環、萘環及吡啶環上的至少一個氫被取代為碳數為1~6的烷基或碳數為3~6的環烷基。 Further, at least one hydrogen on the benzene ring, the naphthalene ring and the pyridine ring in the formulae (1-3) to (1-6) is substituted with an alkyl group having 1 to 6 carbon atoms or a ring having 3 to 6 carbon atoms. alkyl.
[4]如上述[1]所述之化合物,其以下述式(1-7)或(1-8)表示,
式(1-7)及(1-8)中,Py為式(2)、(3)或(4)所表示的基;
R為碳數為1~6的烷基或碳數為3~6的環烷基;並且,p為1~5的整數。 R is an alkyl group having 1 to 6 carbon atoms or a cycloalkyl group having 3 to 6 carbon atoms; and p is an integer of 1 to 5.
[5]如上述[1]項所述之化合物,其以下述式(1-9)或(1-10)表示,
式(1-9)及(1-10)中,Py為式(2)、(3)或(4)所表示的基;
R為碳數為1~6的烷基或碳數為3~6的環烷基;並且,q為1~5的整數。 R is an alkyl group having 1 to 6 carbon atoms or a cycloalkyl group having 3 to 6 carbon atoms; and q is an integer of 1 to 5.
[6]如上述[1]項所述之化合物,其以下述式(1-11)或(1-12)表示,
式(1-11)及(1-12)中,Py1為式(2')、(3')或(4')所表示的基;
式(2')、(3')及(4')中,R為碳數為1~6的烷基或 碳數為3~6的環烷基;並且,s為1~4的整數。 In the formulae (2'), (3') and (4'), R is an alkyl group having 1 to 6 carbon atoms or The cycloalkyl group having a carbon number of 3 to 6; and s is an integer of 1 to 4.
[7]如上述[1]項所述之化合物,其以下述式(1-13)或(1-14)表示,
式(1-13)及(1-14)中,Py1為式(2')、(3')或(4')所表示的基;
式(2')、(3')或(4')中,R為碳數為1~6的烷基或碳數為3~6的環烷基;並且,s為1~4的整數。 In the formula (2'), (3') or (4'), R is an alkyl group having 1 to 6 carbon atoms or a cycloalkyl group having 3 to 6 carbon atoms; and s is an integer of 1 to 4.
[8]如上述[1]項所述之化合物,其以下述式(1-15)或(1-16)表示,
式(1-15)及(1-16)中,Py為式(2)、(3)或(4)所表示的基;
R為碳數為1~6的烷基或碳數為3~6的環烷基;並且,t為1~4的整數。 R is an alkyl group having 1 to 6 carbon atoms or a cycloalkyl group having 3 to 6 carbon atoms; and t is an integer of 1 to 4.
[9]如上述[1]項所述之化合物,其以下述式(1-7-26)表示
[10]如上述[1]項所述之化合物,其以下述式(1-7-74)表示
[11]如上述[1]項所述之化合物,其以下述式(1-7-98)表示
[12]如上述[1]項所述之化合物,其以下述式(1-7-96)表示
[13]如上述[1]項所述之化合物,其以下述式(1-14-14)表示
[14]如上述[1]項所述之化合物,其以下述式(1-11-1)、(1-11-2)、(1-11-3)、(1-11-4)、(1-11-5)、(1-11-6)、(1-11-8)、(1-11-18)、(1-11-39)、(1-14-2)、
(1-14-3)、(1-14-11)、(1-14-12)、(1-14-13)、(1-14-15)、(1-14-16)、(1-14-17)、(1-14-18)、及(1-14-20)中的任一個表示
[15]一種電子傳輸材料,其含有如上述[1]至[14]中任 一項所述之化合物。 [15] An electron transporting material comprising any of the above [1] to [14] a compound as described.
[16]一種有機電激發光元件,其包括:包含陽極及陰極的一對電極、配置在該一對電極之間的發光層、及配置在上述陰極與該發光層之間且含有如上述[15]項所述之電子傳輸材料的電子傳輸層及/或電子注入層。 [16] An organic electroluminescence device comprising: a pair of electrodes including an anode and a cathode; a light-emitting layer disposed between the pair of electrodes; and disposed between the cathode and the light-emitting layer and containing the above The electron transport layer and/or the electron injection layer of the electron transport material of item 15].
[17]如上述[16]項所述之有機電激發光元件,其中上述電子傳輸層及電子注入層中的至少一層更包括選自由羥基喹啉系金屬錯合物、聯吡啶衍生物、啡啉衍生物及硼烷衍生物所組成的群中的至少一種。 [17] The organic electroluminescent device according to the above [16], wherein at least one of the electron transport layer and the electron injecting layer further comprises a hydroxyquinoline-based metal complex, a bipyridine derivative, and a morphine. At least one of a group consisting of a morphine derivative and a borane derivative.
[18]如上述[16]或[17]項所述之有機電激發光元件,其中電子傳輸層及電子注入層中的至少一層更包括選自由鹼金屬、鹼土金屬、稀土金屬、鹼金屬的氧化物、鹼金屬的鹵化物、鹼土金屬的氧化物、鹼土金屬的鹵化物、稀土金屬的氧化物、稀土金屬的鹵化物、鹼金屬的有機錯合物、鹼土金屬的有機錯合物及稀土金屬的有機錯合物所組成的群中的至少一種。 [18] The organic electroluminescent device of the above-mentioned [16] or [17], wherein at least one of the electron transport layer and the electron injecting layer further comprises an alkali metal, an alkaline earth metal, a rare earth metal, an alkali metal Oxides, alkali metal halides, alkaline earth metal oxides, alkaline earth metal halides, rare earth metal oxides, rare earth metal halides, alkali metal organic complexes, alkaline earth metal organic complexes, and rare earths At least one of the group consisting of organic complexes of metals.
本發明的化合物即使在薄膜狀態下施加電壓亦穩定,另外,具有電荷的傳輸能力高的特徵。本發明的化合物適合用作有機EL元件中的電荷傳輸材料。藉由將本發明的化合物用於有機EL元件的電子傳輸層及/或電子注入層,可獲得具有長壽命的有機EL元件。藉由使用本發明的有機EL元件,可製作全彩顯示等的高性能顯示器裝置。 The compound of the present invention is stable even when a voltage is applied in a thin film state, and has a feature that the charge transporting ability is high. The compound of the present invention is suitably used as a charge transport material in an organic EL element. By using the compound of the present invention in an electron transport layer and/or an electron injection layer of an organic EL device, an organic EL device having a long life can be obtained. By using the organic EL element of the present invention, a high-performance display device such as a full-color display can be produced.
以下,更詳細地說明本發明。此外,在本說明書中,例如有時將「式(1-7-26)所表示的化合物」稱為「化合物(1-7-26)」。有時將「式(1-7-74)所表示的化合物」稱為「化合物(1-7-74)」。其他式的符號、式的編號亦相同。 Hereinafter, the present invention will be described in more detail. In the present specification, for example, "the compound represented by the formula (1-7-26)" may be referred to as "compound (1-7-26)". The compound represented by the formula (1-7-74) is sometimes referred to as "compound (1-7-74)". The symbols and formulas of other formulas are also the same.
本案的第1發明是一種下述式(1)所表示的具有吡啶基、聯吡啶基或吡啶基苯基的化合物。 The first invention of the present invention is a compound having a pyridyl group, a bipyridyl group or a pyridylphenyl group represented by the following formula (1).
式(1)中,Py獨立為式(2)、(3)或(4)所表示的基,m及n為0或1,m+n=1。並且,式(1)中的苯環、萘環及吡啶環上的至少一個氫被取代為碳數為1~6的烷基或碳數為3~6的環烷基是本化合物的特徵。 In the formula (1), Py is independently a group represented by the formula (2), (3) or (4), and m and n are 0 or 1, and m + n = 1. Further, the substitution of at least one hydrogen on the benzene ring, the naphthalene ring and the pyridine ring in the formula (1) to an alkyl group having 1 to 6 carbon atoms or a cycloalkyl group having 3 to 6 carbon atoms is a feature of the present compound.
式(2)所表示的吡啶基具體為2-吡啶基、3-吡啶基或4-吡啶基。 The pyridyl group represented by the formula (2) is specifically 2-pyridyl, 3-pyridyl or 4-pyridyl.
式(3)所表示的聯吡啶基具體為2,2'-聯吡啶-5-基、2,2'-聯吡啶-6-基、2,2'-聯吡啶-4-基、2,3'-聯吡啶-5-基、2,3'-聯吡啶-6-基、2,3'-聯吡啶-4-基、2,4'-聯吡啶-5-基、2,4'-聯 吡啶-6-基、2,4'-聯吡啶-4-基、3,2'-聯吡啶-6-基、3,2'-聯吡啶-5-基、3,3'-聯吡啶-6-基、3,3'-聯吡啶-5-基、3,4'-聯吡啶-6-基、3,4'-聯吡啶-5-基、4,2'-聯吡啶-3-基、4,3'-聯吡啶-3-基、或4,4'-聯吡啶-3-基。 The bipyridyl group represented by the formula (3) is specifically 2,2'-bipyridin-5-yl, 2,2'-bipyridyl-6-yl, 2,2'-bipyridin-4-yl, 2, 3'-bipyridyl-5-yl, 2,3'-bipyridyl-6-yl, 2,3'-bipyridin-4-yl, 2,4'-bipyridyl-5-yl, 2,4' -Link Pyridine-6-yl, 2,4'-bipyridin-4-yl, 3,2'-bipyridyl-6-yl, 3,2'-bipyridin-5-yl, 3,3'-bipyridine- 6-yl, 3,3'-bipyridyl-5-yl, 3,4'-bipyridyl-6-yl, 3,4'-bipyridin-5-yl, 4,2'-bipyridine-3- Base, 4,3'-bipyridin-3-yl, or 4,4'-bipyridin-3-yl.
式(4)所表示的吡啶基苯基具體為4-(2-吡啶基)苯基、4-(3-吡啶基)苯基、4-(4-吡啶基)苯基、3-(2-吡啶基)苯基、3-(3-吡啶基)苯基、3-(4-吡啶基)苯基、2-(2-吡啶基)苯基、2-(3-吡啶基)苯基、或2-(4-吡啶基)苯基。 The pyridylphenyl group represented by the formula (4) is specifically 4-(2-pyridyl)phenyl, 4-(3-pyridyl)phenyl, 4-(4-pyridyl)phenyl, 3-(2 -pyridyl)phenyl, 3-(3-pyridyl)phenyl, 3-(4-pyridyl)phenyl, 2-(2-pyridyl)phenyl, 2-(3-pyridyl)phenyl Or 2-(4-pyridyl)phenyl.
式(1)中,Py所連結的位置在苯基、2-萘基上均可為任意位置,在苯基上較佳為4位及3位,在2-萘基上較佳為6位及7位。就不擴大共軛體系方面、及不降低LUMO(lowest unoccupied molecular orbital,最低未佔用分子軌域)的能階方面而言,尤佳為苯基的3位。另外,就原料容易獲得方面而言,尤佳為2-萘基的6位。 In the formula (1), the position at which Py is bonded may be any position on the phenyl group or the 2-naphthyl group, preferably 4 positions and 3 positions on the phenyl group, and preferably 6 positions on the 2-naphthyl group. And 7 digits. In terms of not expanding the conjugated system and not lowering the energy level of LUMO (lowest unoccupied molecular orbital), it is particularly preferable to be the 3-position of the phenyl group. Further, in terms of easy availability of the raw material, it is particularly preferably a 6-position of 2-naphthyl group.
式(1)中的苯環、萘環、及吡啶環上所取代的碳數為1~6的烷基的例子為:甲基、乙基、正丙基、異丙基、正丁基、異丁基、第三丁基、正戊基、異戊基、2,2-二甲基丙基、正己基、及異己基。其中較佳的烷基為甲基、乙基、異丙基、及第三丁基,更佳為甲基及第三丁基。碳數為3~6的環烷基的例子為環丙基、環丁基、環戊基、環己基。其中,若考慮到原料的獲得、合成的容易程度,則較佳的環烷基為環己基。 Examples of the alkyl group having 1 to 6 carbon atoms substituted in the benzene ring, the naphthalene ring, and the pyridine ring in the formula (1) are methyl group, ethyl group, n-propyl group, isopropyl group, n-butyl group, and the like. Isobutyl, tert-butyl, n-pentyl, isopentyl, 2,2-dimethylpropyl, n-hexyl, and isohexyl. Among the preferred alkyl groups are methyl, ethyl, isopropyl, and tert-butyl, more preferably methyl and tert-butyl. Examples of the cycloalkyl group having 3 to 6 carbon atoms are a cyclopropyl group, a cyclobutyl group, a cyclopentyl group, and a cyclohexyl group. Among them, a preferred cycloalkyl group is a cyclohexyl group in consideration of availability of a raw material and ease of synthesis.
式(1)所表示的化合物具體為下述式(1-1)或(1-2)所表示的化合物。 The compound represented by the formula (1) is specifically a compound represented by the following formula (1-1) or (1-2).
式(1-1)及(1-2)中的Py的定義與上述相同。 The definitions of Py in the formulae (1-1) and (1-2) are the same as described above.
式(1)所表示的化合物更具體而言為下述式(1-3)~(1-6)中的任一個所表示的化合物。 More specifically, the compound represented by the formula (1) is a compound represented by any one of the following formulas (1-3) to (1-6).
式(1-3)~(1-6)中的Py的定義與上述相同。 The definition of Py in the formulae (1-3) to (1-6) is the same as described above.
式(1)所表示的化合物更具體為下述式(1-7)~(1-10)中的任一個所表示的化合物。 The compound represented by the formula (1) is more specifically a compound represented by any one of the following formulas (1-7) to (1-10).
式(1-7)~(1-10)中的Py及R的定義與上述相同。式(1-7)及(1-8)中的p為1~5的整數,較佳為1~2的整數,更佳為1。R所取代的苯基的位置並無限制,較佳為3位或4位。式(1-9)及(1-10)中的q為1~5的整數,較佳為1~2的整數,更佳為1。R所取代的萘基的位置並無限制,較佳為6位或7位。 The definitions of Py and R in the formulae (1-7) to (1-10) are the same as described above. p in the formulae (1-7) and (1-8) is an integer of 1 to 5, preferably an integer of 1 to 2, more preferably 1. The position of the phenyl group substituted by R is not limited, and is preferably 3 or 4 positions. q in the formulae (1-9) and (1-10) is an integer of 1 to 5, preferably an integer of 1 to 2, more preferably 1. The position of the naphthyl group substituted by R is not limited, and is preferably 6 or 7 positions.
另外,式(1)所表示的化合物更具體為下述式(1-11)~(1-14)中的任一個所表示的化合物。 In addition, the compound represented by the formula (1) is more specifically a compound represented by any one of the following formulas (1-11) to (1-14).
式(1-11)~(1-14)中的Py1的定義與上述相同。上述式(2')、(3')或(4')中的R的定義與上述相同。s為1~4的整數,較佳為1或2,更佳為1。R所取代的吡啶基的位置並無特別限制。 The definition of Py 1 in the formulae (1-11) to (1-14) is the same as described above. The definition of R in the above formula (2'), (3') or (4') is the same as described above. s is an integer of 1 to 4, preferably 1 or 2, more preferably 1. The position of the pyridyl group substituted by R is not particularly limited.
另外,式(1)所表示的化合物更具體為下述式(1-15)或(1-16)所表示的化合物。 Further, the compound represented by the formula (1) is more specifically a compound represented by the following formula (1-15) or (1-16).
式(1-15)及(1-16)中的Py及R的定義與上述相同。t為1~4的整數,較佳為1或2,更佳為1。R所取代的伸苯基的位置並無限制,若考慮到合成的容易程度,則在為1,4-伸苯基的情況下以與蒽連結的碳為基準較佳為3位。在為1,3-伸苯基的情況下以與蒽連結的碳為基準較佳為4位。 The definitions of Py and R in the formulae (1-15) and (1-16) are the same as described above. t is an integer of 1 to 4, preferably 1 or 2, more preferably 1. The position of the phenyl group substituted by R is not limited, and in view of the ease of synthesis, in the case of a 1,4-phenylene group, the position is preferably 3 positions based on the carbon bonded to ruthenium. In the case of a 1,3-phenylene group, it is preferably 4 positions based on the carbon bonded to the hydrazine.
具體而言,如上述式(1)所表示的化合物大致分為式(1-7)~(1-16)所表示的化合物。該等中,較佳的結構為式(1-7)、式(1-9)~(1-11)及式(1-13)~(1-16),更佳的結構為式(1-7)。 Specifically, the compound represented by the above formula (1) is roughly classified into the compounds represented by the formulae (1-7) to (1-16). Among these, the preferred structures are the formula (1-7), the formula (1-9) to (1-11), and the formula (1-13) to (1-16), and the more preferable structure is the formula (1). -7).
本發明的化合物的具體例可揭示為以下所列舉的式,但本發明並不限定於這些具體結構的揭示。 Specific examples of the compound of the present invention can be disclosed as the following formulas, but the present invention is not limited to the disclosure of these specific structures.
式(1-7)所表示的化合物的具體例如下述式(1-7-1)~(1-7-144)所示。該等中,較佳的化合物為式(1-7-1)~(1-7-6)、式(1-7-10)~(1-7-12)、式(1-7-16)~(1-7-30)、式(1-7-34)~(1-7-36)、式(1-7-40)~(1-7-48)、式(1-7-73)~(1-7-78)、式(1-7-82)~(1-7-84)、式(1-7-88)~(1-7-102)、式(1-7-106)~(1-7-108)及式(1-7-112)~(1-7-120)。 Specific examples of the compound represented by the formula (1-7) are shown by the following formulas (1-7-1) to (1-7-144). Among these, preferred compounds are of the formula (1-7-1) to (1-7-6), the formula (1-7-10) to (1-7-12), and the formula (1-7-16). )~(1-7-30), formula (1-7-34)~(1-7-36), formula (1-7-40)~(1-7-48), formula (1-7- 73)~(1-7-78), formula (1-7-82)~(1-7-84), formula (1-7-88)~(1-7-102), formula (1-7 -106)~(1-7-108) and formula (1-7-112)~(1-7-120).
式(1-8)所表示的化合物的具體例如下述式(1-8-1)~(1-8-105)所示。 Specific examples of the compound represented by the formula (1-8) are shown by the following formulas (1-8-1) to (1-8-105).
式(1-9)所表示的化合物的具體例如下述式(1-9-1)~(1-9-48)所示。該等中,較佳的化合物為式(1-9-10)~(1-9-12)、(1-9-16)~(1-9-18)、式(1-9-34)~(1-9-36)及式(1-9-40)~(1-9-42)。 Specific examples of the compound represented by the formula (1-9) are shown by the following formulas (1-9-1) to (1-9-48). Among these, preferred compounds are of formula (1-9-10)~(1-9-12), (1-9-16)~(1-9-18), formula (1-9-34) ~(1-9-36) and formula (1-9-40)~(1-9-42).
式(1-10)所表示的化合物的具體例如下述式(1-10-1)~(1-10-48)所示。該等中,較佳的化合物為式(1-10-1)~(1-10-6)、(1-10-10)~(1-10-12)及(1-10-16)~(1-10-21)。 Specific examples of the compound represented by the formula (1-10) are shown by the following formulas (1-10-1) to (1-10-48). Among these, preferred compounds are of formula (1-10-1) to (1-10-6), (1-10-10) to (1-10-12) and (1-10-16)~ (1-10-21).
式(1-11)所表示的化合物的具體例如下述式(1-11-1)~(1-11-60)所示。該等中,較佳的化合物為式(1-11-3)~(1-11-10)、(1-11-25)~(1-11-28)及(1-11-51)~(1-11-60)。 Specific examples of the compound represented by the formula (1-11) are shown by the following formulas (1-11-1) to (1-11-60). Among these, preferred compounds are of the formulae (1-11-3) to (1-11-10), (1-11-25) to (1-11-28) and (1-11-51)~ (1-11-60).
式(1-12)所表示的化合物的具體例如下述式(1-12-1)~(1-12-60)所示。 Specific examples of the compound represented by the formula (1-12) are shown by the following formulas (1-12-1) to (1-12-60).
式(1-13)所表示的化合物的具體例如下述式(1-13-1)~(1-13-60)所示。該等中,較佳的化合物為式(1-13-21)~(1-13-28)及式(1-13-31)~(1-31-40)。 Specific examples of the compound represented by the formula (1-13) are shown by the following formulas (1-13-1) to (1-13-60). Among these, preferred compounds are the formulae (1-13-21) to (1-13-28) and the formula (1-13-31) to (1-31-40).
式(1-14)所表示的化合物的具體例如下述式(1-14-1)~(1-14-60)所示。該等中,較佳的化合物為式(1-14-1)~(1-14-18)。 Specific examples of the compound represented by the formula (1-14) are shown by the following formulas (1-14-1) to (1-14-60). Among these, preferred compounds are the formulae (1-14-1) to (1-14-18).
式(1-15)所表示的化合物的具體例如下述式(1-15-1)~(1-15-48)所示。該等中,較佳的化合物為式(1-15-10)~(1-15-12)、(1-15-16)~(1-15-18)、式(1-15-34)~(1-15-36)及(1-15-40)~(1-15-42)。 Specific examples of the compound represented by the formula (1-15) are shown by the following formulas (1-15-1) to (1-15-48). Among these, preferred compounds are of formula (1-15-10)~(1-15-12), (1-15-16)~(1-15-18), formula (1-15-34) ~(1-15-36) and (1-15-40)~(1-15-42).
式(1-16)所表示的化合物的具體例如下述式(1-16-1)~(1-16-24)所示。該等中,較佳的化合物為式(1-16-1)~(1-16-5)。 Specific examples of the compound represented by the formula (1-16) are shown by the following formulas (1-16-1) to (1-16-24). Among these, preferred compounds are the formulae (1-16-1) to (1-16-5).
以下,對本發明的化合物的合成方法進行說明。本發明的化合物可藉由適宜組合利用通用的已知合成方法而合成。 Hereinafter, a method for synthesizing the compound of the present invention will be described. The compounds of the present invention can be synthesized by a suitable combination using a general known synthetic method.
首先,藉由反應1合成苯基經烷基(環烷基)取代的9-苯基蒽。使經烷基取代的溴苯在THF中與金屬鎂反應,製成格林納試劑(Grignard reagent),在觸媒的存在下使其與9-溴蒽反應,製成苯基經烷基(環烷基)取代的9-苯基蒽。將苯環與蒽環偶合並不限定於上述方法,例如可採用使用鋅錯合物的根岸偶合反應、使用硼酸或硼酸酯的鈴木偶合反應等,可根據狀況而適宜使用該等常規方法。 First, 9-phenylindole substituted by an alkyl group (cycloalkyl group) is synthesized by the reaction 1. The alkyl-substituted bromobenzene is reacted with magnesium metal in THF to form a Grignard reagent, which is reacted with 9-bromoindole in the presence of a catalyst to form a phenyl group via an alkyl group (ring). Alkyl) substituted 9-phenylindole. The combination of the benzene ring and the anthracene ring is not limited to the above method, and for example, a root-shore coupling reaction using a zinc complex or a Suzuki coupling reaction using boric acid or a boric acid ester may be employed, and these conventional methods may be suitably used depending on the situation.
反應2是使用N-溴琥珀醯亞胺而將苯基經烷基(環烷基)取代的9-苯基蒽的10位溴化。此處,亦可使用N-溴琥珀醯亞胺以外的常用溴化劑。 Reaction 2 is the bromination of the 10-position of 9-phenylindole substituted with an alkyl group (cycloalkyl group) using N-bromosuccinimide. Here, a conventional brominating agent other than N-bromosuccinimide may also be used.
反應3是將蒽環與萘環偶合。首先依據常規方法將2-溴-6-甲氧基萘製成格林納試劑,在觸媒的存在下使其與反應2所合成的9-溴蒽衍生物反應,合成9-(6-甲氧基萘-2-基)-10-苯基蒽衍生物。與反應1同樣地,將苯環與蒽環偶合並不限定於上述方法,例如可採用使用鋅錯合物的根岸偶合反應、使用硼酸或硼酸酯的鈴木偶合反應等,可根據狀況而適宜使用該等常規方法。 Reaction 3 is the coupling of an anthracene ring to a naphthalene ring. First, 2-bromo-6-methoxynaphthalene is prepared into a Grignard reagent according to a conventional method, and reacted with a 9-bromoindole derivative synthesized in the reaction 2 in the presence of a catalyst to synthesize 9-(6-A). Oxynaphthalen-2-yl)-10-phenylindole derivatives. In the same manner as in the reaction 1, the benzene ring and the anthracene ring are not limited to the above method, and for example, a root-shore coupling reaction using a zinc complex or a Suzuki coupling reaction using boric acid or a boric acid ester may be employed, and may be suitably used depending on the situation. Use these conventional methods.
反應4是將9-(6-甲氧基萘-2-基)-10-苯基蒽衍生物的甲氧基脫甲基而形成萘酚。此處,亦可適宜使用脫甲基化反應常用的試劑。 Reaction 4 is a demethylation of a methoxy group of a 9-(6-methoxynaphthalen-2-yl)-10-phenylindole derivative to form a naphthol. Here, a reagent which is commonly used for the demethylation reaction can also be suitably used.
反應5是將萘酚的-OH轉化為三氟甲磺酸酯(triflate)。反應式中的-OTf為-OSO2CF3的簡稱。 Reaction 5 is the conversion of the -OH of naphthol to triflate. -OTf in the reaction formula is an abbreviation for -OSO 2 CF 3 .
反應6是藉由根岸偶合(Negishi coupling)反應使吡啶 環與萘環結合。首先,將4-溴吡啶製成格林納試劑。此處,由於是使用對原料穩定的4-溴吡啶鹽酸鹽,故而使用2倍莫耳的異丙基氯化鎂,但對於不必使用鹽酸鹽的原料,則為等莫耳亦無妨。向格林納試劑中添加氯化鋅四甲基乙二胺錯合物,合成吡啶的氯化鋅錯合物,在鈀觸媒的存在下使其與反應5所獲得的三氟甲磺酸酯反應,而合成目標物。 Reaction 6 is a pyridine by a Negishi coupling reaction. The ring is bonded to the naphthalene ring. First, 4-bromopyridine was made into a Grignard reagent. Here, since 4-bromopyridine hydrochloride which is stable to a raw material is used, 2-fold molar isopropyl magnesium chloride is used, but it is also possible to use a salt which is not necessary to use a hydrochloride. Adding zinc chloride tetramethylethylenediamine complex to the Grignard reagent, synthesizing zinc chloride complex of pyridine, and reacting it with trifluoromethanesulfonate obtained in reaction 5 in the presence of a palladium catalyst The reaction is combined to synthesize the target.
反應6除根岸偶合反應以外,亦可適宜使用鈴木偶合(Suzuki coupling)反應等常用偶合反應。在使用鈴木偶合反應的情況下,根據目標物來準備最適合的硼酸或硼酸酯即可,例如可使用下述反應7所示的硼酸酯來獲得目標物。 In addition to the root-coupling reaction, the reaction 6 may suitably employ a conventional coupling reaction such as a Suzuki coupling reaction. In the case of using the Suzuki coupling reaction, the most suitable boric acid or boric acid ester may be prepared depending on the target. For example, a boric acid ester represented by the following reaction 7 can be used to obtain a target product.
作為偶合反應所使用的鈀觸媒的具體例,可列舉:Pd(PPh3)4、PdCl2(PPh3)2、Pd(OAc)2、三(二亞苄基丙酮)二 鈀(0)、三(二亞苄基丙酮)二鈀(0)氯仿錯合物、雙(二亞苄基丙酮)鈀(0)、雙(三第三丁基膦基)鈀(0)、或(1,1'-雙(二苯基膦基)二茂鐵)二氯鈀(II)。 Specific examples of the palladium catalyst used for the coupling reaction include Pd(PPh 3 ) 4 , PdCl 2 (PPh 3 ) 2 , Pd(OAc) 2 , and tris(dibenzylideneacetone)dipalladium (0). , tris(dibenzylideneacetone)dipalladium(0)chloroform complex, bis(dibenzylideneacetone)palladium(0), bis(tri-t-butylphosphino)palladium(0), or (1 , 1'-bis(diphenylphosphino)ferrocene)dichloropalladium(II).
另外,為了促進反應,亦可視情況向該等鈀化合物中添加膦化合物。作為此膦化合物的具體例,可列舉:三(第三丁基)膦、三環己基膦、1-(N,N-二甲基胺基甲基)-2-(二第三丁基膦基)二茂鐵、1-(N,N-二丁基胺基甲基)-2-(二第三丁基膦基)二茂鐵、1-(甲氧基甲基)-2-(二第三丁基膦基)二茂鐵、1,1'-雙(二第三丁基膦基)二茂鐵、2,2'-雙(二第三丁基膦基)-1,1'-聯萘、2-甲氧基-2'-(二第三丁基膦基)-1,1'-聯萘、或2-二環己基膦基-2',6'-二甲氧基聯苯。 Further, in order to promote the reaction, a phosphine compound may be added to the palladium compounds as the case may be. Specific examples of the phosphine compound include tris(t-butyl)phosphine, tricyclohexylphosphine, and 1-(N,N-dimethylaminomethyl)-2-(di-t-butylphosphine). Ferrocenyl, 1-(N,N-dibutylaminomethyl)-2-(di-t-butylphosphino)ferrocene, 1-(methoxymethyl)-2-( Di-tert-butylphosphino)ferrocene, 1,1'-bis(di-t-butylphosphino)ferrocene, 2,2'-bis(di-t-butylphosphino)-1,1 '-binaphthyl, 2-methoxy-2'-(di-t-butylphosphino)-1,1'-binaphthyl, or 2-dicyclohexylphosphino-2',6'-dimethoxy Base benzene.
作為反應所使用的鹼的具體例,可列舉:碳酸鈉、碳酸鉀、碳酸銫、碳酸氫鈉、氫氧化鈉、氫氧化鉀、氫氧化鋇、乙醇鈉、第三丁醇鈉、乙酸鈉、磷酸三鉀、或氟化鉀。 Specific examples of the base to be used in the reaction include sodium carbonate, potassium carbonate, cesium carbonate, sodium hydrogencarbonate, sodium hydroxide, potassium hydroxide, barium hydroxide, sodium ethoxide, sodium butoxide, sodium acetate, and the like. Tripotassium phosphate, or potassium fluoride.
另外,作為反應所使用的溶劑的具體例,可列舉:苯、甲苯、二甲苯、1,2,4-三甲基苯、N,N-二甲基甲醯胺、四氫呋喃、二乙基醚、第三丁基甲基醚、1,4-二噁烷、甲醇、乙醇、環戊基甲基醚或異丙醇。該等溶劑可適宜選擇,可單獨使用,亦可製成混合溶劑使用。 Further, specific examples of the solvent used for the reaction include benzene, toluene, xylene, 1,2,4-trimethylbenzene, N,N-dimethylformamide, tetrahydrofuran, and diethyl ether. , tert-butyl methyl ether, 1,4-dioxane, methanol, ethanol, cyclopentyl methyl ether or isopropanol. These solvents may be appropriately selected and used singly or as a mixed solvent.
在上述反應3中,若使用2-溴-7-甲氧基萘代替2-溴-6-甲氧基萘,則可同樣地進行合成。 In the above reaction 3, when 2-bromo-7-methoxynaphthalene is used instead of 2-bromo-6-methoxynaphthalene, the synthesis can be carried out in the same manner.
藉由使用此等苯骨架與萘骨架經取代的原料代替上述反應1~反應3中所使用的原料,可與上述同樣地進行合成。即,將2-溴蒽的格林納試劑與9-溴蒽偶合,依據反應2將蒽的10位溴化,接著使該溴化物與對甲氧基溴苯或間甲氧基溴苯的格林納試劑反應,而獲得9-(4-或3-甲氧基苯基)-10-(2-萘基)蒽。針對該化合物,甲氧基的脫甲基化反應以後的順序依據上述進行即可。此外,除具體例示的化合物以外,當然亦可藉由根據目標物適宜使用原料,依據上述合成方法進行合成。 The raw materials used in the above Reactions 1 to 3 can be used in the same manner as described above by using the raw materials substituted with the benzene skeleton and the naphthalene skeleton instead of the raw materials used in the above Reactions 1 to 3. That is, the 2-bromoindrene Grenner reagent is coupled with 9-bromoindole, and the 10 position of the indole is brominated according to the reaction 2, followed by the bromide with p-methoxybromobenzene or m-methoxybromobenzene. The reagent is reacted to obtain 9-(4- or 3-methoxyphenyl)-10-(2-naphthyl)anthracene. With respect to this compound, the order after the demethylation reaction of the methoxy group may be carried out in accordance with the above. Further, in addition to the specifically exemplified compound, it is of course possible to carry out the synthesis according to the above synthesis method by suitably using a raw material according to the target.
藉由使用經烷基或環烷基取代的吡啶衍生物代替上述反應6或反應7所使用的原料的吡啶衍生物作為原料,可與上述同樣地進行合成。 The pyridine derivative of the starting material used in the above reaction 6 or reaction 7 can be used as a raw material by using a pyridine derivative substituted with an alkyl group or a cycloalkyl group, and the synthesis can be carried out in the same manner as above.
經烷基或環烷基取代的吡啶衍生物可如下述反應8~反應9所示進行合成。此處,雖然例示了式(1-11-11)、式(1-12-11)、式(1-13-11)及式(1-14-11)所表示的化合物中的吡啶部位的合成方法,但藉由適宜變更原料,可合成各種經烷基或環烷基取代的吡啶衍生物。 The pyridine derivative substituted with an alkyl group or a cycloalkyl group can be synthesized as shown in the following Reaction 8 to Reaction 9. Here, although the pyridine moiety in the compound represented by the formula (1-11-11), the formula (1-12-11), the formula (1-13-11), and the formula (1-14-11) is exemplified The synthesis method, but by appropriately changing the starting materials, various alkyl or cycloalkyl-substituted pyridine derivatives can be synthesized.
在上述「式(1-9-1)~式(1-9-48)及式(1-10-1)~式(1-10-48)所表示的化合物的合成方法」中的苯基的導入步驟中,使用經烷基或環烷基取代的苯基即可。例如可使用下述反應10所示的合成方法。 Phenyl group in the above "Formula (1-9-1) to formula (1-9-48) and formula (1-10-1) to formula (1-10-48)" In the introduction step, a phenyl group substituted with an alkyl group or a cycloalkyl group may be used. For example, the synthesis method shown in the following reaction 10 can be used.
式中的R的定義與上述相同。o為1~4的整數。可根據目標化合物在苯環的任意位置僅連結所需數量的R。 The definition of R in the formula is the same as described above. o is an integer from 1 to 4. Only the desired amount of R may be linked at any position of the benzene ring depending on the target compound.
在將本發明的化合物用於有機EL元件中的電子注入層或電子傳輸層的情況下,在施加電場時較穩定。該情況表示本發明的化合物作為電激發光型元件的電子注入材 料、或電子傳輸材料優異。此處所謂電子注入層,是指自陰極接收電子並注入有機層的層;所謂電子傳輸層,是指用於將注入的電子傳輸至發光層的層。另外,電子傳輸層亦可兼為電子注入層。各層所使用的材料稱為電子注入材料及電子傳輸材料。 In the case where the compound of the present invention is used for an electron injecting layer or an electron transporting layer in an organic EL device, it is relatively stable when an electric field is applied. This case indicates that the compound of the present invention is used as an electron injecting material for an electroluminescence type element. Excellent in materials or electron transport materials. Here, the electron injecting layer refers to a layer that receives electrons from the cathode and injects the organic layer; the so-called electron transporting layer refers to a layer for transporting the injected electrons to the light emitting layer. Further, the electron transport layer may also serve as an electron injection layer. The materials used for each layer are referred to as electron injecting materials and electron transporting materials.
本案的第2發明是在電子注入層、或電子傳輸層中包含本發明的式(1)所表示的化合物的有機EL元件。本發明的有機EL元件的驅動電壓低,驅動時的耐久性高。 The second invention of the present invention is an organic EL device comprising a compound represented by the formula (1) of the present invention in an electron injecting layer or an electron transporting layer. The organic EL device of the present invention has a low driving voltage and high durability at the time of driving.
本發明的有機EL元件的結構有各種型態,基本為在陽極與陰極之間至少夾持有電洞傳輸層、發光層、電子傳輸層的多層結構。元件的具體構成的例子為:(1)陽極/電洞傳輸層/發光層/電子傳輸層/陰極、(2)陽極/電洞注入層/電洞傳輸層/發光層/電子傳輸層/陰極、(3)陽極/電洞注入層/電洞傳輸層/發光層/電子傳輸層/電子注入層/陰極等。 The organic EL device of the present invention has various types of structures, and is basically a multilayer structure in which at least a hole transport layer, a light-emitting layer, and an electron transport layer are sandwiched between an anode and a cathode. Examples of specific configurations of components are: (1) anode/hole transport layer/light-emitting layer/electron transport layer/cathode, (2) anode/hole injection layer/hole transport layer/light-emitting layer/electron transport layer/cathode (3) anode/hole injection layer/hole transport layer/light-emitting layer/electron transport layer/electron injection layer/cathode, and the like.
本發明的化合物由於具有高的電子注入性及電子傳輸性,故而可單獨或與其他材料併用而用於電子注入層、或電子傳輸層。本發明的有機EL元件藉由組合在本發明的電子傳輸材料中使用其他材料的電洞注入層、電洞傳輸層、發光層等,亦可獲得藍色、綠色、紅色或白色的發光。 Since the compound of the present invention has high electron injectability and electron transportability, it can be used alone or in combination with other materials for the electron injecting layer or the electron transporting layer. The organic EL device of the present invention can also obtain blue, green, red or white light by using a hole injection layer, a hole transport layer, a light-emitting layer or the like of another material in combination with the electron transport material of the present invention.
可用於本發明的有機EL元件的發光材料或發光性摻雜劑為:高分子學會編、高分子機能材料系列「光機能材料」、共同出版(1991)、P236所記載的日光色螢光材料、螢光增白劑、雷射色素、有機閃爍體(scintillator)、各種螢 光分析試劑等發光材料;城戸淳二主編、「有機EL材料與顯示器」CMC社出版(2001)P155~156所記載的摻雜劑材料、P170~172所記載的三重態材料的發光材料等。 The luminescent material or the luminescent dopant which can be used in the organic EL device of the present invention is a luminescent material such as a polymer functional material, a polymer functional material series "optical functional material", and a co-published (1991) and P236 , fluorescent brightener, laser pigment, scintillator, various kinds of firefly A luminescent material such as a photoanalytical reagent; a masterbatch edited by Cheng Yuji, "Organic EL Materials and Displays", CMC Publications (2001), a dopant material described in P155-156, and a luminescent material of a triplet material described in P170-172.
可用作發光材料或發光性摻雜劑的化合物為:多環芳香族化合物、雜環芳香族化合物、有機金屬錯合物、色素、高分子系發光材料、苯乙烯基衍生物、芳香族胺衍生物、香豆素衍生物、硼烷衍生物、噁嗪衍生物、具有螺環的化合物、噁二唑衍生物、茀衍生物等。多環芳香族化合物的例子為:蒽衍生物、菲衍生物、稠四苯衍生物、芘衍生物、稠二萘衍生物、苝衍生物、蔻衍生物、紅螢烯衍生物等。雜環芳香族化合物的例子為:具有二烷基胺基或二芳基胺基的噁二唑衍生物、吡唑並喹啉衍生物、吡啶衍生物、吡喃衍生物、啡啉衍生物、矽雜環戊二烯衍生物、具有三苯基胺基的噻吩衍生物、喹吖啶酮衍生物等。有機金屬錯合物的例子為:鋅、鋁、鈹、銪、鋱、鏑、銥、鉑、鋨、金等與羥基喹啉衍生物、苯並噁唑衍生物、苯並噻唑衍生物、噁二唑衍生物、噻二唑衍生物、苯並咪唑衍生物、吡咯衍生物、吡啶衍生物、啡啉衍生物等的錯合物。色素的例子可列舉為:呫噸(xanthene)衍生物、聚次甲基衍生物、卟啉衍生物、香豆素衍生物、二氰基亞甲基吡喃衍生物、二氰基亞甲基噻喃衍生物、側氧基苯並蒽衍生物、喹啉酮衍生物、苝衍生物、苯並噁唑衍生物、苯並噻唑衍生物、苯並咪唑衍生物等色素。高分子系發光材料的例子為:聚對苯乙烯衍生物、聚噻吩衍生物、聚乙烯基咔唑衍生物、聚矽 烷衍生物、聚茀衍生物、聚對苯衍生物等。苯乙烯基衍生物的例子為:含胺的苯乙烯基衍生物、苯乙烯基伸芳基衍生物等。 Compounds which can be used as luminescent materials or luminescent dopants are: polycyclic aromatic compounds, heterocyclic aromatic compounds, organometallic complexes, pigments, polymeric luminescent materials, styryl derivatives, aromatic amines A derivative, a coumarin derivative, a borane derivative, an oxazine derivative, a compound having a spiro ring, an oxadiazole derivative, an anthracene derivative, and the like. Examples of the polycyclic aromatic compound are an anthracene derivative, a phenanthrene derivative, a condensed tetraphenyl derivative, an anthracene derivative, a condensed naphthalene derivative, an anthracene derivative, an anthracene derivative, a red fluorene derivative, and the like. Examples of the heterocyclic aromatic compound are: an oxadiazole derivative having a dialkylamino group or a diarylamine group, a pyrazoloquinoline derivative, a pyridine derivative, a pyran derivative, a phenanthroline derivative, A fluorene heterocyclic pentadiene derivative, a thiophene derivative having a triphenylamine group, a quinacridone derivative or the like. Examples of organometallic complexes are: zinc, aluminum, ruthenium, osmium, iridium, osmium, iridium, platinum, rhodium, gold, etc. with hydroxyquinoline derivatives, benzoxazole derivatives, benzothiazole derivatives, evil A complex of an oxadiazole derivative, a thiadiazole derivative, a benzimidazole derivative, a pyrrole derivative, a pyridine derivative, a phenanthroline derivative, or the like. Examples of the coloring matter are: xanthene derivatives, polymethine derivatives, porphyrin derivatives, coumarin derivatives, dicyanomethylenepyran derivatives, dicyanomethylene groups A pigment such as a thiopyran derivative, a pendant oxybenzoxanthene derivative, a quinolinone derivative, an anthracene derivative, a benzoxazole derivative, a benzothiazole derivative, or a benzimidazole derivative. Examples of the polymer light-emitting material are: a polyparaphenylene derivative, a polythiophene derivative, a polyvinylcarbazole derivative, and a polyfluorene. An alkane derivative, a polyfluorene derivative, a polyparaphenylene derivative or the like. Examples of the styryl derivative are an amine-containing styryl derivative, a styryl extended aryl derivative, and the like.
本發明的有機EL元件所使用的其他電子傳輸材料可自可在光導電材料中用作電子傳遞化合物的化合物、可用於有機EL元件的電子傳輸層及電子注入層的化合物中任意選擇使用。 The other electron transporting material used in the organic EL device of the present invention can be arbitrarily selected from the compounds which can be used as an electron transporting compound in the photoconductive material, and the compound which can be used for the electron transporting layer and the electron injecting layer of the organic EL device.
此種電子傳輸材料的具體例為:羥基喹啉系金屬錯合物、2,2'-聯吡啶衍生物、啡啉衍生物、聯苯醌衍生物、苝衍生物、噁二唑衍生物、噻吩衍生物、三唑衍生物、噻二唑衍生物、8-羥基喹啉衍生物的金屬錯合物、喹噁啉衍生物、喹噁啉衍生物的聚合物、吲哚類化合物、鎵錯合物、吡唑衍生物、全氟伸苯基衍生物、三嗪衍生物、吡嗪衍生物、苯並喹啉衍生物、咪唑並吡啶衍生物、硼烷衍生物等。 Specific examples of such an electron transporting material are: a quinolinol metal complex, a 2,2'-bipyridine derivative, a phenanthroline derivative, a biphenyl hydrazine derivative, an anthracene derivative, an oxadiazole derivative, Thiophene derivative, triazole derivative, thiadiazole derivative, metal complex of 8-hydroxyquinoline derivative, quinoxaline derivative, polymer of quinoxaline derivative, terpenoid, gallium maltal a compound, a pyrazole derivative, a perfluorophenylene derivative, a triazine derivative, a pyrazine derivative, a benzoquinoline derivative, an imidazopyridine derivative, a borane derivative or the like.
關於本發明的有機EL元件所使用的電洞注入材料及電洞傳輸材料,可從先前在光導電材料中作為電洞的電荷傳輸材料而慣用的化合物、或有機EL元件的電洞注入層及電洞傳輸層所使用的眾所周知的材料中任意選擇使用。此等的具體例為:咔唑衍生物、三芳基胺衍生物、酞菁衍生物等。 The hole injecting material and the hole transporting material used in the organic EL device of the present invention can be a compound which is conventionally used as a charge transporting material of a hole in a photoconductive material, or a hole injecting layer of an organic EL element, and The well-known materials used in the hole transport layer are arbitrarily selected for use. Specific examples of these are: carbazole derivatives, triarylamine derivatives, phthalocyanine derivatives, and the like.
構成本發明的有機EL元件的各層可藉由將應構成各層的材料以蒸鍍法、旋轉塗佈法或澆鑄法等方法製成薄膜而形成。如此而形成的各層的膜厚並無特別限定,可根據材料的性質而適宜設定,通常為2nm~5000nm的範圍。 此外,將發光材料薄膜化的方法較佳為採用蒸鍍法,其原因在於易獲得均質的膜,且不易生成小孔(pinholes)等。在使用蒸鍍法進行薄膜化的情況下,其蒸鍍條件根據本發明的發光材料的種類而有所不同。蒸鍍條件通常較佳為在如下範圍內適宜設定:加熱舟溫度為50℃~400℃、真空度為10-6Pa~10-3Pa、蒸鍍速度為0.01nm/秒~50nm/秒、基板溫度為-150℃~+300℃、膜厚為5nm~5μm。 Each layer constituting the organic EL device of the present invention can be formed by forming a film of a material to be formed into each layer by a vapor deposition method, a spin coating method, or a casting method. The film thickness of each layer formed in this manner is not particularly limited, and may be appropriately set depending on the properties of the material, and is usually in the range of 2 nm to 5000 nm. Further, the method of thinning the luminescent material is preferably a vapor deposition method because it is easy to obtain a homogeneous film and it is difficult to form pinholes or the like. In the case of thin film formation by a vapor deposition method, the vapor deposition conditions vary depending on the kind of the light-emitting material of the present invention. The evaporation condition is usually preferably set within the following range: the heating boat temperature is 50 ° C to 400 ° C, the vacuum degree is 10 -6 Pa to 10 -3 Pa, and the evaporation rate is 0.01 nm / sec to 50 nm / sec. The substrate temperature is -150 ° C to +300 ° C, and the film thickness is 5 nm to 5 μm.
本發明的有機EL元件無論為上述任何結構,均較佳為受基板支撐。基板只要具有機械強度、熱穩定性及透明性即可,可使用玻璃、透明塑膠膜等。陽極物質可使用功函數大於4eV的金屬、合金、導電性化合物及該等的混合物。其具體例為:Au等金屬、CuI、氧化銦錫(以下,簡稱為ITO)、SnO2、ZnO等。 The organic EL device of the present invention is preferably supported by a substrate regardless of any of the above structures. As long as the substrate has mechanical strength, thermal stability, and transparency, a glass, a transparent plastic film, or the like can be used. The anode material may use a metal having a work function greater than 4 eV, an alloy, a conductive compound, and mixtures thereof. Specific examples thereof include a metal such as Au, CuI, indium tin oxide (hereinafter abbreviated as ITO), SnO 2 , ZnO, or the like.
陰極物質可使用功函數小於4eV的金屬、合金、導電性化合物、及該等的混合物。其具體例為:鋁、鈣、鎂、鋰、鎂合金、鋁合金等。合金的具體例為:鋁/氟化鋰、鋁/鋰、鎂/銀、鎂/銦等。為了效率良好地取出有機EL元件的發光,較理想為至少一個電極的透光率為10%以上。作為電極的片電阻較佳為數百Ω/□以下。此外,膜厚雖然亦取決於電極材料的性質,但通常在10nm~1μm、較佳為10nm~400nm的範圍內設定。此種電極可藉由使用上述電極物質,藉由蒸鍍或濺鍍等方法形成薄膜而製作。 As the cathode material, a metal, an alloy, a conductive compound, and a mixture of these having a work function of less than 4 eV can be used. Specific examples thereof include aluminum, calcium, magnesium, lithium, magnesium alloys, and aluminum alloys. Specific examples of the alloy are: aluminum/lithium fluoride, aluminum/lithium, magnesium/silver, magnesium/indium, and the like. In order to efficiently extract the light emission of the organic EL element, it is preferable that the light transmittance of at least one of the electrodes is 10% or more. The sheet resistance as the electrode is preferably several hundred Ω/□ or less. Further, although the film thickness is also dependent on the properties of the electrode material, it is usually set in the range of 10 nm to 1 μm, preferably 10 nm to 400 nm. Such an electrode can be produced by forming a thin film by a method such as vapor deposition or sputtering using the above electrode material.
其次,作為使用本發明的發光材料來製作有機EL元件的方法的一例,對包含上述陽極/電洞注入層/電洞傳輸 層/發光層/本發明的電子傳輸材料/陰極的有機EL元件的製作方法進行說明。在適當基板上藉由蒸鍍法形成陽極材料的薄膜而製作陽極後,在該陽極上形成電洞注入層及電洞傳輸層的薄膜。在其上形成發光層的薄膜。在該發光層上真空蒸鍍本發明的電子傳輸材料,形成薄膜,而製成電子傳輸層。接著,藉由蒸鍍法形成包含陰極用物質的薄膜,而製成陰極,藉此獲得目標有機EL元件。此外,在上述有機EL元件的製作中,亦可顛倒製作順序,而以陰極、電子傳輸層、發光層、電洞傳輸層、電洞注入層、陽極的順序進行製作。 Next, as an example of a method of producing an organic EL element using the luminescent material of the present invention, the above-described anode/hole injection layer/hole transmission is included. A method of producing an organic EL device of a layer/light-emitting layer/electron transport material/cathode of the present invention will be described. A thin film of an anode material is formed on a suitable substrate by a vapor deposition method to form an anode, and then a film of a hole injection layer and a hole transport layer is formed on the anode. A film on which a light-emitting layer is formed. The electron transporting material of the present invention was vacuum-deposited on the light-emitting layer to form a thin film, thereby forming an electron transporting layer. Next, a film containing a substance for a cathode was formed by a vapor deposition method to form a cathode, whereby a target organic EL element was obtained. Further, in the production of the above-described organic EL device, the order of fabrication may be reversed, and the cathode, the electron transport layer, the light-emitting layer, the hole transport layer, the hole injection layer, and the anode may be sequentially formed.
在對如此而獲得的有機EL元件施加直流電壓的情況下,以陽極作為+的極性且以陰極作為-的極性施加電壓即可,若施加2V~40V左右的電壓,則可從透明或半透明的電極側(陽極或陰極、及雙方)觀測到發光。另外,該有機EL元件在施加交流電壓的情況下亦發光。此外,所施加的交流電的波形可為任意。 When a DC voltage is applied to the organic EL element obtained in this way, a voltage may be applied to the polarity in which the anode is + and the cathode is -, and when a voltage of about 2 V to 40 V is applied, it may be transparent or translucent. Luminescence was observed on the electrode side (anode or cathode, and both sides). Further, the organic EL element emits light even when an alternating voltage is applied. Further, the waveform of the applied alternating current may be arbitrary.
以下,基於實例更詳細地說明本發明。首先,對實例所使用的化合物的合成例說明如下。 Hereinafter, the present invention will be described in more detail based on examples. First, a synthesis example of the compound used in the examples will be described below.
在氮氣環境下,將添加有9-溴蒽31g、4-第三丁基苯基硼酸25g、Pd(PPh3)4 1.3g、磷酸鉀51g及1,2,4-三甲基苯150ml的燒瓶在回流溫度下攪拌21小時。將反應液冷 卻至室溫後,添加水及甲苯進行液體分離(liquid separation)。藉由吸濾採集藉由減壓蒸餾除去溶劑而析出的固體,利用甲醇洗淨,再利用乙酸乙酯洗淨,獲得9-(4-第三丁基苯基)蒽28g。 Under nitrogen atmosphere, 31 g of 9-bromoindole, 25 g of 4-t-butylphenylboronic acid, 1.3 g of Pd(PPh 3 ) 4 , 51 g of potassium phosphate and 150 ml of 1,2,4-trimethylbenzene were added. The flask was stirred at reflux temperature for 21 hours. After cooling the reaction liquid to room temperature, water and toluene were added for liquid separation. The solid which precipitated by solvent distillation under reduced pressure was collected by suction filtration, washed with methanol, and washed with ethyl acetate to obtain 28 g of 9-(4-t-butylphenyl)fluorene.
向添加有9-(4-第三丁基苯基)蒽27g、碘0.1g及THF 300ml的燒瓶中,在氮氣環境下,添加N-溴琥珀醯亞胺19g。在室溫下攪拌18小時,添加硫代硫酸鈉水溶液而停止反應。將該溶液轉移至液體分離漏斗中,利用氯仿進行萃取。藉由吸濾採集藉由減壓蒸餾除去溶劑而析出的固體,接著從氯苯中進行再結晶,獲得9-溴-10-(4-第三丁基苯基)蒽29g。 To a flask to which 27 g of 9-(4-t-butylphenyl)anthracene, 0.1 g of iodine and 300 ml of THF were added, 19 g of N-bromosuccinimide was added under a nitrogen atmosphere. After stirring at room temperature for 18 hours, an aqueous sodium thiosulfate solution was added to stop the reaction. The solution was transferred to a liquid separation funnel and extracted with chloroform. The solid precipitated by distillation under reduced pressure was collected by suction filtration, followed by recrystallization from chlorobenzene to obtain 29 g of 9-bromo-10-(4-t-butylphenyl)phosphonium.
將添加有3-溴吡啶10g及THF 60ml的燒瓶在冰浴中冷卻,在氮氣環境下,一邊攪拌一邊滴加2M的異丙基氯化鎂的THF溶液35ml。滴加完畢後暫時升溫到室溫後,在冰水中冷卻,一邊攪拌一邊添加氯化鋅四甲基乙二胺錯合物17g。其後,在室溫下攪拌1小時後,添加三氟甲磺酸6-溴萘-2-酯18g及PdCl2(dppp)1.6g,在回流溫度下攪拌3小時。將反應液冷卻至室溫後,為了除去觸媒的金屬離子,而添加將相對於目標化合物約相當於3倍莫耳的乙二胺四乙酸‧四鈉鹽二水合物溶解到適量的水中而成的溶液(以下,簡稱為EDTA‧4Na水溶液)及甲苯進行液體分離。在減壓蒸餾除去溶劑後,藉由矽膠管柱層析法(甲 苯/乙酸乙酯=7/3(容積比))進行純化,獲得3-(6-溴萘-2-基)吡啶12g。 A flask containing 10 g of 3-bromopyridine and 60 ml of THF was cooled in an ice bath, and 35 ml of a 2 M solution of isopropylmagnesium chloride in THF was added dropwise while stirring under a nitrogen atmosphere. After the completion of the dropwise addition, the temperature was raised to room temperature, and then cooled in ice water, and 17 g of zinc chloride tetramethylethylenediamine complex was added while stirring. Thereafter, the mixture was stirred at room temperature for 1 hour, and then 18 g of 6-bromo naphthalene-2-carboxylate and 1.6 g of PdCl 2 (dppp) were added, and the mixture was stirred at reflux temperature for 3 hours. After cooling the reaction solution to room temperature, in order to remove the metal ions of the catalyst, ethylenediaminetetraacetic acid tetrasodium salt dihydrate which is equivalent to about 3 times the molar amount of the target compound is added and dissolved in an appropriate amount of water. The resulting solution (hereinafter, abbreviated as EDTA‧4Na aqueous solution) and toluene were subjected to liquid separation. After distilling off the solvent under reduced pressure, the residue was purified by silica gel column chromatography (toluene / ethyl acetate = 7 / 3 (volume ratio)) to obtain 12 g of 3-(6-bromonaphthalen-2-yl)pyridine.
將添加有3-(6-溴萘-2-基)吡啶6.2g、聯硼酸頻那醇酯5.9g、雙(二亞苄基丙酮)鈀(0)0.4g、三環己基膦0.5g、乙酸鉀3.9g及二甲氧基乙烷50ml的燒瓶在氮氣環境下,在回流溫度下攪拌4小時。向該溶液中添加9-溴-10-(4-第三丁基苯基)蒽8.6g、磷酸鉀9.3g及1,2,4-三甲基苯50ml,使用迪恩-斯達克管將二甲氧基乙烷在常溫下加熱蒸餾除去。添加第三丁醇5ml、水5ml、雙(二亞苄基丙酮)鈀(0)0.4g及三環己基膦0.5g,在回流溫度下進一步攪拌5小時。將反應液冷卻到室溫,進行水洗而使鹽溶解後,藉由吸濾採集固體。利用甲醇洗淨所獲得的固體,再利用乙酸乙酯洗浄後,藉由矽膠管柱層析法(甲苯/乙酸乙酯=9/1(容積比))進行純化,獲得化合物(1-7-74):3-(6-(10-(4-第三丁基)苯基)蒽-9-基)萘-2-基)吡啶1.0g。藉由NMR測定而確認化合物的結構。 6.2 g of 3-(6-bromonaphthalen-2-yl)pyridine, 5.9 g of pinacol borate, bis (dibenzylideneacetone)palladium (0) 0.4 g, and tricyclohexylphosphine 0.5 g were added. A flask of 3.9 g of potassium acetate and 50 ml of dimethoxyethane was stirred at reflux temperature for 4 hours under a nitrogen atmosphere. To the solution, 8.6 g of 9-bromo-10-(4-t-butylphenyl)phosphonium, 9.3 g of potassium phosphate and 50 ml of 1,2,4-trimethylbenzene were added, using a Dean-Stark tube. Dimethoxyethane was removed by heating and distillation at normal temperature. 5 ml of tributanol, 5 ml of water, 0.4 g of bis(dibenzylideneacetone)palladium(0) and 0.5 g of tricyclohexylphosphine were added, and the mixture was further stirred at reflux temperature for 5 hours. The reaction solution was cooled to room temperature, washed with water to dissolve the salt, and then a solid was collected by suction filtration. The obtained solid was washed with methanol, washed with ethyl acetate, and purified by silica gel column chromatography (toluene / ethyl acetate = 9 / 1 (volume ratio)) to obtain compound (1-7- 74): 3-(6-(10-(4-T-butyl)phenyl)fluoren-9-yl)naphthalen-2-yl)pyridine 1.0 g. The structure of the compound was confirmed by NMR measurement.
1H-NMR(CDCl3):δ=9.07(m,1H),8.68(dd,1H),8.23(m,1H),8.15(d,1H),8.08(m,1H),8.03(m,2H),7.83(dd,1H),7.78(d,2H),7.72(d,2H),7.68(dd,1H),7.63(d,2H),7.42-7.48(m,3H),7.30-7.38(m,4H),1.49(s,9H)。 1 H-NMR (CDCl 3 ): δ=9.07 (m, 1H), 8.68 (dd, 1H), 8.23 (m, 1H), 8.15 (d, 1H), 8.08 (m, 1H), 8.03 (m, 2H), 7.83 (dd, 1H), 7.78 (d, 2H), 7.72 (d, 2H), 7.68 (dd, 1H), 7.63 (d, 2H), 7.42-7.48 (m, 3H), 7.30-7.38 (m, 4H), 1.49 (s, 9H).
在氮氣環境下,將添加有9-溴蒽36g、3-甲基苯基硼酸21g、Pd(PPh3)4 1.4g、磷酸鉀59g及1,2,4-三甲基苯150ml的燒瓶在回流溫度下攪拌2.5小時。將反應液冷卻至室溫後,添加水及甲苯進行液體分離。利用短矽膠管柱純化所獲得的甲苯溶液後,減壓蒸餾除去溶劑。向所獲得的油中添加庚烷,藉由吸濾採集析出的固體,獲得9-(3-甲苯基)蒽31g。 Under a nitrogen atmosphere, a flask containing 36 g of 9-bromoindole, 21 g of 3-methylphenylboronic acid, 1.4 g of Pd(PPh 3 ) 4 , 59 g of potassium phosphate and 150 ml of 1,2,4-trimethylbenzene was added. Stir at reflux temperature for 2.5 hours. After cooling the reaction liquid to room temperature, water and toluene were added to carry out liquid separation. After the obtained toluene solution was purified by a short-twist hose column, the solvent was evaporated under reduced pressure. Heptane was added to the obtained oil, and the precipitated solid was collected by suction filtration to obtain 9-(3-tolyl)indole 31 g.
向添加有9-(3-甲苯基)蒽30g及THF 200ml的燒瓶中,在氮氣環境下在冰浴中冷卻,添加N-溴琥珀醯亞胺20g及碘0.1g。在室溫下攪拌15小時,添加硫代硫酸鈉水溶液而停止反應。將該溶液轉移至液體分離漏斗中,利用甲苯進行萃取後,用短矽膠管柱進行純化。減壓蒸餾除去溶劑,向所獲得的溶液中添加庚烷,藉由吸濾採集析出的固體,獲得9-溴-10-(3-甲苯基)蒽30g。 To a flask to which 30 g of 9-(3-methylphenyl)indole and 200 ml of THF were added, the mixture was cooled in an ice bath under a nitrogen atmosphere, and 20 g of N-bromosuccinimide and 0.1 g of iodine were added. After stirring at room temperature for 15 hours, an aqueous sodium thiosulfate solution was added to stop the reaction. The solution was transferred to a liquid separation funnel, extracted with toluene, and purified using a short-twist hose column. The solvent was distilled off under reduced pressure, and heptane was added to the obtained solution, and the precipitated solid was collected by suction filtration to obtain 30 g of 9-bromo-10-(3-methylphenyl)indole.
將添加有9-溴-10-(3-甲苯基)蒽30g、聯硼酸頻那醇酯26g、雙(二亞苄基丙酮)鈀(0)1.5g、三環己基膦1.4g、乙酸鉀15g、碳酸鉀12g及環戊基甲基醚100ml的燒瓶在氮氣環境下,在回流溫度下攪拌16小時。將反應液冷卻至室溫後,添加水及甲苯進行液體分離,利用短矽膠管柱純化所獲得的甲苯溶液。減壓蒸餾除去溶劑,向所獲得的油中添加庚烷,藉由吸濾採集析出的固體,獲得4,4,5,5- 四甲基-2-(10-(3-甲苯基)蒽-9-基)-1,3,2-二氧雜硼戊環24g。 30 g of 9-bromo-10-(3-tolyl)fluorene, 26 g of pinacol borate, 26 g of bis(dibenzylideneacetone)palladium(0), 1.4 g of tricyclohexylphosphine, and potassium acetate were added. A flask of 15 g, 12 g of potassium carbonate and 100 ml of cyclopentylmethyl ether was stirred at reflux temperature for 16 hours under a nitrogen atmosphere. After cooling the reaction liquid to room temperature, water and toluene were added for liquid separation, and the obtained toluene solution was purified by a short-twist hose column. The solvent was distilled off under reduced pressure, and heptane was added to the obtained oil, and the precipitated solid was collected by suction filtration to obtain 4, 4, 5, 5 - Tetramethyl-2-(10-(3-methyl)indol-9-yl)-1,3,2-dioxaborolane 24g.
將添加有4,4,5,5-四甲基-2-(10-(3-甲苯基)蒽-9-基)-1,3,2-二氧雜硼戊環12g、3-(6-溴萘-2-基)吡啶10g、Pd(PPh3)4 1.0g、磷酸鉀13g、1,2,4-三甲基苯50ml、第三丁醇10ml及水10ml的燒瓶在回流溫度下攪拌1小時。將反應液冷卻至室溫後,添加水及甲苯進行液體分離,減壓蒸餾除去溶劑。藉由矽膠管柱層析法(甲苯/乙酸乙酯=20/1(容積比))純化所獲得的粗產物後,從甲苯/庚烷混合溶液中進行再結晶,獲得化合物(1-7-26):3-(6-(10-(3-甲苯基)蒽-9-基)萘-2-基)吡啶7.1g。藉由NMR測定而確認化合物的結構。 4,4,5,5-tetramethyl-2-(10-(3-methylphenyl)fluoren-9-yl)-1,3,2-dioxaborolane 12g, 3-( 6-bromonaphthalen-2-yl)pyridine 10 g, Pd(PPh 3 ) 4 1.0 g, potassium phosphate 13 g, 1,2,4-trimethylbenzene 50 ml, third butanol 10 ml, and water 10 ml flask at reflux temperature Stir under 1 hour. After cooling the reaction liquid to room temperature, water and toluene were added to carry out liquid separation, and the solvent was distilled off under reduced pressure. The obtained crude product was purified by a ruthenium column chromatography (toluene/ethyl acetate = 20/1 (volume ratio)), and then recrystallized from a toluene/heptane mixed solution to obtain a compound (1-7- 26): 7.1 g of 3-(6-(10-(3-methylphenyl)fluoren-9-yl)naphthalen-2-yl)pyridine. The structure of the compound was confirmed by NMR measurement.
1H-NMR(CDCl3):δ=9.06(m,1H),8.67(dd,1H),8.22(m,1H),8.14(d,1H),8.06(m,1H),8.02(m,2H),7.81(m,1H),7.75(d,2H),7.72(d,2H),7.66(dd,1H),7.50(t,1H),7.45(m,1H),7.27-7.39(m,7H),2.50(s,3H)。 1 H-NMR (CDCl 3 ): δ=9.06 (m, 1H), 8.67 (dd, 1H), 8.22 (m, 1H), 8.14 (d, 1H), 8.06 (m, 1H), 8.02 (m, 2H), 7.81 (m, 1H), 7.75 (d, 2H), 7.72 (d, 2H), 7.66 (dd, 1H), 7.50 (t, 1H), 7.45 (m, 1H), 7.27-7.39 (m) , 7H), 2.50 (s, 3H).
在氮氣環境下,將添加有9-溴蒽23g、2-(3-第三丁基苯基)-4,4,5,5-四甲基-1,3,2-二氧雜硼戊環25g、Pd(PPh3)4 3.1g、磷酸鉀37g、1,2,4-三甲基苯250ml、第三丁醇50ml及水30ml的燒瓶在回流溫度下攪拌21小時。將反應液冷卻至室溫後,添加水及甲苯進行液體分離。利用短矽膠管 柱純化所獲得的甲苯溶液,減壓蒸餾除去溶劑,藉由吸濾採集藉由添加甲醇而析出的固體,獲得9-(3-第三丁基苯基)蒽24g。 Under nitrogen, 23 g of 2-bromoindole, 2-(3-t-butylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborate will be added. A flask of 25 g of a ring, Pd(PPh 3 ) 4 3.1 g, 37 g of potassium phosphate, 250 ml of 1,2,4-trimethylbenzene, 50 ml of a third butanol, and 30 ml of water were stirred at reflux temperature for 21 hours. After cooling the reaction liquid to room temperature, water and toluene were added to carry out liquid separation. The obtained toluene solution was purified by a short-twist hose column, and the solvent was evaporated under reduced pressure, and a solid precipitated by the addition of methanol was collected by suction filtration to obtain 24 g of 9-(3-t-butylphenyl)fluorene.
向添加有9-(3-第三丁基苯基)蒽23g、碘0.1g及THF 100ml的燒瓶中,在氮氣環境下添加N-溴琥珀醯亞胺13g。在室溫下攪拌1小時,添加硫代硫酸鈉水溶液而停止反應。將該溶液轉移至液體分離漏斗中,利用甲苯進行萃取。利用短矽膠管柱純化所獲得的甲苯溶液,在減壓蒸餾除去溶劑後,進行甲苯/甲醇再沈澱,獲得9-溴-10-(3-第三丁基苯基)蒽23g。 To a flask to which 23 g of 9-(3-t-butylphenyl)fluorene, 0.1 g of iodine, and 100 ml of THF were added, 13 g of N-bromosuccinimide was added under a nitrogen atmosphere. After stirring at room temperature for 1 hour, an aqueous sodium thiosulfate solution was added to stop the reaction. The solution was transferred to a liquid separation funnel and extracted with toluene. The obtained toluene solution was purified by a short-twist hose column, and the solvent was distilled off under reduced pressure, and then toluene/methanol was re-precipitated to obtain 23 g of 9-bromo-10-(3-t-butylphenyl)fluorene.
將添加有3-(6-溴萘-2-基)吡啶6.2g、聯硼酸頻那醇酯5.9g、雙(二亞苄基丙酮)鈀(0)0.4g、三環己基膦0.5g、乙酸鉀3.9g及二甲氧基乙烷50ml的燒瓶在氮氣環境下,在回流溫度下攪拌4小時。向該溶液中添加9-溴-10-(3-第三丁基苯基)蒽8.6g、磷酸鉀9.3g及1,2,4-三甲基苯50ml,使用迪恩-斯達克管,將二甲氧基乙烷在常溫下加熱蒸餾除去。添加第三丁醇5ml、水5ml、雙(二亞苄基丙酮)鈀(0)0.4g及三環己基膦0.5g,在回流溫度下進一步攪拌2小時。將反應液冷卻到室溫,進行水洗而使鹽溶解後,藉由吸濾採集固體。藉由矽膠管柱層析法(甲苯/乙酸乙酯=9/1(容積比))純化所獲得的固體後,從甲苯中進行再結晶,獲得化合物(1-7-98):3-(6-(10-(3-第三丁基苯基) 蒽-9-基)萘-2-基)吡啶1.5g。藉由NMR測定而確認化合物的結構。 6.2 g of 3-(6-bromonaphthalen-2-yl)pyridine, 5.9 g of pinacol borate, bis (dibenzylideneacetone)palladium (0) 0.4 g, and tricyclohexylphosphine 0.5 g were added. A flask of 3.9 g of potassium acetate and 50 ml of dimethoxyethane was stirred at reflux temperature for 4 hours under a nitrogen atmosphere. To the solution, 8.6 g of 9-bromo-10-(3-tert-butylphenyl)phosphonium, 9.3 g of potassium phosphate, and 50 ml of 1,2,4-trimethylbenzene were added, using a Dean-Stark tube. The dimethoxyethane was removed by heating and distillation at normal temperature. 5 ml of a third butanol, 5 ml of water, 0.4 g of bis(dibenzylideneacetone)palladium (0), and 0.5 g of tricyclohexylphosphine were added, and the mixture was further stirred at reflux temperature for 2 hours. The reaction solution was cooled to room temperature, washed with water to dissolve the salt, and then a solid was collected by suction filtration. The obtained solid was purified by ruthenium column chromatography (toluene / ethyl acetate = 9 / 1 (volume ratio)), and then recrystallized from toluene to obtain compound (1-7-98): 3-( 6-(10-(3-tert-butylphenyl) 蒽-9-yl)naphthalen-2-yl)pyridine 1.5 g. The structure of the compound was confirmed by NMR measurement.
1H-NMR(CDCl3):δ=9.07(m,1H),8.68(dd,1H),8.23(s,1H),8.16(d,1H),8.08(m,1H),8.03(m,2H),7.83(m,1H),7.75(d,2H),7.72(d,2H),7.68(m,1H),7.52-7.61(m,3H),7.46(m,1H),7.30-7.38(m,5H),1.41(s,9H)。 1 H-NMR (CDCl 3 ): δ=9.07 (m, 1H), 8.68 (dd, 1H), 8.23 (s, 1H), 8.16 (d, 1H), 8.08 (m, 1H), 8.03 (m, 2H), 7.83 (m, 1H), 7.75 (d, 2H), 7.72 (d, 2H), 7.68 (m, 1H), 7.52-7.61 (m, 3H), 7.46 (m, 1H), 7.30-7.38 (m, 5H), 1.41 (s, 9H).
將添加有9-溴-10-(4-第三丁基苯基)蒽7.8g、聯硼酸頻那醇酯6.1g、雙(二亞苄基丙酮)鈀(0)0.3g、三環己基膦0.3g、乙酸鉀3.9g、碳酸鉀2.8g、及環戊基甲基醚40ml的燒瓶在氮氣環境下,在回流溫度下攪拌6.5小時。將反應液冷卻至室溫後,添加水及甲苯進行液體分離,減壓蒸餾除去溶劑。向所獲得的油中添加庚烷,藉由吸濾採集析出的固體,獲得2-(10-(4-第三丁基苯基)蒽-9-基)-4,4,5,5-四甲基-1,3,2-二氧雜硼戊環6.9g。 7.8 g of 9-bromo-10-(4-t-butylphenyl)phosphonium, 6.1 g of pinacol borate, bis(dibenzylideneacetone)palladium(0) 0.3 g, tricyclohexyl group were added. A flask of 0.3 g of phosphine, 3.9 g of potassium acetate, 2.8 g of potassium carbonate, and 40 ml of cyclopentylmethyl ether was stirred at reflux temperature for 6.5 hours under a nitrogen atmosphere. After cooling the reaction liquid to room temperature, water and toluene were added to carry out liquid separation, and the solvent was distilled off under reduced pressure. Heptane was added to the obtained oil, and the precipitated solid was collected by suction filtration to obtain 2-(10-(4-t-butylphenyl)fluoren-9-yl)-4,4,5,5- Tetramethyl-1,3,2-dioxaborolane 6.9 g.
在氮氣環境下,將添加有4-(3-溴苯基)吡啶9.8g及THF 20ml的燒瓶在乾冰/甲醇浴中冷卻到-70℃以下,緩慢滴加2.6M的正丁基鋰17ml。滴加完畢後,在同溫度下攪拌0.5小時,添加氯化鋅四甲基乙二胺錯合物12g。其後,在室溫下攪拌0.5小時後,添加三氟甲磺酸6-溴萘-2-酯15 g、雙(二亞苄基丙酮)鈀(0)及1,2-雙(二苯基膦基)丙烷0.5g,在回流溫度下攪拌1小時。反應完畢後,添加EDTA‧4Na水溶液、乙酸乙酯進行液體分離,在減壓蒸餾除去溶劑後,藉由活性氧化鋁管柱層析法(甲苯/乙酸乙酯=9/1(容積比))進行純化。接著,利用甲醇洗浄,從乙酸乙酯/甲醇混合溶劑中進行再結晶,獲得4-(3-(6-溴萘-2-基)苯基)吡啶5.3g。 A flask to which 9.8 g of 4-(3-bromophenyl)pyridine and 20 ml of THF were added was cooled to -70 ° C or less in a dry ice/methanol bath under nitrogen atmosphere, and 17 ml of 2.6 M n-butyllithium was slowly added dropwise. After completion of the dropwise addition, the mixture was stirred at the same temperature for 0.5 hour, and 12 g of zinc chloride tetramethylethylenediamine complex was added. Thereafter, after stirring at room temperature for 0.5 hour, 6-bromonaphthalene-2-ester trifluoromethanesulfonate 15 was added. g, bis(dibenzylideneacetone)palladium(0) and 1,2-bis(diphenylphosphino)propane 0.5 g, and stirred at reflux temperature for 1 hour. After completion of the reaction, an aqueous solution of EDTA‧4Na and ethyl acetate were added to carry out liquid separation, and the solvent was distilled off under reduced pressure, followed by active alumina column chromatography (toluene / ethyl acetate = 9 / 1 (volume ratio)) Purification was carried out. Subsequently, it was washed with methanol and recrystallized from a mixed solvent of ethyl acetate/methanol to obtain 5.3 g of 4-(3-(6-bromonaphthalen-2-yl)phenyl)pyridine.
將添加有2-(10-(4-第三丁基苯基)蒽-9-基)-4,4,5,5-四甲基-1,3,2-二氧雜硼戊環6.1g、4-(3-(6-溴萘-2-基)苯基)吡啶5.0g、Pd(PPh3)4 0.5g、磷酸鉀3.0g、1,2,4-三甲基苯25ml、第三丁醇5ml及水5ml的燒瓶在回流溫度下攪拌6小時。將反應液冷卻至室溫後,添加EDTA‧4Na水溶液及甲苯進行液體分離,減壓蒸餾除去溶劑。藉由活性氧化鋁管柱層析法(甲苯/乙酸乙酯=9/1(容積比))純化所獲得的粗產物。利用乙酸乙酯將減壓蒸餾除去溶劑而獲得的固體洗浄後,從甲苯中進行再結晶,獲得化合物(1-7-96):4(3-(6-(10-(4-第三丁基苯基)蒽-9-基)萘-2-基)苯基)吡啶3.3g。藉由NMR測定而確認化合物的結構。 2-(10-(4-Tertibutylphenyl)fluoren-9-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 6.1 will be added. g, 4-(3-(6-bromonaphthalen-2-yl)phenyl)pyridine 5.0 g, Pd(PPh 3 ) 4 0.5 g, potassium phosphate 3.0 g, 1,2,4-trimethylbenzene 25 ml, A flask of 5 ml of butanol and 5 ml of water was stirred at reflux temperature for 6 hours. After cooling the reaction liquid to room temperature, an aqueous solution of EDTA‧4Na and toluene were added to carry out liquid separation, and the solvent was distilled off under reduced pressure. The obtained crude product was purified by activated alumina column chromatography (toluene / ethyl acetate = 9 / 1 (volume ratio)). The solid obtained by distilling off the solvent under reduced pressure with ethyl acetate was washed, and then recrystallized from toluene to obtain compound (1-7-96): 4 (3-(6-(10-(4-) Phenylphenyl)fluoren-9-yl)naphthalen-2-yl)phenyl)pyridine 3.3 g. The structure of the compound was confirmed by NMR measurement.
1H-NMR(CDCl3):8.73(dd,2H),8.27(m,1H),8.15(d,1H),8.03(m,3H),7.99(m,2H),7.78(d,2H),7.73(d,2H),7.61~7.70(m,7H),7.44(m,2H),7.30~7.38(m,4H)、1.49(s,9H)。 1 H-NMR (CDCl 3 ): 8.73 (dd, 2H), 8.27 (m, 1H), 8.15 (d, 1H), 8.03 (m, 3H), 7.99 (m, 2H), 7.78 (d, 2H) , 7.73 (d, 2H), 7.61 to 7.70 (m, 7H), 7.44 (m, 2H), 7.30 to 7.38 (m, 4H), 1.49 (s, 9H).
向燒瓶中添加1-溴-3-乙氧基苯72.4g、(10-(萘-2-基)蒽-9-基)硼酸104.5g、Pd(PPh3)4 10.4g、磷酸鉀127.4g、1,2,4-三甲基苯600ml、2-丙醇120ml、及水120ml,在氮氣環境下,在回流溫度下攪拌6小時。將反應液冷卻至室溫後,藉由吸濾採集液中的固體,利用甲醇洗浄,獲得9-(3-乙氧基苯基)-10-(萘-2-基)蒽82g。 72.4 g of 1-bromo-3-ethoxybenzene, 104.5 g of (10-(naphthalen-2-yl)fluoren-9-yl)boronic acid, 10.4 g of Pd(PPh 3 ) 4 , and 127.4 g of potassium phosphate were added to the flask. 600 ml of 1,2,4-trimethylbenzene, 120 ml of 2-propanol, and 120 ml of water were stirred under a nitrogen atmosphere at reflux temperature for 6 hours. After cooling the reaction liquid to room temperature, the solid in the liquid was collected by suction filtration, and washed with methanol to obtain 82 g of 9-(3-ethoxyphenyl)-10-(naphthalen-2-yl)anthracene.
向燒瓶中添加9-(3-乙氧基苯基)-10-(萘-2-基)蒽82g及吡啶鹽酸鹽446.0g,在氮氣環境下,在回流溫度下攪拌8小時。將反應液冷卻至室溫後,添加水,藉由吸濾採集析出的固體,利用甲醇洗淨,再利用甲苯洗浄,獲得3-(10-(萘-2-基)蒽-9-基)苯酚76.0g。 82 g of 9-(3-ethoxyphenyl)-10-(naphthalen-2-yl)indole and 446.0 g of pyridine hydrochloride were added to the flask, and the mixture was stirred at reflux temperature for 8 hours under a nitrogen atmosphere. After cooling the reaction liquid to room temperature, water was added, and the precipitated solid was collected by suction filtration, washed with methanol, and washed with toluene to obtain 3-(10-(naphthalen-2-yl)fluoren-9-yl) Phenol 76.0 g.
將添加有3-(10-(萘-2-基)蒽-9-基)苯酚(76.0g)及吡啶(1L)的燒瓶在冰浴中冷卻,在氮氣環境下,向其中滴加三氟甲磺酸酐65.0g。滴加完畢後,進一步在室溫下攪拌15小時,添加水,藉由吸濾採集析出的固體。利用甲醇將該固體洗浄,獲得三氟甲烷磺酸3-(10-(萘-2-基)蒽-9-基)苯酯90.3g。 The flask to which 3-(10-(naphthalen-2-yl)fluoren-9-yl)phenol (76.0 g) and pyridine (1 L) were added was cooled in an ice bath, and trifluorogen was added dropwise thereto under a nitrogen atmosphere. Methanesulfonic anhydride 65.0 g. After completion of the dropwise addition, the mixture was further stirred at room temperature for 15 hours, water was added, and the precipitated solid was collected by suction filtration. The solid was washed with methanol to obtain 90.3 g of 3-(10-(naphthalen-2-yl)indol-9-yl)phenyl trifluoromethanesulfonate.
向燒瓶中添加三氟甲烷磺酸3-(10-(萘-2-基)蒽-9-基) 苯酯90.3g、聯硼酸頻那醇酯52.1g、雙(二亞苄基丙酮)鈀(0)7.4g、三環己基膦7.2g、乙酸鉀33.6g、碳酸鉀23.6g、及苯甲醚500ml,在回流溫度下攪拌5小時。將反應液冷卻至室溫後,利用塗敷有矽藻土的桐山漏斗進行吸濾而除去不溶物,利用EDTA‧4Na水溶液將濾液洗浄。利用庚烷將減壓蒸餾除去濾液的溶劑而獲得的固體洗浄,獲得4,4,5,5-四甲基-2-(3-(10-(萘-2-基)蒽-9-基)苯基)-1,3,2-二氧雜硼戊環(52.0g)。 Add 3-(10-(naphthalen-2-yl)fluoren-9-yl trifluoromethanesulfonate to the flask 90.3 g of phenyl ester, 52.1 g of pinacol borate, 7.4 g of bis(dibenzylideneacetone)palladium (0), 7.2 g of tricyclohexylphosphine, 33.6 g of potassium acetate, 23.6 g of potassium carbonate, and anisole 500 ml, stirred at reflux temperature for 5 hours. After cooling the reaction solution to room temperature, the insoluble matter was removed by suction filtration using a Kiriyama funnel coated with diatomaceous earth, and the filtrate was washed with an aqueous solution of EDTA‧4Na. The solid obtained by distilling off the solvent of the filtrate under reduced pressure was washed with heptane to obtain 4,4,5,5-tetramethyl-2-(3-(10-(naphthalen-2-yl)fluoren-9-yl) Phenyl)-1,3,2-dioxaborolane (52.0 g).
向燒瓶中添加4,4,5,5-四甲基-2-(3-(10-(萘-2-基)蒽-9-基)苯基)-1,3,2-二氧雜硼戊環8.6g、藉由日本專利特開2009-124114中記載的方法而合成的5'-溴-3-甲基-2,2'-聯吡啶5.1g、Pd(PPh3)4 0.6g、磷酸鉀7.2g、1,2,4-三甲基苯25ml、第三丁醇5ml、及水1ml,在回流溫度下攪拌2.5小時。將反應液冷卻至室溫後,添加水後,藉由吸濾採集液中的固體,利用甲醇洗浄。藉由矽膠管柱層析法(甲苯/乙酸乙酯=9/1(容積比))純化該固體,接著藉由活性碳管柱層析法進一步純化。濃縮溶液,從氯苯中進行再結晶,獲得化合物(1-14-14):3-甲基-5'-(3-(10-(萘-2-基)蒽-9-基)苯基)-2,2'-聯吡啶2.3g。藉由NMR測定而確認化合物的結構。 Add 4,4,5,5-tetramethyl-2-(3-(10-(naphthalen-2-yl)fluoren-9-yl)phenyl)-1,3,2-dioxa to the flask 8.5 g of boron pentane ring, 5.1 g of 5'-bromo-3-methyl-2,2'-bipyridine synthesized by the method described in JP-A-2009-124114, Pd(PPh 3 ) 4 0.6 g 7.2 g of potassium phosphate, 25 ml of 1,2,4-trimethylbenzene, 5 ml of third butanol, and 1 ml of water were stirred at reflux temperature for 2.5 hours. After cooling the reaction liquid to room temperature, water was added, and the solid in the liquid was collected by suction filtration, and washed with methanol. The solid was purified by oxime column chromatography (toluene / ethyl acetate = 9 / 1 (volume ratio)) and then purified further by activated carbon column chromatography. The solution is concentrated and recrystallized from chlorobenzene to give compound (1-14-14): 3-methyl-5'-(3-(10-(naphthalen-2-yl)fluoren-9-yl)phenyl 2,2'-bipyridyl 2.3 g. The structure of the compound was confirmed by NMR measurement.
1H-NMR(CDCl3):δ=9.05(m,1H),8.55(d,1H),8.11(dd,1H),8.09(d,1H),8.02(m,1H),8.00(s,1H),7.73-7.95(m,9H),7.60(m,5H),7.30-7.40(m,4H),7.23(m,1H), 2.56(s,3H)。 1 H-NMR (CDCl 3 ): δ=9.05 (m, 1H), 8.55 (d, 1H), 8.11 (dd, 1H), 8.09 (d, 1H), 8.02 (m, 1H), 8.00 (s, 1H), 7.73-7.95 (m, 9H), 7.60 (m, 5H), 7.30-7.40 (m, 4H), 7.23 (m, 1H), 2.56 (s, 3H).
將4,4,5,5-四甲基-2-(6-(10-苯基蒽-9-基)萘-2-基)-1,3,2-二氧雜硼戊環(2.0g)、4-溴-2-甲基吡啶(0.8g)、Pd(PPh3)4(0.3g)、磷酸鉀(1.7g)、1,2,4-三甲基苯(20ml)、第三丁醇(5ml)及水(1ml)添加到燒瓶中,在氮氣環境下在回流溫度下攪拌7.5小時。加熱完畢後,將反應液冷卻到室溫,添加水及甲苯進行液體分離。減壓蒸餾除去溶劑,藉由矽膠管柱層析法(展開液(developing solvent):甲苯/乙酸乙酯=95/5)純化所獲得的固體。接著,將所獲得的溶出液通入短活性碳管柱,除去著色成分。採集減壓蒸餾除去所獲得的濾液的過程中析出的結晶,獲得(1-11-1)所表示的化合物2-甲基-4-(6-(10-苯基蒽-9-基)萘-2-基)吡啶(0.7g)。 4,4,5,5-tetramethyl-2-(6-(10-phenylfluoren-9-yl)naphthalen-2-yl)-1,3,2-dioxaborolan (2.0 g), 4-bromo-2-methylpyridine (0.8 g), Pd(PPh 3 ) 4 (0.3 g), potassium phosphate (1.7 g), 1,2,4-trimethylbenzene (20 ml), Tributyl alcohol (5 ml) and water (1 ml) were added to the flask, and stirred at reflux temperature for 7.5 hours under a nitrogen atmosphere. After the completion of the heating, the reaction solution was cooled to room temperature, and water and toluene were added for liquid separation. The solvent was distilled off under reduced pressure, and the obtained solid was purified by silica gel column chromatography (developing solvent: toluene/ethyl acetate = 95/5). Next, the obtained eluate was passed through a short activated carbon tube column to remove the coloring component. The crystals precipitated during the distillation of the obtained filtrate were distilled off under reduced pressure to obtain the compound 2-methyl-4-(6-(10-phenylfluoren-9-yl)naphthalene represented by (1-11-1). 2-yl)pyridine (0.7 g).
藉由NMR測定而確認化合物的結構。 The structure of the compound was confirmed by NMR measurement.
1H-NMR(CDCl3):δ=8.66(d,1H),8.30(s,1H),8.17(d,1H),8.03(m,2H),7.87(d,1H),7.72-7.78(m,4H),7.70(d,1H),7.65(m,2H),7.58(m,2H),7.56(m,3H),7.31-7.39(m,4H),2.73(s,3H)。 1 H-NMR (CDCl 3 ): δ=8.66 (d, 1H), 8.30 (s, 1H), 8.17 (d, 1H), 8.03 (m, 2H), 7.87 (d, 1H), 7.72-7.78 ( m, 4H), 7.70 (d, 1H), 7.65 (m, 2H), 7.58 (m, 2H), 7.56 (m, 3H), 7.31-7.39 (m, 4H), 2.73 (s, 3H).
將4,4,5,5-四甲基-2-(6-(10-苯基蒽-9-基)萘-2-基)-1,3,2-二氧雜硼戊環(2.0g)、4-溴-3-甲基吡啶鹽酸鹽 (1.0g)、Pd(PPh3)4(0.3g)、磷酸鉀(1.7g)、1,2,4-三甲基苯(20ml)、第三丁醇(5ml)及水(1ml)添加到燒瓶中,在氮氣環境下,在回流溫度下攪拌24.5小時。加熱完畢後,將反應液冷卻到室溫,添加水及甲苯進行液體分離。減壓蒸餾除去溶劑,藉由矽膠管柱層析法(展開液:甲苯/乙酸乙酯=95/5)純化所獲得的固體。接著,將所獲得的溶出液通入短活性碳管柱,除去著色成分。採集減壓蒸餾除去所獲得的濾液的過程中析出的結晶,進一步在甲苯中進行再結晶,獲得(1-11-2)所表示的化合物3-甲基-4-(6-(10-苯基蒽-9-基)萘-2-基)吡啶(0.5g)。 4,4,5,5-tetramethyl-2-(6-(10-phenylfluoren-9-yl)naphthalen-2-yl)-1,3,2-dioxaborolan (2.0 g), 4-bromo-3-methylpyridine hydrochloride (1.0 g), Pd(PPh 3 ) 4 (0.3 g), potassium phosphate (1.7 g), 1,2,4-trimethylbenzene (20 ml) The third butanol (5 ml) and water (1 ml) were added to the flask, and the mixture was stirred at reflux temperature for 24.5 hours under a nitrogen atmosphere. After the completion of the heating, the reaction solution was cooled to room temperature, and water and toluene were added for liquid separation. The solvent was evaporated under reduced pressure, and the obtained solid was purified by silica gel column chromatography (eluent: toluene/ethyl acetate = 95/5). Next, the obtained eluate was passed through a short activated carbon tube column to remove the coloring component. The crystals precipitated in the process of removing the obtained filtrate by distillation under reduced pressure were further subjected to recrystallization in toluene to obtain the compound represented by (1-11-2) 3-methyl-4-(6-(10-benzene). Based on 9-yl)naphthalen-2-yl)pyridine (0.5 g).
藉由NMR測定而確認化合物的結構。 The structure of the compound was confirmed by NMR measurement.
1H-NMR(CDCl3):δ=8.62(s,1H),8.58(d,1H),8.13(d,1H),8.06(s,1H),8.02(d,1H),7.99(s,1H),7.75(d,4H),7.70(dd,1H),7.65(t,2H),7.59(t,2H),7.53(m,2H),7.33-7.39(m,5H),2.44(s,3H)。 1 H-NMR (CDCl 3 ): δ=8.62 (s, 1H), 8.58 (d, 1H), 8.13 (d, 1H), 8.06 (s, 1H), 8.02 (d, 1H), 7.99 (s, 1H), 7.75 (d, 4H), 7.70 (dd, 1H), 7.65 (t, 2H), 7.59 (t, 2H), 7.53 (m, 2H), 7.33 - 7.39 (m, 5H), 2.44 (s , 3H).
將4,4,5,5-四甲基-2-(6-(10-苯基蒽-9-基)萘-2-基)-1,3,2-二氧雜硼戊環(2.0g)、5-溴-2-甲基吡啶(0.8g)、Pd(PPh3)4(0.15g)、磷酸鉀(1.7g)、1,2,4-三甲基苯(20ml)、第三丁醇(5ml)及水(1ml)添加到燒瓶中,在氮氣環境下,在回流溫度下攪拌5小時。加熱完畢後,將反應液冷卻到室溫,添加水及甲苯進行液體分離。減壓蒸餾除去溶劑,藉由矽膠管柱層析法(展開液:甲苯/乙酸乙酯 =95/5)純化所獲得的固體。將減壓蒸餾除去溶劑而獲得的固體從甲苯中進行再結晶,獲得(1-11-3)所表示的化合物2-甲基-5-(6-(10-苯基蒽-9-基)萘-2-基)吡啶(1.2g)。 4,4,5,5-tetramethyl-2-(6-(10-phenylfluoren-9-yl)naphthalen-2-yl)-1,3,2-dioxaborolan (2.0 g), 5-bromo-2-methylpyridine (0.8 g), Pd(PPh 3 ) 4 (0.15 g), potassium phosphate (1.7 g), 1,2,4-trimethylbenzene (20 ml), Tributyl alcohol (5 ml) and water (1 ml) were added to the flask, and the mixture was stirred at reflux temperature for 5 hours under a nitrogen atmosphere. After the completion of the heating, the reaction solution was cooled to room temperature, and water and toluene were added for liquid separation. The solvent was evaporated under reduced pressure, and the obtained solid was purified by silica gel column chromatography (eluent: toluene/ethyl acetate = 95/5). The solid obtained by distilling off the solvent under reduced pressure was recrystallized from toluene to obtain the compound 2-methyl-5-(6-(10-phenylfluoren-9-yl) represented by (1-11-3). Naphthalen-2-yl)pyridine (1.2 g).
藉由NMR測定而確認化合物的結構。 The structure of the compound was confirmed by NMR measurement.
1H-NMR(CDCl3):δ=8.95(m,1H),8.20(s,1H),8.14(d,1H),8.01(m,2H),7.96(dd,1H),7.81(dd,1H),7.74(m,4H),7.67(dd,1H),7.63(t,2H),7.57(t,1H),7.52(m,2H),7.30-7.37(m,5H),2.67(s,3H)。 1 H-NMR (CDCl 3 ): δ=8.95 (m, 1H), 8.20 (s, 1H), 8.14 (d, 1H), 8.01 (m, 2H), 7.96 (dd, 1H), 7.81 (dd, 1H), 7.74 (m, 4H), 7.67 (dd, 1H), 7.63 (t, 2H), 7.57 (t, 1H), 7.52 (m, 2H), 7.30-7.37 (m, 5H), 2.67 (s) , 3H).
將4,4,5,5-四甲基-2-(6-(10-苯基蒽-9-基)萘-2-基)-1,3,2-二氧雜硼戊環(2.0g)、3-溴-5-甲基吡啶(0.8g)、Pd(PPh3)4(0.3g)、磷酸鉀(1.7g)、1,2,4-三甲基苯(20ml)、第三丁醇(5ml)及水(1ml)添加到燒瓶中,在氮氣環境下,在回流溫度下攪拌7.5小時。加熱完畢後,將反應液冷卻到室溫,添加水及甲苯進行液體分離。減壓蒸餾除去溶劑,藉由矽膠管柱層析法(展開液:甲苯/乙酸乙酯=95/5)純化所獲得的固體。接著,將所獲得的溶出液通入短活性碳管柱,除去著色成分。減壓蒸餾除去溶劑,添加庚烷進行再沈澱,獲得(1-11-4)所表示的化合物3-甲基-5-(6-(10-苯基蒽-9-基)萘-2-基)吡啶(1.3g)。 4,4,5,5-tetramethyl-2-(6-(10-phenylfluoren-9-yl)naphthalen-2-yl)-1,3,2-dioxaborolan (2.0 g), 3-bromo-5-methylpyridine (0.8 g), Pd(PPh 3 ) 4 (0.3 g), potassium phosphate (1.7 g), 1,2,4-trimethylbenzene (20 ml), Tributyl alcohol (5 ml) and water (1 ml) were added to the flask, and the mixture was stirred at reflux temperature for 7.5 hours under a nitrogen atmosphere. After the completion of the heating, the reaction solution was cooled to room temperature, and water and toluene were added for liquid separation. The solvent was evaporated under reduced pressure, and the obtained solid was purified by silica gel column chromatography (eluent: toluene/ethyl acetate = 95/5). Next, the obtained eluate was passed through a short activated carbon tube column to remove the coloring component. The solvent was distilled off under reduced pressure, and heptane was added for reprecipitation to obtain the compound represented by (1-11-4) 3-methyl-5-(6-(10-phenylfluoren-9-yl)naphthalene-2- Pyridine (1.3 g).
藉由NMR測定而確認化合物的結構。 The structure of the compound was confirmed by NMR measurement.
1H-NMR(CDCl3):δ=8.87(m,1H),8.51(m,1H),8.22(s,1H),8.15(d,1H),8.03(m,2H),7.89(m,1H), 7.83(dd,1H),7.73(m,4H),7.67(dd,1H),7.63(m,2H),7.57(t,1H),7.52(m,2H),7.30-7.37(m,4H),2.49(s,3H)。 1 H-NMR (CDCl 3 ): δ=8.87 (m, 1H), 8.51 (m, 1H), 8.22 (s, 1H), 8.15 (d, 1H), 8.03 (m, 2H), 7.89 (m, 1H), 7.83 (dd, 1H), 7.73 (m, 4H), 7.67 (dd, 1H), 7.63 (m, 2H), 7.57 (t, 1H), 7.52 (m, 2H), 7.30-7.37 (m) , 4H), 2.49 (s, 3H).
將4,4,5,5-四甲基-2-(6-(10-苯基蒽-9-基)萘-2-基)-1,3,2-二氧雜硼戊環(2.0g)、3-溴-4-甲基吡啶鹽酸鹽(1.0g)、Pd(PPh3)4(0.3g)、磷酸鉀(1.7g)、1,2,4-三甲基苯(20ml)、第三丁醇(5ml)及水(1ml)添加到燒瓶中,在氮氣環境下,在回流溫度下攪拌7小時。加熱完畢後,將反應液冷卻到室溫,添加水及甲苯進行液體分離。減壓蒸餾除去溶劑,藉由矽膠管柱層析法(展開液:甲苯/乙酸乙酯=95/5)純化所獲得的固體。接著,將所獲得的溶出液通入短活性碳管柱,除去著色成分。減壓蒸餾除去溶劑,將所獲得的固體從甲苯中進行再結晶,獲得(1-11-5)所表示的化合物4-甲基-3-(6-(10-苯基蒽-9-基)萘-2-基)吡啶(0.6g)。 4,4,5,5-tetramethyl-2-(6-(10-phenylfluoren-9-yl)naphthalen-2-yl)-1,3,2-dioxaborolan (2.0 g), 3-bromo-4-methylpyridine hydrochloride (1.0 g), Pd(PPh 3 ) 4 (0.3 g), potassium phosphate (1.7 g), 1,2,4-trimethylbenzene (20 ml) ), tert-butanol (5 ml) and water (1 ml) were added to the flask, and the mixture was stirred at reflux temperature for 7 hours under a nitrogen atmosphere. After the completion of the heating, the reaction solution was cooled to room temperature, and water and toluene were added for liquid separation. The solvent was evaporated under reduced pressure, and the obtained solid was purified by silica gel column chromatography (eluent: toluene/ethyl acetate = 95/5). Next, the obtained eluate was passed through a short activated carbon tube column to remove the coloring component. The solvent was distilled off under reduced pressure, and the obtained solid was recrystallized from toluene to obtain the compound (1-11-5) represented by (1-11-5) 4-methyl-3-(6-(10-phenylfluoren-9-yl) Naphthyl-2-yl)pyridine (0.6 g).
藉由NMR測定而確認化合物的結構。 The structure of the compound was confirmed by NMR measurement.
1H-NMR(CDCl3):δ=8.64(s,1H),8.55(d,1H),8.14(d,1H),8.06(s,1H),8.02(d,1H),7.99(s,1H),7.76(m,4H),7.70(dd,1H),7.63(m,2H),7.59(t,2H),7.53(m,2H),7.32-7.39(m,4H),7.30(d,1H),2.45(s,3H)。 1 H-NMR (CDCl 3 ): δ=8.64 (s, 1H), 8.55 (d, 1H), 8.14 (d, 1H), 8.06 (s, 1H), 8.02 (d, 1H), 7.99 (s, 1H), 7.76 (m, 4H), 7.70 (dd, 1H), 7.63 (m, 2H), 7.59 (t, 2H), 7.53 (m, 2H), 7.32 - 7.39 (m, 4H), 7.30 (d) , 1H), 2.45 (s, 3H).
將4,4,5,5-四甲基-2-(6-(10-苯基蒽-9-基)萘-2- 基)-1,3,2-二氧雜硼戊環(2.0g)、3-溴-2-甲基吡啶(0.8g)、Pd(PPh3)4(0.15g)、磷酸鉀(1.7g)、1,2,4-三甲基苯(20ml)、第三丁醇(5ml)及水(1ml)添加到燒瓶中,在氮氣環境下,在回流溫度下攪拌4小時。加熱完畢後,將反應液冷卻到室溫,添加水及甲苯進行液體分離。減壓蒸餾除去溶劑,藉由矽膠管柱層析法(展開液:甲苯/乙酸乙酯=95/5)純化所獲得的固體。接著,將所獲得的溶出液通入短活性碳管柱,除去著色成分。減壓蒸餾除去溶劑,添加庚烷進行再沈澱,獲得(1-11-6)所表示的化合物2-甲基-3-(6-(10-苯基蒽-9-基)萘-2-基)吡啶(1.1g)。 4,4,5,5-tetramethyl-2-(6-(10-phenylfluoren-9-yl)naphthalen-2-yl)-1,3,2-dioxaborolan (2.0 g), 3-bromo-2-methylpyridine (0.8 g), Pd(PPh 3 ) 4 (0.15 g), potassium phosphate (1.7 g), 1,2,4-trimethylbenzene (20 ml), Tributyl alcohol (5 ml) and water (1 ml) were added to the flask, and the mixture was stirred at reflux temperature for 4 hours under a nitrogen atmosphere. After the completion of the heating, the reaction solution was cooled to room temperature, and water and toluene were added for liquid separation. The solvent was evaporated under reduced pressure, and the obtained solid was purified by silica gel column chromatography (eluent: toluene/ethyl acetate = 95/5). Next, the obtained eluate was passed through a short activated carbon tube column to remove the coloring component. The solvent was distilled off under reduced pressure, and heptane was added for reprecipitation to obtain a compound represented by (1-11-6) 2-methyl-3-(6-(10-phenylfluoren-9-yl)naphthalene-2- Pyridine (1.1 g).
藉由NMR測定而確認化合物的結構。 The structure of the compound was confirmed by NMR measurement.
1H-NMR(CDCl3):δ=8.60(m,1H),8.11(d,1H),8.05(s,1H),8.00(d,1H),7.96(s,1H),7.74(m,4H),7.69(m,2H),7.63(m,2H),7.57(m,2H),7.52(m,2H),7.30-7.37(m,4H),7.28(m,1H),2.66(s,3H)。 1 H-NMR (CDCl 3 ): δ=8.60 (m, 1H), 8.11 (d, 1H), 8.05 (s, 1H), 8.00 (d, 1H), 7.96 (s, 1H), 7.74 (m, 4H), 7.69 (m, 2H), 7.63 (m, 2H), 7.57 (m, 2H), 7.52 (m, 2H), 7.30-7.37 (m, 4H), 7.28 (m, 1H), 2.66 (s) , 3H).
將4,4,5,5-四甲基-2-(6-(10-苯基蒽-9-基)萘-2-基)-1,3,2-二氧雜硼戊環(2.5g)、3-溴-2-甲基吡啶(1.0g)、Pd(PPh3)4(0.15g)、磷酸鉀(2.1g)、1,2,4-三甲基苯(20ml)、第三丁醇(5ml)及水(1ml)添加到燒瓶中,在氮氣環境下,在回流溫度下攪拌18小時。加熱完畢後,將反應液冷卻到室溫,藉由吸濾採集析出的固體。藉由矽膠管柱層析法(展開液:甲苯)純化所獲得的固體。接著,將 所獲得的溶出液通入短活性碳管柱,除去著色成分。減壓蒸餾除去溶劑,添加乙酸乙酯進行再沈澱,獲得(1-11-8)所表示的化合物5-甲基-2-(6-(10-苯基蒽-9-基)萘-2-基)吡啶(1.5g)。 4,4,5,5-tetramethyl-2-(6-(10-phenylfluoren-9-yl)naphthalen-2-yl)-1,3,2-dioxaborolan (2.5 g), 3-bromo-2-methylpyridine (1.0 g), Pd(PPh 3 ) 4 (0.15 g), potassium phosphate (2.1 g), 1,2,4-trimethylbenzene (20 ml), Tributyl alcohol (5 ml) and water (1 ml) were added to the flask, and the mixture was stirred at reflux temperature for 18 hours under a nitrogen atmosphere. After the completion of the heating, the reaction solution was cooled to room temperature, and the precipitated solid was collected by suction filtration. The obtained solid was purified by oxime column chromatography (developing solution: toluene). Next, the obtained eluate was passed through a short activated carbon tube column to remove the coloring component. The solvent was distilled off under reduced pressure, and ethyl acetate was added to reprecipitate to obtain the compound 5-methyl-2-(6-(10-phenylfluoren-9-yl)naphthalene-2 represented by (1-11-8). -yl)pyridine (1.5 g).
藉由NMR測定而確認化合物的結構。 The structure of the compound was confirmed by NMR measurement.
1H-NMR(CDCl3):δ=8.63(m,2H),8.23(dd,1H),8.16(d,1H),8.00(m,2H),7.86(d,1H),7.73(m,4H),7.60-7.67(m,4H),7.56(t,1H),7.51(m,2H),7.30-7.36(m,4H),2.44(s,3H)。 1 H-NMR (CDCl 3 ): δ=8.63 (m, 2H), 8.23 (dd, 1H), 8.16 (d, 1H), 8.00 (m, 2H), 7.86 (d, 1H), 7.73 (m, 4H), 7.60-7.67 (m, 4H), 7.56 (t, 1H), 7.51 (m, 2H), 7.30-7.36 (m, 4H), 2.44 (s, 3H).
將添加有4-溴-2-甲基吡啶(13.8g)及甲苯(150ml)的燒瓶在丙酮/乾冰浴中冷卻。向該溶液中滴加1.6M的正丁基鋰的己烷溶液(55ml)。滴加完畢後,一邊在丙酮/乾冰浴中冷卻一邊攪拌1小時,添加氯化鋅四甲基乙二胺(29.3g)及THF(45ml),撤去丙酮/乾冰浴並升溫。在升溫到室溫後,添加甲苯(20ml)、3,5-二溴吡啶(19.0g)及Pd(PPh3)4(2.8g),在回流溫度下攪拌2小時。將反應液冷卻至室溫後,EDTA‧4Na水溶液及甲苯進行液體分離。在減壓蒸餾除去溶劑後,藉由矽膠管柱層析法(展開液:甲苯/乙酸乙酯)純化所獲得的固體。此時,參考「有機化學實驗入門(1)-物質處理法與分離純化法-」化學同人出版股份有限公司、第94頁所記載的方法,緩慢地增加展開液中的乙酸乙酯的比率,使目標物溶出。接著,減壓蒸餾 除去溶劑,將所獲得的固體從庚烷進行再結晶,獲得5-溴-2'-甲基-3,4'-聯吡啶(5.3g)。 A flask to which 4-bromo-2-methylpyridine (13.8 g) and toluene (150 ml) were added was cooled in an acetone/dry ice bath. To the solution was added dropwise a 1.6 M solution of n-butyllithium in hexane (55 ml). After completion of the dropwise addition, the mixture was stirred for 1 hour while cooling in an acetone/dry ice bath, and zinc chloride tetramethylethylenediamine (29.3 g) and THF (45 ml) were added thereto, and the acetone/dry ice bath was removed and the temperature was raised. After warming to room temperature, toluene (20 ml), 3,5-dibromopyridine (19.0 g) and Pd(PPh 3 ) 4 (2.8 g) were added, and the mixture was stirred at reflux temperature for 2 hours. After cooling the reaction solution to room temperature, the EDTA‧4Na aqueous solution and toluene were separated by liquid. After the solvent was distilled off under reduced pressure, the obtained solid was purified by silica gel column chromatography (eluent: toluene / ethyl acetate). At this time, refer to the method described in "Introduction to Organic Chemistry (1) - Substance Treatment and Separation and Purification -" Chemicals, Inc., page 94, to slowly increase the ratio of ethyl acetate in the developing solution. The target is dissolved. Then, the solvent was distilled off under reduced pressure, and the obtained solid was recrystallized from heptane to obtain 5-bromo-2'-methyl-3,4'-bipyridine (5.3 g).
將4,4,5,5-四甲基-2-(6-(10-苯基蒽-9-基)萘-2-基)-1,3,2-二氧雜硼戊環(2.5g)、5-溴-2'-甲基-3,4'-聯吡啶(1.1g)、Pd(PPh3)4(0.15g)、磷酸鉀(1.7g)、1,2,4-三甲基苯(20ml)、第三丁醇(5ml)及水(1ml)添加到燒瓶中,在氮氣環境下,在回流溫度下攪拌3小時。加熱完畢後,將反應液冷卻到室溫,添加水及甲苯進行液體分離。減壓蒸餾除去溶劑,藉由矽膠管柱層析法(展開液:甲苯/乙酸乙酯=1/1)純化所獲得的固體。減壓蒸餾除去溶劑,將所獲得的固體從甲苯中進行再結晶,獲得(1-11-39)所表示的化合物2'-甲基-5-(6-(10-苯基蒽-9-基)萘-2-基)-3,4'-聯吡啶(0.3g)。 4,4,5,5-tetramethyl-2-(6-(10-phenylfluoren-9-yl)naphthalen-2-yl)-1,3,2-dioxaborolan (2.5 g), 5-bromo-2'-methyl-3,4'-bipyridine (1.1 g), Pd(PPh 3 ) 4 (0.15 g), potassium phosphate (1.7 g), 1,2,4-three Methylbenzene (20 ml), tert-butanol (5 ml) and water (1 ml) were added to the flask, and stirred at reflux temperature for 3 hours under a nitrogen atmosphere. After the completion of the heating, the reaction solution was cooled to room temperature, and water and toluene were added for liquid separation. The solvent was evaporated under reduced pressure, and the obtained solid was purified by silica gel column chromatography (eluent: toluene/ethyl acetate = 1/1). The solvent was distilled off under reduced pressure, and the obtained solid was recrystallized from toluene to obtain the compound 2'-methyl-5-(6-(10-phenylindole-9-) represented by (1-11-39). Naphthyl-2-yl)-3,4'-bipyridine (0.3 g).
藉由NMR測定而確認化合物的結構。 The structure of the compound was confirmed by NMR measurement.
1H-NMR(CDCl3):δ=9.11(m,1H),8.92(m,1H),8.65(d,1H),8.28(m,2H),8.17(d,1H),8.05(m,2H),7.87(d,1H),7.68-7.75(m,5H),7.61(m,2H),7.56(t,1H),7.51(m,3H),7.45(m,1H),7.30-7.37(m,4H),2.70(s,3H)。 1 H-NMR (CDCl 3 ): δ=9.11 (m, 1H), 8.92 (m, 1H), 8.65 (d, 1H), 8.28 (m, 2H), 8.17 (d, 1H), 8.05 (m, 2H), 7.87 (d, 1H), 7.68-7.75 (m, 5H), 7.61 (m, 2H), 7.56 (t, 1H), 7.51 (m, 3H), 7.45 (m, 1H), 7.30-7.37 (m, 4H), 2.70 (s, 3H).
添加4,4,5,5-四甲基-2-(3-(10-(萘-2-基)蒽-9-基)苯 基)-1,3,2-二氧雜硼戊環(2.5g)、4-溴-3-甲基吡啶鹽酸鹽(1.3g)、Pd(PPh3)4(0.35g)、磷酸鉀(3.2g)、1,2,4-三甲基苯20ml、第三丁醇5ml、及水1ml,在回流溫度下攪拌11.5小時。將反應液冷卻至室溫後,添加甲苯及水進行液體分離。減壓蒸餾除去溶劑,藉由矽膠管柱層析法(展開液:甲苯/乙酸乙酯=95/5)純化所獲得的固體。接著,將所獲得的溶出液通入短活性碳管柱,除去著色成分。減壓蒸餾除去溶劑,添加庚烷進行再沈澱,獲得(1-14-2)所表示的化合物3-甲基-4-(3-(10-(萘-2-基)蒽-9-基)苯基)吡啶(1.4g)。 Add 4,4,5,5-tetramethyl-2-(3-(10-(naphthalen-2-yl)indol-9-yl)phenyl)-1,3,2-dioxaborolan (2.5g), 4-bromo-3-methylpyridine hydrochloride (1.3g), Pd(PPh 3 ) 4 (0.35g), potassium phosphate (3.2g), 1,2,4-trimethylbenzene 20 ml, 5 ml of third butanol, and 1 ml of water were stirred at reflux temperature for 11.5 hours. After cooling the reaction solution to room temperature, toluene and water were added to carry out liquid separation. The solvent was evaporated under reduced pressure, and the obtained solid was purified by silica gel column chromatography (eluent: toluene/ethyl acetate = 95/5). Next, the obtained eluate was passed through a short activated carbon tube column to remove the coloring component. The solvent was distilled off under reduced pressure, and heptane was added for reprecipitation to obtain the compound 3-methyl-4-(3-(10-(naphthalen-2-yl)fluoren-9-yl) represented by (1-14-2). Phenyl)pyridine (1.4 g).
藉由NMR測定而確認化合物的結構。 The structure of the compound was confirmed by NMR measurement.
1H-NMR(CDCl3):δ=8.53(s,1H),8.50(d,1H),8.08(dd,1H),8.02(m,1H),7.97(d,1H),7.92(m,1H),7.70-7.78(m,5H),7.48-7.63(m,6H),7.35-7.39(m,2H),7.29-7.34(m,3H),2.41(s,3H)。 1 H-NMR (CDCl 3 ): δ=8.53 (s, 1H), 8.50 (d, 1H), 8.08 (dd, 1H), 8.02 (m, 1H), 7.97 (d, 1H), 7.92 (m, 1H), 7.70-7.78 (m, 5H), 7.48-7.63 (m, 6H), 7.35-7.39 (m, 2H), 7.29-7.34 (m, 3H), 2.41 (s, 3H).
添加4,4,5,5-四甲基-2-(3-(10-(萘-2-基)蒽-9-基)苯基)-1,3,2-二氧雜硼戊環(2.5g)、5-溴-2-甲基吡啶(1.0g)、Pd(PPh3)4(0.35g)、磷酸鉀(3.2g)、1,2,4-三甲基苯20ml、第三丁醇5ml、及水1ml,在回流溫度下攪拌8.5小時。將反應液冷卻至室溫後,藉由吸濾採集析出的固體。藉由矽膠管柱層析法(展開液:甲苯/乙酸乙酯=95/5)純化所 獲得的固體。接著,將所獲得的溶出液通入短活性碳管柱,除去著色成分。減壓蒸餾除去溶劑,將所獲得的固體利用乙酸乙酯洗浄,獲得(1-14-3)所表示的化合物2-甲基-5-(3-(10-(萘-2-基)蒽-9-基)苯基)吡啶(1.5g)。 Add 4,4,5,5-tetramethyl-2-(3-(10-(naphthalen-2-yl)indol-9-yl)phenyl)-1,3,2-dioxaborolan (2.5 g), 5-bromo-2-methylpyridine (1.0 g), Pd(PPh 3 ) 4 (0.35 g), potassium phosphate (3.2 g), 1,2,4-trimethylbenzene 20 ml, 5 ml of tributyl alcohol and 1 ml of water were stirred at reflux temperature for 8.5 hours. After the reaction solution was cooled to room temperature, the precipitated solid was collected by suction filtration. The obtained solid was purified by hydrazine column chromatography (developing solvent: toluene / ethyl acetate = 95/5). Next, the obtained eluate was passed through a short activated carbon tube column to remove the coloring component. The solvent was distilled off under reduced pressure, and the obtained solid was washed with ethyl acetate to give the compound 2-methyl-5-(3-(10-(naphthalen-2-yl)) represented by (1-14-3). -9-yl)phenyl)pyridine (1.5 g).
藉由NMR測定而確認化合物的結構。 The structure of the compound was confirmed by NMR measurement.
1H-NMR(CDCl3):δ=8.45(m,1H),8.08(d,1H),8.03(m,1H),7.99(s,1H),7.93(m,1H),7.87(dd,1H),7.70-7.81(m,7H),7.57-7.63(m,3H),7.54(m,1H),7.30-7.40(m,4H),7.23(d,1H),2.61(s,3H)。 1 H-NMR (CDCl 3 ): δ=8.45 (m, 1H), 8.08 (d, 1H), 8.03 (m, 1H), 7.99 (s, 1H), 7.93 (m, 1H), 7.78 (dd, 1H), 7.70-7.81 (m, 7H), 7.57-7.63 (m, 3H), 7.54 (m, 1H), 7.30-7.40 (m, 4H), 7.23 (d, 1H), 2.61 (s, 3H) .
將添加有2-溴-6-甲基吡啶(5.2g)及環戊基甲基醚(30ml)的燒瓶在甲醇/乾冰浴中冷卻。向該溶液中滴加1.6M的正丁基鋰的己烷溶液(22ml)。滴加完畢後,一邊在甲醇/乾冰浴中冷卻一邊攪拌2小時,添加氯化鋅四甲基乙二胺(8.3g),撤去甲醇/乾冰浴並升溫。在升溫到室溫後,添加2,5-二溴吡啶(7.1g)及Pd(PPh3)4(1.0g),在回流溫度下攪拌3.5小時。將反應液冷卻至室溫後,添加EDTA‧4Na水溶液及甲苯進行液體分離。在減壓蒸餾除去溶劑後,藉由矽膠管柱層析法(展開液:甲苯/乙酸乙酯)純化所獲得的固體。此時,緩慢地增加展開液中的乙酸乙酯的比率,使目標物溶出。接著,減壓蒸餾除去溶劑,將所獲得的固體從庚烷中進行再結晶,獲得5-溴-6'-甲基-2,2'-聯吡啶(1.4g)。 A flask to which 2-bromo-6-methylpyridine (5.2 g) and cyclopentylmethyl ether (30 ml) were added was cooled in a methanol/dry ice bath. To the solution was added dropwise a 1.6 M solution of n-butyllithium in hexane (22 ml). After completion of the dropwise addition, the mixture was stirred for 2 hours while cooling in a methanol/dry ice bath, and zinc chloride tetramethylethylenediamine (8.3 g) was added thereto, and the methanol/dry ice bath was removed and the temperature was raised. After warming to room temperature, 2,5-dibromopyridine (7.1 g) and Pd(PPh 3 ) 4 (1.0 g) were added, and the mixture was stirred at reflux temperature for 3.5 hours. After cooling the reaction solution to room temperature, an aqueous solution of EDTA‧4Na and toluene were added to carry out liquid separation. After the solvent was distilled off under reduced pressure, the obtained solid was purified by silica gel column chromatography (eluent: toluene / ethyl acetate). At this time, the ratio of ethyl acetate in the developing solution was gradually increased to elute the target. Then, the solvent was distilled off under reduced pressure, and the obtained solid was recrystallized from heptane to obtain 5-bromo-6'-methyl-2,2'-bipyridine (1.4 g).
添加4,4,5,5-四甲基-2-(3-(10-(萘-2-基)蒽-9-基)苯基)-1,3,2-二氧雜硼戊環(2.0g)、5-溴-6'-甲基-2,2'-聯吡啶(1.0g)、Pd(PPh3)4(0.15g)、磷酸鉀(1.7g)、1,2,4-三甲基苯20ml、第三丁醇5ml、及水1ml,在回流溫度下攪拌7.5小時。將反應液冷卻至室溫後,藉由吸濾採集析出的固體。藉由矽膠管柱層析法(展開液:甲苯/乙酸乙酯=95/5)純化所獲得的固體,將所獲得的溶出液直接使用塗敷有活性碳的桐山漏斗進行吸濾,除去著色成分。減壓蒸餾除去溶劑,添加乙酸乙酯進行再沈澱,獲得(1-14-11)所表示的化合物6'-甲基-5-(3-(10-(萘-2-基)蒽-9-基)苯基)-2,2'-聯吡啶(1.2g)。 Add 4,4,5,5-tetramethyl-2-(3-(10-(naphthalen-2-yl)indol-9-yl)phenyl)-1,3,2-dioxaborolan (2.0 g), 5-bromo-6'-methyl-2,2'-bipyridine (1.0 g), Pd(PPh 3 ) 4 (0.15 g), potassium phosphate (1.7 g), 1, 2, 4 20 ml of trimethylbenzene, 5 ml of third butanol, and 1 ml of water were stirred at reflux temperature for 7.5 hours. After the reaction solution was cooled to room temperature, the precipitated solid was collected by suction filtration. The obtained solid was purified by a silica gel column chromatography (developing solution: toluene/ethyl acetate = 95/5), and the obtained eluate was directly subjected to suction filtration using a Kiriyama funnel coated with activated carbon to remove the coloring. ingredient. The solvent was distilled off under reduced pressure, and ethyl acetate was added to reprecipitate to obtain the compound 6'-methyl-5-(3-(10-(naphthalen-2-yl)indole-9) represented by (1-14-11). -yl)phenyl)-2,2'-bipyridine (1.2 g).
藉由NMR測定而確認化合物的結構。 The structure of the compound was confirmed by NMR measurement.
1H-NMR(CDCl3):δ=9.03(m,1H),8.49(dd,1H),8.22(d,1H),8.09(m,2H),8.03(m,1H),8.00(s,1H),7.93(m,1H),7.87(d,1H),7.68-7.83(m,7H),7.55-7.64(m,4H),7.30-7.40(m,4H),7.17(d,1H),2.65(s,3H)。 1 H-NMR (CDCl 3 ): δ=9.03 (m, 1H), 8.49 (dd, 1H), 8.22 (d, 1H), 8.09 (m, 2H), 8.03 (m, 1H), 8.00 (s, 1H), 7.93 (m, 1H), 7.87 (d, 1H), 7.68-7.83 (m, 7H), 7.55-7.64 (m, 4H), 7.30-7.40 (m, 4H), 7.17 (d, 1H) , 2.65 (s, 3H).
將添加有2-溴-5-甲基吡啶(1.7g)及THF(5ml)的燒瓶在冰浴中冷卻,向該溶液中滴加2M的異丙基氯化鎂的THF溶液(5.5ml)。滴加完畢後,撤去冰浴在室溫下攪拌3.5小時後,再次在冰浴中冷卻,添加氯化鋅四甲基乙 二胺(2.8g)。撤去冰浴並升溫到室溫後,添加2,5-二溴吡啶(2.4g)及Pd(PPh3)4(0.35g),在回流溫度下攪拌1.5小時。將反應液冷卻至室溫後,添加EDTA‧4Na水溶液及甲苯進行液體分離。在減壓蒸餾除去溶劑後,藉由矽膠管柱層析法(展開液:甲苯/乙酸乙酯=9/1)純化所獲得的固體。減壓蒸餾除去溶劑,添加庚烷進行再沈澱,獲得5-溴-5'-甲基-2,2'-聯吡啶(1.5g)。 The flask to which 2-bromo-5-methylpyridine (1.7 g) and THF (5 ml) were added was cooled in an ice bath, and a 2 M solution of isopropylmagnesium chloride in THF (5.5 ml) was added dropwise. After completion of the dropwise addition, the ice bath was removed and stirred at room temperature for 3.5 hours, and then cooled again in an ice bath, and zinc chloride tetramethylethylenediamine (2.8 g) was added. After removing the ice bath and warming to room temperature, 2,5-dibromopyridine (2.4 g) and Pd(PPh 3 ) 4 (0.35 g) were added, and the mixture was stirred at reflux temperature for 1.5 hours. After cooling the reaction solution to room temperature, an aqueous solution of EDTA‧4Na and toluene were added to carry out liquid separation. After distilling off the solvent under reduced pressure, the obtained solid was purified by silica gel column chromatography (eluent: toluene/ethyl acetate = 9/1). The solvent was distilled off under reduced pressure, and heptane was added and reprecipitated to obtain 5-bromo-5'-methyl-2,2'-bipyridine (1.5 g).
添加4,4,5,5-四甲基-2-(3-(10-(萘-2-基)蒽-9-基)苯基)-1,3,2-二氧雜硼戊環(2.0g)、5-溴-5'-甲基-2,2'-聯吡啶(1.2g)、Pd(PPh3)4(0.15g)、磷酸鉀(1.7g)、1,2,4-三甲基苯20ml、第三丁醇5ml、及水1ml,在回流溫度下攪拌6小時。將反應液冷卻至室溫後,添加甲苯及水進行液體分離。減壓蒸餾除去溶劑,藉由矽膠管柱層析法(展開液:甲苯/乙酸乙酯=95/5)純化所獲得的固體,將所獲得的溶出液通入短活性碳管柱,除去著色成分。減壓蒸餾除去溶劑,添加乙酸乙酯進行再沈澱,將所獲得的固體進一步從甲苯中進行再結晶,獲得(1-14-12)所表示的化合物5-甲基-5'-(3-(10-(萘-2-基)蒽-9-基)苯基)-2,2'-聯吡啶(1.2g)。 Add 4,4,5,5-tetramethyl-2-(3-(10-(naphthalen-2-yl)indol-9-yl)phenyl)-1,3,2-dioxaborolan (2.0 g), 5-bromo-5'-methyl-2,2'-bipyridine (1.2 g), Pd(PPh 3 ) 4 (0.15 g), potassium phosphate (1.7 g), 1,2,4 20 ml of trimethylbenzene, 5 ml of third butanol, and 1 ml of water were stirred at reflux temperature for 6 hours. After cooling the reaction solution to room temperature, toluene and water were added to carry out liquid separation. The solvent was distilled off under reduced pressure, and the obtained solid was purified by silica gel column chromatography (developing solvent: toluene/ethyl acetate = 95/5), and the obtained solvent was passed through a short activated carbon tube column to remove the coloring. ingredient. The solvent was distilled off under reduced pressure, and ethyl acetate was added to reprecipitate, and the obtained solid was further recrystallized from toluene to obtain a compound represented by (1-14-12) 5-methyl-5'-(3- (10-(Naphthalen-2-yl)fluoren-9-yl)phenyl)-2,2'-bipyridine (1.2 g).
藉由NMR測定而確認化合物的結構。 The structure of the compound was confirmed by NMR measurement.
1H-NMR(CDCl3):δ=9.03(m,1H),8.52(s,1H),8.44(dd,1H),8.33(d,1H),8.09(m,1H),8.03(m,1H),8.00 (s,2H),7.93(m,1H),7.87(m,1H),7.73-7.83(m,6H),7.56-7.66(m,5H),7.31-7.39(m,4H),2.41(s,3H)。 1 H-NMR (CDCl 3 ): δ=9.03 (m, 1H), 8.52 (s, 1H), 8.44 (dd, 1H), 8.33 (d, 1H), 8.09 (m, 1H), 8.03 (m, 1H), 8.00 (s, 2H), 7.93 (m, 1H), 7.87 (m, 1H), 7.73-7.83 (m, 6H), 7.56-7.66 (m, 5H), 7.31-7.39 (m, 4H) , 2.41 (s, 3H).
將添加有2-溴-4-甲基吡啶(6.9g)及THF(20ml)的燒瓶在冰浴中冷卻,向該溶液中滴加2M的異丙基氯化鎂的THF溶液(24ml)。滴加完畢後,撤去冰浴在室溫下攪拌1小時後,再次在冰浴中冷卻,添加氯化鋅四甲基乙二胺(12.1g)。撤去冰浴並升溫到室溫後,添加2,5-二溴吡啶(9.5g)及Pd(PPh3)4(1.4g),在回流溫度下攪拌2.5小時。將反應液冷卻至室溫後,添加EDTA‧4Na水溶液及甲苯進行液體分離。在減壓蒸餾除去溶劑後,藉由矽膠管柱層析法(展開液:甲苯/乙酸乙酯=9/1)純化所獲得的固體。減壓蒸餾除去溶劑,將所獲得的固體從庚烷中進行再結晶,獲得5'-溴-4-甲基-2,2'-聯吡啶(5.5g)。 A flask to which 2-bromo-4-methylpyridine (6.9 g) and THF (20 ml) were added was cooled in an ice bath, and a 2 M solution of isopropylmagnesium chloride in THF (24 ml) was added dropwise. After completion of the dropwise addition, the ice bath was removed and stirred at room temperature for 1 hour, and then cooled again in an ice bath, and zinc chloride tetramethylethylenediamine (12.1 g) was added. After removing the ice bath and warming to room temperature, 2,5-dibromopyridine (9.5 g) and Pd(PPh 3 ) 4 (1.4 g) were added, and the mixture was stirred at reflux temperature for 2.5 hours. After cooling the reaction solution to room temperature, an aqueous solution of EDTA‧4Na and toluene were added to carry out liquid separation. After distilling off the solvent under reduced pressure, the obtained solid was purified by silica gel column chromatography (eluent: toluene/ethyl acetate = 9/1). The solvent was distilled off under reduced pressure, and the obtained solid was recrystallized from heptane to obtain 5'-bromo-4-methyl-2,2'-bipyridine (5.5 g).
添加4,4,5,5-四甲基-2-(3-(10-(萘-2-基)蒽-9-基)苯基)-1,3,2-二氧雜硼戊環(2.0g)、5'-溴-4-甲基-2,2'-聯吡啶(1.2g)、Pd(PPh3)4(0.15g)、磷酸鉀(1.7g)、1,2,4-三甲基苯20ml、第三丁醇5ml、及水1ml,在回流溫度下攪拌16小時。將反應液冷卻至室溫後,添加甲苯及水進行液體分離。減壓蒸餾除去溶劑,藉由矽膠管柱層析法(展開液:甲苯/乙酸乙酯=95/5)純化所獲得的固體,將所獲得 的溶出液通入短活性碳管柱,除去著色成分。減壓蒸餾除去溶劑,利用庚烷洗浄,藉此獲得(1-14-13)所表示的化合物4-甲基-5'-(3-(10-(萘-2-基)蒽-9-基)苯基)-2,2'-聯吡啶(1.4g)。 Add 4,4,5,5-tetramethyl-2-(3-(10-(naphthalen-2-yl)indol-9-yl)phenyl)-1,3,2-dioxaborolan (2.0g), 5'-bromo-4-methyl-2,2'-bipyridine (1.2g), Pd(PPh 3 ) 4 (0.15g), potassium phosphate (1.7g), 1,2,4 20 ml of trimethylbenzene, 5 ml of third butanol, and 1 ml of water were stirred at reflux temperature for 16 hours. After cooling the reaction solution to room temperature, toluene and water were added to carry out liquid separation. The solvent was distilled off under reduced pressure, and the obtained solid was purified by silica gel column chromatography (developing solvent: toluene/ethyl acetate = 95/5), and the obtained solvent was passed through a short activated carbon tube column to remove the coloring. ingredient. The solvent was distilled off under reduced pressure and washed with heptane to give the compound 4-methyl-5'-(3-(10-(naphthalen-2-yl)indole-9- represented by (1-14-13). Phenyl)-2,2'-bipyridyl (1.4 g).
藉由NMR測定而確認化合物的結構。 The structure of the compound was confirmed by NMR measurement.
1H-NMR(CDCl3):δ=9.04(m,1H),8.55(d,1H),8.47(dd,1H),8.28(s,1H),8.11(dd,1H),8.09(d,1H),8.03(m,1H),8.00(s,1H),7.93(m,1H),7.88(d,1H),7.73-7.83(m,6H),7.57-7.63(m,4H),7.30-7.40(m,4H),7.14(d,1H),2.45(s,3H)。 1 H-NMR (CDCl 3 ): δ=9.04 (m, 1H), 8.55 (d, 1H), 8.47 (dd, 1H), 8.28 (s, 1H), 8.11 (dd, 1H), 8.09 (d, 1H), 8.03 (m, 1H), 8.00 (s, 1H), 7.93 (m, 1H), 7.88 (d, 1H), 7.73-7.83 (m, 6H), 7.57-7.63 (m, 4H), 7.30 - 7.40 (m, 4H), 7.14 (d, 1H), 2.45 (s, 3H).
將添加有5-溴-2-甲基吡啶(3.4g)及THF(10ml)的燒瓶在冰浴中冷卻,向該溶液中滴加2M的異丙基氯化鎂的THF溶液(11ml)。滴加完畢後,撤去冰浴在室溫下攪拌3小時後,再次在冰浴中冷卻,添加氯化鋅四甲基乙二胺(5.5g)。撤去冰浴並升溫到室溫後,添加2,5-二溴吡啶(4.7g)及Pd(PPh3)4(0.7g),在回流溫度下攪拌5小時。將反應液冷卻至室溫後,添加EDTA‧4Na水溶液及甲苯進行液體分離。在減壓蒸餾除去溶劑後,藉由矽膠管柱層析法(展開液:甲苯/乙酸乙酯=7/3)純化所獲得的固體,獲得5-溴-6'-甲基-2,3'-聯吡啶(1.5g)。 The flask to which 5-bromo-2-methylpyridine (3.4 g) and THF (10 ml) were added was cooled in an ice bath, and a 2 M solution of isopropylmagnesium chloride in THF (11 ml) was added dropwise. After completion of the dropwise addition, the ice bath was removed and stirred at room temperature for 3 hours, and then cooled again in an ice bath, and zinc chloride tetramethylethylenediamine (5.5 g) was added. After removing the ice bath and warming to room temperature, 2,5-dibromopyridine (4.7 g) and Pd(PPh 3 ) 4 (0.7 g) were added, and the mixture was stirred at reflux temperature for 5 hours. After cooling the reaction solution to room temperature, an aqueous solution of EDTA‧4Na and toluene were added to carry out liquid separation. After distilling off the solvent under reduced pressure, the obtained solid was purified by silica gel column chromatography (eluent: toluene/ethyl acetate = 7/3) to give 5-bromo-6'-methyl-2,3. '-Bipyridine (1.5 g).
添加4,4,5,5-四甲基-2-(3-(10-(萘-2-基)蒽-9-基)苯基)-1,3,2-二氧雜硼戊環(2.0g)、5-溴-6'-甲基-2,3'-聯吡啶(1.2g)、Pd(PPh3)4(0.15g)、磷酸鉀(1.7g)、1,2,4-三甲基苯25ml、第三丁醇5ml、及水1ml,在回流溫度下攪拌5小時。將反應液冷卻至室溫後,藉由吸濾採集析出的固體,利用甲醇洗淨,再利用乙酸乙酯洗浄。接著,藉由矽膠管柱層析法(展開液:甲苯/乙酸乙酯=4/1)進行純化,將所獲得的溶出液通入短活性碳管柱,除去著色成分。減壓蒸餾除去溶劑,將所獲得的固體進一步從氯苯中進行再結晶,獲得(1-14-15)所表示的化合物6'-甲基-5-(3-(10-(萘-2-基)蒽-9-基)苯基)-2,3'-聯吡啶(1.3g)。 Add 4,4,5,5-tetramethyl-2-(3-(10-(naphthalen-2-yl)indol-9-yl)phenyl)-1,3,2-dioxaborolan (2.0 g), 5-bromo-6'-methyl-2,3'-bipyridine (1.2 g), Pd(PPh 3 ) 4 (0.15 g), potassium phosphate (1.7 g), 1, 2, 4 25 ml of trimethylbenzene, 5 ml of third butanol, and 1 ml of water were stirred at reflux temperature for 5 hours. After cooling the reaction liquid to room temperature, the precipitated solid was collected by suction filtration, washed with methanol, and washed with ethyl acetate. Subsequently, the mixture was purified by a silica gel column chromatography (developing solution: toluene/ethyl acetate = 4/1), and the obtained eluate was passed through a short activated carbon tube column to remove the coloring component. The solvent was distilled off under reduced pressure, and the obtained solid was further recrystallized from chlorobenzene to obtain the compound 6'-methyl-5-(3-(10-(naphthalene-2) represented by (1-14-15). -yl)fluoren-9-yl)phenyl)-2,3'-bipyridine (1.3 g).
藉由NMR測定而確認化合物的結構。 The structure of the compound was confirmed by NMR measurement.
1H-NMR(CDCl3):δ=9.13(m,1H),9.07(m,1H),8.28(dd,1H),8.01-8.11(m,3H),8.00(s,1H),7.93(m,1H),7.86(m,1H),7.73-7.83(m,7H),7.57-7.64(m,4H),7.31-7.39(m,4H),7.28(d,1H),2.63(s,3H)。 1 H-NMR (CDCl 3 ): δ=9.13 (m, 1H), 9.07 (m, 1H), 8.28 (dd, 1H), 8.01 to 8.11 (m, 3H), 8.00 (s, 1H), 7.93 ( m,1H), 7.86 (m, 1H), 7.73-7.83 (m, 7H), 7.57-7.64 (m, 4H), 7.31-7.39 (m, 4H), 7.28 (d, 1H), 2.63 (s, 3H).
將添加有3-溴-5-甲基吡啶(3.4g)及THF(10ml)的燒瓶在冰浴中冷卻,向該溶液中滴加2M的異丙基氯化鎂的THF溶液(11ml)。滴加完畢後,撤去冰浴在室溫下攪拌1.5小時後,再次在冰浴中冷卻,添加氯化鋅四甲基乙二胺(5.5g)。撤去冰浴並升溫到室溫後,添加2,5-二溴吡啶(4.7g)及Pd(PPh3)4(0.7g),在回流溫度下攪拌5 小時。將反應液冷卻至室溫後,添加EDTA‧4Na水溶液及甲苯進行液體分離。在減壓蒸餾除去溶劑後,藉由矽膠管柱層析法(展開液:甲苯/乙酸乙酯=7/3)純化所獲得的固體,獲得5-溴-5'-甲基-2,3'-聯吡啶(1.4g)。 A flask to which 3-bromo-5-methylpyridine (3.4 g) and THF (10 ml) were added was cooled in an ice bath, and a 2 M solution of isopropylmagnesium chloride in THF (11 ml) was added dropwise. After completion of the dropwise addition, the ice bath was removed and stirred at room temperature for 1.5 hours, and then cooled again in an ice bath, and zinc chloride tetramethylethylenediamine (5.5 g) was added. After removing the ice bath and warming to room temperature, 2,5-dibromopyridine (4.7 g) and Pd(PPh 3 ) 4 (0.7 g) were added, and the mixture was stirred at reflux temperature for 5 hours. After cooling the reaction solution to room temperature, an aqueous solution of EDTA‧4Na and toluene were added to carry out liquid separation. After distilling off the solvent under reduced pressure, the obtained solid was purified by silica gel column chromatography (eluent: toluene/ethyl acetate = 7/3) to give 5-bromo-5'-methyl-2,3. '-Bipyridine (1.4 g).
添加4,4,5,5-四甲基-2-(3-(10-(萘-2-基)蒽-9-基)苯基)-1,3,2-二氧雜硼戊環(2.0g)、5-溴-6'-甲基-2,3'-聯吡啶(1.2g)、Pd(PPh3)4(0.15g)、磷酸鉀(1.7g)、1,2,4-三甲基苯25ml、第三丁醇5ml、及水1ml,在回流溫度下攪拌5小時。將反應液冷卻至室溫後,藉由吸濾採集析出的固體,利用甲醇洗淨,再利用乙酸乙酯洗浄。接著,藉由矽膠管柱層析法(展開液:甲苯/乙酸乙酯=4/1)進行純化,再將所獲得的溶出液通入短活性碳管柱,除去著色成分。減壓蒸餾除去溶劑,將所獲得的固體進一步從氯苯中進行再結晶,獲得(1-14-16)所表示的化合物5'-甲基-5-(3-(10-(萘-2-基)蒽-9-基)苯基)-2,3'-聯吡啶(1.3g)。 Add 4,4,5,5-tetramethyl-2-(3-(10-(naphthalen-2-yl)indol-9-yl)phenyl)-1,3,2-dioxaborolan (2.0 g), 5-bromo-6'-methyl-2,3'-bipyridine (1.2 g), Pd(PPh 3 ) 4 (0.15 g), potassium phosphate (1.7 g), 1, 2, 4 25 ml of trimethylbenzene, 5 ml of third butanol, and 1 ml of water were stirred at reflux temperature for 5 hours. After cooling the reaction liquid to room temperature, the precipitated solid was collected by suction filtration, washed with methanol, and washed with ethyl acetate. Subsequently, the mixture was purified by ruthenium column chromatography (developing solution: toluene/ethyl acetate = 4/1), and the obtained eluate was passed through a short activated carbon tube column to remove the coloring component. The solvent was distilled off under reduced pressure, and the obtained solid was further recrystallized from chlorobenzene to obtain the compound 5'-methyl-5-(3-(10-(naphthalene-2)) represented by (1-14-16). -yl)fluoren-9-yl)phenyl)-2,3'-bipyridine (1.3 g).
藉由NMR測定而確認化合物的結構。 The structure of the compound was confirmed by NMR measurement.
1H-NMR(CDCl3):δ=9.08(m,1H),9.04(s,1H),8.50(s,1H),8.21(s,1H),8.09(m,2H),8.04(m,1H),8.00(s,1H),7.93(m,1H),7.73-7.88(m,8H),7.62(m,4H),7.31-7.40(m,4H),2.45(s,3H)。 1 H-NMR (CDCl 3 ): δ=9.08 (m, 1H), 9.04 (s, 1H), 8.50 (s, 1H), 8.21 (s, 1H), 8.09 (m, 2H), 8.04 (m, 1H), 8.00 (s, 1H), 7.93 (m, 1H), 7.73-7.88 (m, 8H), 7.62 (m, 4H), 7.31-7.40 (m, 4H), 2.45 (s, 3H).
將添加有3-溴-4-甲基吡啶(5.2g)及THF(10ml)的燒瓶在冰浴中冷卻,向該溶液中滴加2M的異丙基氯化鎂的THF溶液(17ml)。滴加完畢後,撤去冰浴在室溫下攪拌9小時後,再次在冰浴中冷卻,添加氯化鋅四甲基乙二胺(8.3g)。撤去冰浴並升溫到室溫後,添加2,5-二溴吡啶(7.1g)、Pd-137(英國莊信萬豐公司)(0.4g)及NMP(25ml),在回流溫度下攪拌6小時。將反應液冷卻至室溫後,添加EDTA‧4Na水溶液及甲苯進行液體分離。在減壓蒸餾除去溶劑後,藉由矽膠管柱層析法(展開液:甲苯/乙酸乙酯=7/3)純化所獲得的固體。減壓蒸餾除去溶劑,將所獲得的固體利用庚烷洗浄,獲得5-溴-4'-甲基-2,3'-聯吡啶(2.4g)。 A flask to which 3-bromo-4-methylpyridine (5.2 g) and THF (10 ml) were added was cooled in an ice bath, and a 2 M solution of isopropylmagnesium chloride in THF (17 ml) was added dropwise. After completion of the dropwise addition, the ice bath was removed and stirred at room temperature for 9 hours, and then cooled again in an ice bath, and zinc chloride tetramethylethylenediamine (8.3 g) was added. After removing the ice bath and warming to room temperature, 2,5-dibromopyridine (7.1 g), Pd-137 (British Johnson Matthey) (0.4 g) and NMP (25 ml) were added, and the mixture was stirred at reflux temperature. hour. After cooling the reaction solution to room temperature, an aqueous solution of EDTA‧4Na and toluene were added to carry out liquid separation. After the solvent was distilled off under reduced pressure, the obtained solid was purified by silica gel column chromatography (eluent: toluene / ethyl acetate = 7 / 3). The solvent was distilled off under reduced pressure, and the obtained solid was washed with heptane to give 5-bromo-4'-methyl-2,3'-bipyridine (2.4 g).
添加4,4,5,5-四甲基-2-(3-(10-(萘-2-基)蒽-9-基)苯基)-1,3,2-二氧雜硼戊環(2.0g)、5-溴-6'-甲基-2,3'-聯吡啶(1.2g)、Pd(PPh3)4(0.15g)、磷酸鉀(1.7g)、1,2,4-三甲基苯25ml、第三丁醇5ml、及水1ml,在回流溫度下攪拌5小時。將反應液冷卻至室溫後,添加甲苯及水進行液體分離。減壓蒸餾除去溶劑,藉由矽膠管柱層析法(展開液:甲苯/乙酸乙酯=7/3)純化所獲得的固體,再將所獲得的溶出液通入短活性碳管柱,除去著色成分。減壓蒸餾除去溶劑,將所獲得的固體進一步從甲苯中進行再結晶,獲得(1-14-17)所表示的化合物4'-甲基-5-(3-(10-(萘-2-基) 蒽-9-基)苯基)-2,3'-聯吡啶(0.7g)。 Add 4,4,5,5-tetramethyl-2-(3-(10-(naphthalen-2-yl)indol-9-yl)phenyl)-1,3,2-dioxaborolan (2.0 g), 5-bromo-6'-methyl-2,3'-bipyridine (1.2 g), Pd(PPh 3 ) 4 (0.15 g), potassium phosphate (1.7 g), 1, 2, 4 25 ml of trimethylbenzene, 5 ml of third butanol, and 1 ml of water were stirred at reflux temperature for 5 hours. After cooling the reaction solution to room temperature, toluene and water were added to carry out liquid separation. The solvent was distilled off under reduced pressure, and the obtained solid was purified by silica gel column chromatography (developing solvent: toluene/ethyl acetate = 7/3), and the obtained solvent was passed through a short activated carbon column to remove Coloring ingredients. The solvent was distilled off under reduced pressure, and the obtained solid was further recrystallized from toluene to obtain the compound 4'-methyl-5-(3-(10-(naphthalene-2-)) represented by (1-14-17). )-9-yl)phenyl)-2,3'-bipyridyl (0.7 g).
藉由NMR測定而確認化合物的結構。 The structure of the compound was confirmed by NMR measurement.
1H-NMR(CDCl3):δ=9.09(s,1H),8.67(s,1H),8.51(d,1H),8.09(m,2H),8.03(m,1H),8.00(m,1H),7.93(m,1H),7.88(d,1H),7.73-7.84(m,6H),7.61(m,4H),7.52(d,1H),7.31-7.40(m,4H),7.23(d,1H),2.46(s,3H)。 1 H-NMR (CDCl 3 ): δ=9.09 (s, 1H), 8.67 (s, 1H), 8.51 (d, 1H), 8.09 (m, 2H), 8.03 (m, 1H), 8.00 (m, 1H), 7.93 (m, 1H), 7.88 (d, 1H), 7.73-7.84 (m, 6H), 7.61 (m, 4H), 7.52 (d, 1H), 7.31-7.40 (m, 4H), 7.23 (d, 1H), 2.46 (s, 3H).
將添加有3-溴-2-甲基吡啶(5.2g)及THF(10ml)的燒瓶在冰浴中冷卻,向該溶液中滴加2M的異丙基氯化鎂的THF溶液(17ml)。滴加完畢後,撤去冰浴在室溫下攪拌2小時後,再次在冰浴中冷卻,添加氯化鋅四甲基乙二胺(8.3g)。撤去冰浴並升溫到室溫後,添加2,5-二溴吡啶(7.1g)、Pd(PPh3)4(1.0g)及二甲苯(10ml),在回流溫度下攪拌7小時。將反應液冷卻至室溫後,添加EDTA‧4Na水溶液及甲苯進行液體分離。在減壓蒸餾除去溶劑後,藉由矽膠管柱層析法(展開液:甲苯/乙酸乙酯=4/1)純化所獲得的固體,獲得5-溴-2'-甲基-2,3'-聯吡啶(1.3g)。 The flask to which 3-bromo-2-methylpyridine (5.2 g) and THF (10 ml) were added was cooled in an ice bath, and a 2 M solution of isopropylmagnesium chloride in THF (17 ml) was added dropwise. After completion of the dropwise addition, the ice bath was removed and stirred at room temperature for 2 hours, and then cooled again in an ice bath, and zinc chloride tetramethylethylenediamine (8.3 g) was added. After removing the ice bath and warming to room temperature, 2,5-dibromopyridine (7.1 g), Pd(PPh 3 ) 4 (1.0 g) and xylene (10 ml) were added, and the mixture was stirred at reflux temperature for 7 hours. After cooling the reaction solution to room temperature, an aqueous solution of EDTA‧4Na and toluene were added to carry out liquid separation. After distilling off the solvent under reduced pressure, the obtained solid was purified by silica gel column chromatography (eluent: toluene/ethyl acetate = 4/1) to give 5-bromo-2'-methyl-2,3. '-Bipyridine (1.3 g).
添加4,4,5,5-四甲基-2-(3-(10-(萘-2-基)蒽-9-基)苯基)-1,3,2-二氧雜硼戊環(2.0g)、5-溴-6'-甲基-2,3'-聯吡啶(1.2g)、Pd(PPh3)4(0.15g)、磷酸鉀(1.7g)、1,2,4-三甲基苯25ml、第三丁醇5ml、及水1ml,在回流溫度下攪 拌12小時。將反應液冷卻至室溫後,添加甲苯及水進行液體分離。減壓蒸餾除去溶劑,藉由矽膠管柱層析法(展開液:甲苯/乙酸乙酯=4/1)純化所獲得的固體,再將所獲得的溶出液通入短活性碳管柱,除去著色成分。減壓蒸餾除去溶劑,藉由吸濾採集析出的固體,獲得(1-14-18)所表示的化合物2'-甲基-5-(3-(10-(萘-2-基)蒽-9-基)苯基)-2,3'-聯吡啶(0.8g)。 Add 4,4,5,5-tetramethyl-2-(3-(10-(naphthalen-2-yl)indol-9-yl)phenyl)-1,3,2-dioxaborolan (2.0 g), 5-bromo-6'-methyl-2,3'-bipyridine (1.2 g), Pd(PPh 3 ) 4 (0.15 g), potassium phosphate (1.7 g), 1, 2, 4 25 ml of trimethylbenzene, 5 ml of third butanol, and 1 ml of water were stirred at reflux temperature for 12 hours. After cooling the reaction solution to room temperature, toluene and water were added to carry out liquid separation. The solvent was distilled off under reduced pressure, and the obtained solid was purified by silica gel column chromatography (developing solvent: toluene/ethyl acetate = 4/1), and the obtained eluate was passed through a short activated carbon column to remove Coloring ingredients. The solvent was distilled off under reduced pressure, and the precipitated solid was collected by suction filtration to obtain the compound 2'-methyl-5-(3-(10-(naphthalen-2-yl)indole) represented by (1-14-18). 9-yl)phenyl)-2,3'-bipyridine (0.8 g).
藉由NMR測定而確認化合物的結構。 The structure of the compound was confirmed by NMR measurement.
1H-NMR(CDCl3):δ=9.08(m,1H),8.57(m,1H),7.99-8.10(m,4H),7.92(m,1H),7.88(d,1H),7.73-7.83(m,7H),7.61(m,4H),7.51(dd,1H),7.30-7.40(m,4H),7.25(m,1H),2.66(s,3H)。 1 H-NMR (CDCl 3 ): δ=9.08 (m, 1H), 8.57 (m, 1H), 7.99-8.10 (m, 4H), 7.92 (m, 1H), 7.88 (d, 1H), 7.73 7.83 (m, 7H), 7.61 (m, 4H), 7.51 (dd, 1H), 7.30-7.40 (m, 4H), 7.25 (m, 1H), 2.66 (s, 3H).
將添加有4-溴-3-甲基吡啶(5.0g)及THF(30ml)的燒瓶在乾冰/甲醇浴中冷卻,向該溶液中滴加2M的異丙基氯化鎂的THF溶液(16ml)。滴加完畢後,撤去冷卻用浴,在室溫下攪拌2.5小時後,在冰浴中冷卻,添加氯化鋅四甲基乙二胺(8.0g)。撤去冰浴並升溫到室溫後,添加2,5-二溴吡啶(7.6g)及Pd(PPh3)4(1.0g),在回流溫度下攪拌2小時。將反應液冷卻至室溫後,添加EDTA‧4Na水溶液及乙酸乙酯進行液體分離。在減壓蒸餾除去溶劑後,藉由矽膠管柱層析法(展開液:甲苯/乙酸乙酯=5/1)純化所獲得的固體,獲得5-溴-3'-甲基-2,4'-聯吡啶(5.6g)。 The flask to which 4-bromo-3-methylpyridine (5.0 g) and THF (30 ml) were added was cooled in a dry ice/methanol bath, and 2M isopropylmagnesium chloride in THF (16 ml) was added dropwise. After completion of the dropwise addition, the cooling bath was removed, and the mixture was stirred at room temperature for 2.5 hours, and then cooled in an ice bath to add zinc chloride tetramethylethylenediamine (8.0 g). After removing the ice bath and warming to room temperature, 2,5-dibromopyridine (7.6 g) and Pd(PPh 3 ) 4 (1.0 g) were added, and the mixture was stirred at reflux temperature for 2 hours. After cooling the reaction mixture to room temperature, an aqueous solution of EDTA‧4Na and ethyl acetate were added to carry out liquid separation. After distilling off the solvent under reduced pressure, the obtained solid was purified by silica gel column chromatography (eluent: toluene/ethyl acetate = 5/1) to give 5-bromo-3'-methyl-2,4. '-Bipyridine (5.6 g).
添加4,4,5,5-四甲基-2-(3-(10-(萘-2-基)蒽-9-基)苯基)-1,3,2-二氧雜硼戊環(2.0g)、5-溴-3'-甲基-2,4'-聯吡啶(1.2g)、Pd(PPh3)4(0.15g)、磷酸鉀(1.7g)、1,2,4-三甲基苯1ml、第三丁醇1ml、及水1ml,在回流溫度下攪拌4小時。將反應液冷卻至室溫後,添加水,藉由吸濾採集析出物。將所獲得的固體利用水及甲醇洗浄後,藉由NH基修飾矽膠(DM1020:富士矽化學公司製造)管柱層析法(展開液:甲苯)進行純化,獲得(1-14-20)所表示的化合物3'-甲基-5-(3-(10-(萘-2-基)蒽-9-基)苯基)-2,4'-聯吡啶(1.7g)。 Add 4,4,5,5-tetramethyl-2-(3-(10-(naphthalen-2-yl)indol-9-yl)phenyl)-1,3,2-dioxaborolan (2.0 g), 5-bromo-3'-methyl-2,4'-bipyridine (1.2 g), Pd(PPh 3 ) 4 (0.15 g), potassium phosphate (1.7 g), 1, 2, 4 1 ml of trimethylbenzene, 1 ml of tributanol, and 1 ml of water were stirred at reflux temperature for 4 hours. After cooling the reaction liquid to room temperature, water was added, and the precipitate was collected by suction filtration. The obtained solid was washed with water and methanol, and then purified by an NH-based modified silicone (DM1020: manufactured by Fuji Chemical Co., Ltd.) column chromatography (developing solution: toluene) to obtain (1-14-20) The compound represented by 3'-methyl-5-(3-(10-(naphthalen-2-yl)indol-9-yl)phenyl)-2,4'-bipyridine (1.7 g).
藉由NMR測定而確認化合物的結構。 The structure of the compound was confirmed by NMR measurement.
1H-NMR(CDCl3):δ=9.09(m,1H),8.56(s,1H),8.55(d,1H),8.10(m,2H),8.03(m,1H),8.00(d,1H),7.93(d,1H),7.88(d,1H),7.73-7.83(m,6H),7.61(m,4H),7.53(d,1H),7.31-7.41(m,5H),2.44(s,3H)。 1 H-NMR (CDCl 3 ): δ=9.09 (m, 1H), 8.56 (s, 1H), 8.55 (d, 1H), 8.10 (m, 2H), 8.03 (m, 1H), 8.00 (d, 1H), 7.93 (d, 1H), 7.88 (d, 1H), 7.73-7.83 (m, 6H), 7.61 (m, 4H), 7.53 (d, 1H), 7.31-7.41 (m, 5H), 2.44 (s, 3H).
將4,4,5,5-四甲基-2-(6-(10-苯基蒽-9-基)萘-2-基)-1,3,2-二氧雜硼戊環(2.0g)、5-溴-2'-甲基-2,3'-聯吡啶(1.2g)、Pd(PPh3)4(0.15g)、磷酸鉀(1.7g)、1,2,4-三甲基苯(20ml)、第三丁醇(5ml)及水(1ml)添加到燒瓶 中,在氮氣環境下,在回流溫度下攪拌8小時。加熱完畢後,將反應液冷卻至室溫後,藉由吸濾採集析出的固體,利用甲醇洗淨,再利用乙酸乙酯洗浄。接著,藉由矽膠管柱層析法(展開液:甲苯/乙酸乙酯=7/3)進行純化,再將所獲得的溶出液通入短活性碳管柱,除去著色成分。減壓蒸餾除去溶劑,藉由吸濾採集析出的固體,獲得(1-11-18)所表示的化合物2'-甲基-5-(6-(10-苯基蒽-9-基)萘-2-基)2,3'-聯吡啶(1.1g)。 4,4,5,5-tetramethyl-2-(6-(10-phenylfluoren-9-yl)naphthalen-2-yl)-1,3,2-dioxaborolan (2.0 g), 5-bromo-2'-methyl-2,3'-bipyridine (1.2g), Pd(PPh 3 ) 4 (0.15g), potassium phosphate (1.7g), 1,2,4-three Methylbenzene (20 ml), third butanol (5 ml) and water (1 ml) were added to the flask, and the mixture was stirred at reflux temperature for 8 hours under a nitrogen atmosphere. After the completion of the heating, the reaction liquid was cooled to room temperature, and the precipitated solid was collected by suction filtration, washed with methanol, and then washed with ethyl acetate. Subsequently, purification was carried out by silica gel column chromatography (developing solution: toluene/ethyl acetate = 7/3), and the obtained eluate was passed through a short activated carbon tube column to remove the coloring component. The solvent was distilled off under reduced pressure, and the precipitated solid was collected by suction filtration to obtain the compound 2'-methyl-5-(6-(10-phenylfluoren-9-yl)naphthalene represented by (1-11-18). 2-yl) 2,3'-bipyridyl (1.1 g).
藉由NMR測定而確認化合物的結構。 The structure of the compound was confirmed by NMR measurement.
1H-NMR(CDCl3):δ=9.17(m,1H),8.60(dd,1H),8.230(s,1H),8.19(m,2H),8.06(m,2H),7.87(dd,1H),7.85(dd,1H),7.73(m,4H),7.69(dd,1H),7.55-7.65(m,4H),7.51(m,2H),7.26-7.37(m,5H),2.73(s,3H)。 1 H-NMR (CDCl 3 ): δ=9.17 (m, 1H), 8.60 (dd, 1H), 8.230 (s, 1H), 8.19 (m, 2H), 8.06 (m, 2H), 7.78 (dd, 1H), 7.85 (dd, 1H), 7.73 (m, 4H), 7.69 (dd, 1H), 7.55-7.65 (m, 4H), 7.51 (m, 2H), 7.26-7.37 (m, 5H), 2.73 (s, 3H).
可藉由適宜變更原料的化合物,並藉由依據上述合成例的方法,而合成本發明的其他衍生物化合物。 The other derivative compound of the present invention can be synthesized by a method suitable for changing the starting material and by a method according to the above synthesis example.
以下,為了進一步詳細說明本發明,而揭示使用本發明的化合物的有機EL元件的實例,但本發明並不限定於該等。 Hereinafter, in order to explain the present invention in further detail, an example of an organic EL device using the compound of the present invention is disclosed, but the present invention is not limited thereto.
製作實例1至實例4及比較例1至比較例2的元件,分別測定恆定電流驅動試驗中的驅動開始電壓(V)、保持初始值的90%以上的亮度的時間(小時)。以下,詳細地說明實例及比較例。 The elements of Examples 1 to 4 and Comparative Examples 1 to 2 were produced, and the driving start voltage (V) in the constant current driving test and the time (hour) at which the luminance of 90% or more of the initial value was maintained were measured. Hereinafter, examples and comparative examples will be described in detail.
將所製作的實例1至實例4及比較例1至比較例2的元件中的各層的材料構成示於下述表1。 The material compositions of the respective layers of the produced Examples 1 to 4 and Comparative Examples 1 to 2 are shown in Table 1 below.
在表1中,「HI」為N4,N4'-二苯基-N4,N4'-雙(9-苯基-9H-咔唑-3-基)-[1,1'-聯苯]-4,4'-二胺,「NPD」為N4,N4'-二(萘-1-基)-N4,N4'-二苯基-[1,1'-聯苯]-4,4'-二胺,化合物(A)為9-苯基-10-(4-苯基萘-1-基)蒽,化合物(B)為N5,N5,N9,N9-7,7-六苯基-7H-苯並[c]茀-5,9-二胺,化合物(C)為9,10-二([2,2'-聯吡啶]-5-基)蒽,化合物(D)為9,10-雙(4-(吡啶-3-基)萘-1-基)蒽。將該等化合物與形成在電子傳輸層與陰極之間的層所使用的「Liq」的化學結構一併揭示如下。 In Table 1, "HI" is N 4 , N 4 ' -diphenyl-N 4 , N 4 ' -bis (9-phenyl-9H-carbazol-3-yl)-[1,1'- Biphenyl]-4,4'-diamine, "NPD" is N 4 , N 4 ' -di(naphthalen-1-yl)-N 4 , N 4 ' -diphenyl-[1,1'-linked Benzene]-4,4'-diamine, compound (A) is 9-phenyl-10-(4-phenylnaphthalen-1-yl)anthracene, and compound (B) is N 5 , N 5 , N 9 , N 9 -7,7-hexaphenyl-7H-benzo[c]indole-5,9-diamine, compound (C) is 9,10-di([2,2'-bipyridine]-5- The compound (D) is 9,10-bis(4-(pyridin-3-yl)naphthalen-1-yl)anthracene. The chemical structure of "Liq" used for the compound and the layer formed between the electron transport layer and the cathode is disclosed as follows.
以將藉由濺鍍製成厚度為180nm的膜的ITO研磨至150nm的26mm×28mm×0.7mm的玻璃基板(Opto Science(股份)製造)作為透明支撐基板。將該透明支撐基板固定在市售的蒸鍍裝置(昭和真空(股份)製造)的基板固持器上,安裝添加有HI的蒸鍍用鉬舟、添加有NPD的蒸鍍用鉬舟、添加有化合物(A)的蒸鍍用鉬舟、添加有化 合物(B)的蒸鍍用鉬舟、添加有化合物(1-7-74)的蒸鍍用鉬舟、添加有Liq的蒸鍍用鉬舟、添加有鎂的鉬舟及添加有銀的蒸鍍用鎢舟。 A glass substrate (manufactured by Opto Science Co., Ltd.) of 26 mm × 28 mm × 0.7 mm polished to 150 nm by ITO having a film having a thickness of 180 nm by sputtering was used as a transparent supporting substrate. The transparent support substrate is fixed to a substrate holder of a commercially available vapor deposition device (manufactured by Showa Vacuum Co., Ltd.), and a molybdenum boat for vapor deposition to which HI is added, a molybdenum boat for vapor deposition to which NPD is added, and a Molybdenum boat for vapor deposition of compound (A), added Molybdenum boat for vapor deposition of compound (B), molybdenum boat for vapor deposition to which compound (1-7-74) is added, molybdenum boat for vapor deposition to which Liq is added, molybdenum boat to which magnesium is added, and silver added with silver A tungsten boat for vapor deposition.
在透明支撐基板的ITO膜上,依序形成下述各層。將真空槽減壓到5×10-4Pa,首先,加熱添加有HI的蒸鍍用舟,以膜厚成為40nm的方式進行蒸鍍而形成電洞注入層,接著,加熱添加有NPD的蒸鍍用舟,以膜厚成為30nm的方式進行蒸鍍而形成電洞傳輸層。其次,同時加熱添加有化合物(A)的蒸鍍用舟與添加有化合物(B)的蒸鍍用舟,以膜厚成為35nm的方式進行蒸鍍而形成發光層。以化合物(A)與化合物(B)的重量比成為約95:5的方式調節蒸鍍速度。其次,加熱添加有化合物(1-7-74)的蒸鍍用舟,以膜厚成為15nm的方式進行蒸鍍而形成電子傳輸層。各層的蒸鍍速度為0.01nm/秒~1nm/秒。 The following layers were sequentially formed on the ITO film of the transparent supporting substrate. The vacuum chamber was depressurized to 5 × 10 -4 Pa. First, the boat for vapor deposition to which HI was added was heated, and vapor deposition was performed so as to have a film thickness of 40 nm to form a hole injection layer, followed by heating the steam to which NPD was added. The plating boat was vapor-deposited so that the film thickness became 30 nm, and the hole transport layer was formed. Then, the vapor deposition boat to which the compound (A) was added and the vapor deposition boat to which the compound (B) was added were heated, and vapor deposition was performed so that the film thickness became 35 nm, and the light-emitting layer was formed. The vapor deposition rate was adjusted so that the weight ratio of the compound (A) to the compound (B) became about 95:5. Next, the boat for vapor deposition to which the compound (1-7-74) was added was heated, and vapor deposition was performed so that the film thickness became 15 nm, and the electron transport layer was formed. The vapor deposition rate of each layer is from 0.01 nm/sec to 1 nm/sec.
其後,加熱添加有Liq的蒸鍍用舟,以膜厚成為1nm的方式以0.01nm/秒~0.1nm/秒的蒸鍍速度進行蒸鍍。接著,同時加熱添加有鎂的舟與添加有銀的舟,以膜厚成為100nm的方式進行蒸鍍而形成陰極。此時,以鎂與銀的原子數比成為10:1的方式調節蒸鍍速度,以蒸鍍速度成為0.1nm/秒~10nm/秒的方式形成陰極,獲得有機電激發光元件。 Thereafter, the boat for vapor deposition to which Liq was added was heated, and vapor deposition was performed at a vapor deposition rate of 0.01 nm/sec to 0.1 nm/sec so that the film thickness became 1 nm. Next, the boat to which magnesium was added and the boat to which silver was added were simultaneously heated, and vapor deposition was performed so that the film thickness became 100 nm, and a cathode was formed. At this time, the vapor deposition rate was adjusted so that the atomic ratio of magnesium and silver became 10:1, and the cathode was formed so that the vapor deposition rate became 0.1 nm/sec to 10 nm/sec, and the organic electroluminescent device was obtained.
若以ITO電極作為陽極且以鎂/銀電極作為陰極而施加直流電壓,則獲得波長約為460nm的藍色發光。另外,藉由用於獲得初始亮度2000cd/m2的電流密度而實施恆定 電流驅動試驗,結果驅動試驗開始電壓為7.33V,保持初始值的90%(1800cd/m2)以上的亮度的時間為45小時。 When a direct current voltage is applied using an ITO electrode as an anode and a magnesium/silver electrode as a cathode, blue light emission having a wavelength of about 460 nm is obtained. Further, for obtaining the initial luminance by 2000cd / m 2 and a current density of the constant current driving test, driving test initiation voltage of 7.33V, holding time 90% of the initial value of the luminance (1800cd / m 2) or more of 45 hours.
除了將化合物(1-7-74)換為化合物(1-7-26)以外,藉由依據實例1的方法獲得有機EL元件。以ITO電極作為陽極,以鎂/銀電極作為陰極,藉由用於獲得初始亮度2000cd/m2的電流密度而實施恆定電流驅動試驗。驅動試驗開始電壓為6.36V,保持初始值的90%以上的亮度的時間為151小時。 An organic EL element was obtained by the method according to Example 1, except that the compound (1-7-74) was replaced with the compound (1-7-26). A constant current driving test was carried out by using an ITO electrode as an anode and a magnesium/silver electrode as a cathode to obtain a current density of an initial luminance of 2000 cd/m 2 . The driving test starting voltage was 6.36 V, and the time for maintaining the brightness of 90% or more of the initial value was 151 hours.
除了將化合物(1-7-74)換為化合物(1-7-98)以外,藉由依據實例1的方法獲得有機EL元件。以ITO電極作為陽極,以鎂/銀電極作為陰極,藉由用於獲得初始亮度2000cd/m2的電流密度而實施恆定電流驅動試驗。驅動試驗開始電壓為7.34V,保持初始值的90%以上的亮度的時間為265小時。 An organic EL element was obtained by the method according to Example 1, except that the compound (1-7-74) was replaced with the compound (1-7-98). A constant current driving test was carried out by using an ITO electrode as an anode and a magnesium/silver electrode as a cathode to obtain a current density of an initial luminance of 2000 cd/m 2 . The driving test starting voltage was 7.34 V, and the time for maintaining the brightness of 90% or more of the initial value was 265 hours.
除了將化合物(1-7-74)換為化合物(1-7-96)以外,藉由依據實例1的方法獲得有機EL元件。以ITO電極作為陽極,以鎂/銀電極作為陰極,藉由用於獲得初始亮度2000cd/m2的電流密度而實施恆定電流驅動試驗。驅動試 驗開始電壓為5.33V,保持初始值的90%以上的亮度的時間為103小時。 An organic EL element was obtained by the method according to Example 1, except that the compound (1-7-74) was replaced with the compound (1-7-96). A constant current driving test was carried out by using an ITO electrode as an anode and a magnesium/silver electrode as a cathode to obtain a current density of an initial luminance of 2000 cd/m 2 . The driving test start voltage was 5.33 V, and the time for maintaining the brightness of 90% or more of the initial value was 103 hours.
除了將化合物(1-7-74)換為化合物(C)以外,藉由依據實例1的方法獲得有機EL元件。以ITO電極作為陽極,以鎂/銀電極作為陰極,藉由用於獲得初始亮度2000cd/m2的電流密度而實施恆定電流驅動試驗。結果驅動試驗開始電壓為5.06V,保持初始值的90%以上的亮度的時間為6小時。 An organic EL element was obtained by the method according to Example 1, except that the compound (1-7-74) was replaced with the compound (C). A constant current driving test was carried out by using an ITO electrode as an anode and a magnesium/silver electrode as a cathode to obtain a current density of an initial luminance of 2000 cd/m 2 . As a result, the driving test starting voltage was 5.06 V, and the time for maintaining the brightness of 90% or more of the initial value was 6 hours.
除了將化合物(1-7-74)換為化合物(D)以外,藉由依據實例1的方法獲得有機EL元件。以ITO電極作為陽極,以鎂/銀電極作為陰極,藉由用於獲得初始亮度2000cd/m2的電流密度而實施恆定電流驅動試驗。結果驅動試驗開始電壓為5.05V,保持初始值的90%以上的亮度的時間為10小時。 An organic EL element was obtained by the method according to Example 1, except that the compound (1-7-74) was replaced with the compound (D). A constant current driving test was carried out by using an ITO electrode as an anode and a magnesium/silver electrode as a cathode to obtain a current density of an initial luminance of 2000 cd/m 2 . As a result, the driving test start voltage was 5.05 V, and the time for maintaining the brightness of 90% or more of the initial value was 10 hours.
將以上結果匯總於表2。 The above results are summarized in Table 2.
製作實例5至實例20及比較例3至比較例5的元件,分別測定恆定電流驅動試驗中的驅動開始電壓(V)、保持初始值的90%以上的亮度的時間(小時)。以下,詳細地說明實例及比較例。 The elements of Examples 5 to 20 and Comparative Examples 3 to 5 were produced, and the driving start voltage (V) in the constant current driving test and the time (hour) at which the luminance of 90% or more of the initial value was maintained were measured. Hereinafter, examples and comparative examples will be described in detail.
將所製作的實例5至實例20及比較例3至比較例5的元件中的各層的材料構成示於下述表3。 The material constitution of each of the elements of Examples 5 to 20 and Comparative Examples 3 to 5 produced was shown in Table 3 below.
在表3中,HT為N-([1,1'-聯苯]-4-基)-9,9-二甲基 -N-(4-(9-苯基-9H-咔唑-3-基)苯基)-9H-茀-2-胺,化合物(E)為9-(4-(萘-1-基)苯基)-10-苯基蒽,化合物(F)為4,4'-((7,7-二苯基-7H-苯並[c]茀-5,9-二基)雙((苯基)胺基))二苄腈,化合物(G)為4'-(4-(10-(萘-2-基)蒽-9-基)苯基)-2,2':6',2"-三聯吡啶,化合物(H)為3-(6-(10-苯基蒽-9-基)萘-2-基)吡啶,化合物(I)為6-(4-(10-(萘-1-基)蒽-9-基)苯基)-2,4'-聯吡啶。 In Table 3, HT is N-([1,1'-biphenyl]-4-yl)-9,9-dimethyl -N-(4-(9-phenyl-9H-indazol-3-yl)phenyl)-9H-indol-2-amine, compound (E) is 9-(4-(naphthalen-1-yl) Phenyl)-10-phenylindole, compound (F) is 4,4'-((7,7-diphenyl-7H-benzo[c]indole-5,9-diyl)bis((phenyl) Amino))dibenzonitrile, compound (G) is 4'-(4-(10-(naphthalen-2-yl)fluoren-9-yl)phenyl)-2,2':6',2 "-terpyridine, compound (H) is 3-(6-(10-phenylfluoren-9-yl)naphthalen-2-yl)pyridine, and compound (I) is 6-(4-(10-(naphthalene)- 1-yl)fluoren-9-yl)phenyl)-2,4'-bipyridine.
以將藉由濺鍍製成厚度為180nm的膜的ITO研磨至150nm的26mm×28mm×0.7mm的玻璃基板(Opto Science(股份)製造)作為透明支撐基板。將該透明支撐基板固定在市售的蒸鍍裝置(昭和真空(股份)製造)的基板固持器上,安裝添加有HI的蒸鍍用鉬舟、添加有HT的蒸鍍用鉬舟、添加有化合物(E)的蒸鍍用鉬舟、添加有化合物(F)的蒸鍍用鉬舟、添加有化合物(1-11-1)的蒸鍍用鉬舟、添加有Liq的蒸鍍用鉬舟、添加有鎂的鉬舟及添加有銀的蒸鍍用鎢舟。 A glass substrate (manufactured by Opto Science Co., Ltd.) of 26 mm × 28 mm × 0.7 mm polished to 150 nm by ITO having a film having a thickness of 180 nm by sputtering was used as a transparent supporting substrate. The transparent support substrate is fixed to a substrate holder of a commercially available vapor deposition device (manufactured by Showa Vacuum Co., Ltd.), and a molybdenum boat for vapor deposition to which HI is added and a molybdenum boat for vapor deposition to which HT is added are added. Molybdenum boat for vapor deposition of compound (E), molybdenum boat for vapor deposition to which compound (F) is added, molybdenum boat for vapor deposition to which compound (1-11-1) is added, and molybdenum boat for vapor deposition to which Liq is added A molybdenum boat to which magnesium is added and a tungsten boat for vapor deposition to which silver is added.
在透明支撐基板的ITO膜上依序形成下述各層。將真空槽減壓到5×10-4Pa,首先,加熱添加有HI的蒸鍍用舟,以膜厚成為40nm的方式進行蒸鍍而形成電洞注入層,接著加熱添加有HT的蒸鍍用舟,以膜厚成為30nm的方式進行蒸鍍而形成電洞傳輸層。其次,同時加熱添加有化合物(E)的蒸鍍用舟與添加有化合物(F)的蒸鍍用舟,以膜厚成為35nm的方式進行蒸鍍而形成發光層。以化合物(E)與化合物(F)的重量比成為約95:5的方式調節蒸鍍速度。其次,同時加熱添加有化合物(1-11-1)的蒸鍍用舟與添加有Liq的蒸鍍用舟,以膜厚成為25nm的方式進行蒸鍍而形成電子傳輸層。以化合物(1-11-1)與Liq的重量比成為約1:1的方式調節蒸鍍速度。各層的蒸鍍速度為0.01nm/秒~1nm/秒。 The following layers were sequentially formed on the ITO film of the transparent supporting substrate. The vacuum chamber was depressurized to 5 × 10 -4 Pa. First, the boat for vapor deposition to which HI was added was heated, and vapor deposition was performed so as to have a film thickness of 40 nm to form a hole injection layer, followed by heating and evaporation of HT. The hole transport layer was formed by vapor deposition so that the film thickness became 30 nm. Next, the boat for vapor deposition to which the compound (E) was added and the boat for vapor deposition to which the compound (F) was added were simultaneously heated to form a light-emitting layer so as to have a film thickness of 35 nm. The vapor deposition rate was adjusted so that the weight ratio of the compound (E) to the compound (F) became about 95:5. Then, the vapor deposition boat to which the compound (1-11-1) was added and the boat for vapor deposition to which Liq was added were heated, and vapor deposition was performed so that the film thickness became 25 nm, and the electron transport layer was formed. The vapor deposition rate was adjusted so that the weight ratio of the compound (1-11-1) to Liq became about 1:1. The vapor deposition rate of each layer is from 0.01 nm/sec to 1 nm/sec.
其後,加熱添加有Liq的蒸鍍用舟,以膜厚成為1nm 的方式以0.01nm/秒~0.1nm/秒的蒸鍍速度進行蒸鍍。接著,同時加熱添加有鎂的舟與添加有銀的舟,以膜厚成為100nm的方式進行蒸鍍而形成陰極。此時,以鎂與銀的原子數比成為10:1的方式調節蒸鍍速度,以蒸鍍速度成為0.1nm/秒~10nm/秒的方式形成陰極,獲得有機電激發光元件。 Thereafter, the boat for vapor deposition to which Liq was added was heated to have a film thickness of 1 nm. The method was carried out at a vapor deposition rate of 0.01 nm/sec to 0.1 nm/sec. Next, the boat to which magnesium was added and the boat to which silver was added were simultaneously heated, and vapor deposition was performed so that the film thickness became 100 nm, and a cathode was formed. At this time, the vapor deposition rate was adjusted so that the atomic ratio of magnesium and silver became 10:1, and the cathode was formed so that the vapor deposition rate became 0.1 nm/sec to 10 nm/sec, and the organic electroluminescent device was obtained.
若以ITO電極作為陽極,以鎂/銀電極作為陰極而施加直流電壓,則獲得波長約為450nm的藍色發光。另外,藉由用於獲得初始亮度2000cd/m2的電流密度而實施恆定電流驅動試驗,結果驅動試驗開始電壓為4.00V,保持初始值的90%(1800cd/m2)以上的亮度的時間為87小時。 When a direct current voltage is applied using an ITO electrode as an anode and a magnesium/silver electrode as a cathode, blue light emission having a wavelength of about 450 nm is obtained. Further, for obtaining the initial luminance by 2000cd / m 2 and a current density of the constant current driving test, driving test initiation voltage of 4.00V, holding time 90% of the initial value of the luminance (1800cd / m 2) or more of 87 hours.
除了將化合物(1-11-1)換為化合物(1-11-2)以外,藉由依據實例5的方法獲得有機EL元件。以ITO電極作為陽極,以鎂/銀電極作為陰極,藉由用於獲得初始亮度2000cd/m2的電流密度而實施恆定電流驅動試驗。驅動試驗開始電壓為4.12V,保持初始值的90%以上的亮度的時間為85小時。 An organic EL element was obtained by the method according to Example 5, except that the compound (1-11-1) was replaced with the compound (1-11-2). A constant current driving test was carried out by using an ITO electrode as an anode and a magnesium/silver electrode as a cathode to obtain a current density of an initial luminance of 2000 cd/m 2 . The drive test start voltage was 4.12 V, and the time to maintain the brightness of 90% or more of the initial value was 85 hours.
除了將化合物(1-11-1)換為化合物(1-11-3)以外,藉由依據實例5的方法獲得有機EL元件。以ITO電極作為陽極,以鎂/銀電極作為陰極,藉由用於獲得初始亮度 2000cd/m2的電流密度而實施恆定電流驅動試驗。驅動試驗開始電壓為3.78V,保持初始值的90%以上的亮度的時間為97小時。 An organic EL element was obtained by the method according to Example 5, except that the compound (1-11-1) was replaced with the compound (1-11-3). A constant current driving test was carried out by using an ITO electrode as an anode and a magnesium/silver electrode as a cathode to obtain a current density of an initial luminance of 2000 cd/m 2 . The driving test starting voltage was 3.78 V, and the time for maintaining the brightness of 90% or more of the initial value was 97 hours.
除了將化合物(1-11-1)換為化合物(1-11-4)以外,藉由依據實例5的方法獲得有機EL元件。以ITO電極作為陽極,以鎂/銀電極作為陰極,藉由用於獲得初始亮度2000cd/m2的電流密度而實施恆定電流驅動試驗。驅動試驗開始電壓為3.95V,保持初始值的90%以上的亮度的時間為83小時。 An organic EL element was obtained by the method according to Example 5, except that the compound (1-11-1) was replaced with the compound (1-11-4). A constant current driving test was carried out by using an ITO electrode as an anode and a magnesium/silver electrode as a cathode to obtain a current density of an initial luminance of 2000 cd/m 2 . The driving test starting voltage was 3.95 V, and the time for maintaining the brightness of 90% or more of the initial value was 83 hours.
除了將化合物(1-11-1)換為化合物(1-11-5)以外,藉由依據實例5的方法獲得有機EL元件。以ITO電極作為陽極,以鎂/銀電極作為陰極,藉由用於獲得初始亮度2000cd/m2的電流密度而實施恆定電流驅動試驗。驅動試驗開始電壓為3.88V,保持初始值的90%以上的亮度的時間為93小時。 An organic EL element was obtained by the method according to Example 5, except that the compound (1-11-1) was replaced with the compound (1-11-5). A constant current driving test was carried out by using an ITO electrode as an anode and a magnesium/silver electrode as a cathode to obtain a current density of an initial luminance of 2000 cd/m 2 . The driving test starting voltage was 3.88 V, and the time for maintaining the brightness of 90% or more of the initial value was 93 hours.
除了將化合物(1-11-1)換為化合物(1-11-39)以外,藉由依據實例5的方法獲得有機EL元件。以ITO電極作為陽極,以鎂/銀電極作為陰極,藉由用於獲得初始亮度 2000cd/m2的電流密度而實施恆定電流驅動試驗。驅動試驗開始電壓為4.16V,保持初始值的90%以上的亮度的時間為74小時。 An organic EL element was obtained by the method according to Example 5, except that the compound (1-11-1) was replaced with the compound (1-11-39). A constant current driving test was carried out by using an ITO electrode as an anode and a magnesium/silver electrode as a cathode to obtain a current density of an initial luminance of 2000 cd/m 2 . The driving test starting voltage was 4.16 V, and the time for maintaining the brightness of 90% or more of the initial value was 74 hours.
除了將化合物(1-11-1)換為化合物(1-14-2)以外,藉由依據實例5的方法獲得有機EL元件。以ITO電極作為陽極,以鎂/銀電極作為陰極,藉由用於獲得初始亮度2000cd/m2的電流密度而實施恆定電流驅動試驗。驅動試驗開始電壓為3.61V,保持初始值的90%以上的亮度的時間為76小時。 An organic EL element was obtained by the method according to Example 5, except that the compound (1-11-1) was replaced with the compound (1-14-2). A constant current driving test was carried out by using an ITO electrode as an anode and a magnesium/silver electrode as a cathode to obtain a current density of an initial luminance of 2000 cd/m 2 . The drive test start voltage was 3.61 V, and the time for maintaining the brightness of 90% or more of the initial value was 76 hours.
除了將化合物(1-11-1)換為化合物(1-14-3)以外,藉由依據實例5的方法獲得有機EL元件。以ITO電極作為陽極,以鎂/銀電極作為陰極,藉由用於獲得初始亮度2000cd/m2的電流密度而實施恆定電流驅動試驗。驅動試驗開始電壓為3.85V,保持初始值的90%以上的亮度的時間為141小時。 An organic EL element was obtained by the method according to Example 5, except that the compound (1-11-1) was replaced with the compound (1-14-3). A constant current driving test was carried out by using an ITO electrode as an anode and a magnesium/silver electrode as a cathode to obtain a current density of an initial luminance of 2000 cd/m 2 . The driving test starting voltage was 3.85 V, and the time for maintaining the brightness of 90% or more of the initial value was 141 hours.
除了將化合物(1-11-1)換為化合物(1-14-11)以外,藉由依據實例5的方法獲得有機EL元件。以ITO電極作為陽極,以鎂/銀電極作為陰極,藉由用於獲得初始亮度 2000cd/m2的電流密度而實施恆定電流驅動試驗。驅動試驗開始電壓為4.16V,保持初始值的90%以上的亮度的時間為162小時。 An organic EL element was obtained by the method according to Example 5, except that the compound (1-11-1) was replaced with the compound (1-14-11). A constant current driving test was carried out by using an ITO electrode as an anode and a magnesium/silver electrode as a cathode to obtain a current density of an initial luminance of 2000 cd/m 2 . The drive test start voltage was 4.16 V, and the time to maintain the brightness of 90% or more of the initial value was 162 hours.
除了將化合物(1-11-1)換為化合物(1-14-12)以外,藉由依據實例5的方法獲得有機EL元件。以ITO電極作為陽極,以鎂/銀電極作為陰極,藉由用於獲得初始亮度2000cd/m2的電流密度而實施恆定電流驅動試驗。驅動試驗開始電壓為3.87V,保持初始值的90%以上的亮度的時間為75小時。 An organic EL element was obtained by the method according to Example 5, except that the compound (1-11-1) was replaced with the compound (1-14-12). A constant current driving test was carried out by using an ITO electrode as an anode and a magnesium/silver electrode as a cathode to obtain a current density of an initial luminance of 2000 cd/m 2 . The driving test starting voltage was 3.87 V, and the time for maintaining the brightness of 90% or more of the initial value was 75 hours.
除了將化合物(1-11-1)換為化合物(1-14-14)以外,藉由依據實例5的方法獲得有機EL元件。以ITO電極作為陽極,以鎂/銀電極作為陰極,藉由用於獲得初始亮度2000cd/m2的電流密度而實施恆定電流驅動試驗。驅動試驗開始電壓為3.82V,保持初始值的90%以上的亮度的時間為227小時。 An organic EL element was obtained by the method according to Example 5 except that the compound (1-11-1) was replaced with the compound (1-14-14). A constant current driving test was carried out by using an ITO electrode as an anode and a magnesium/silver electrode as a cathode to obtain a current density of an initial luminance of 2000 cd/m 2 . The driving test start voltage was 3.82 V, and the time for maintaining the brightness of 90% or more of the initial value was 227 hours.
除了將化合物(1-11-1)換為化合物(1-14-15)以外,藉由依據實例5的方法獲得有機EL元件。以ITO電極作為陽極,以鎂/銀電極作為陰極,藉由用於獲得初始亮度 2000cd/m2的電流密度而實施恆定電流驅動試驗。驅動試驗開始電壓為3.98V,保持初始值的90%以上的亮度的時間為101小時。 An organic EL element was obtained by the method according to Example 5, except that the compound (1-11-1) was replaced with the compound (1-14-15). A constant current driving test was carried out by using an ITO electrode as an anode and a magnesium/silver electrode as a cathode to obtain a current density of an initial luminance of 2000 cd/m 2 . The drive test start voltage was 3.98 V, and the time for maintaining the brightness of 90% or more of the initial value was 101 hours.
除了將化合物(1-11-1)換為化合物(1-14-16)以外,藉由依據實例5的方法獲得有機EL元件。以ITO電極作為陽極,以鎂/銀電極作為陰極,藉由用於獲得初始亮度2000cd/m2的電流密度而實施恆定電流驅動試驗。驅動試驗開始電壓為4.25V,保持初始值的90%以上的亮度的時間為70小時。 An organic EL element was obtained by the method according to Example 5, except that the compound (1-11-1) was replaced with the compound (1-14-16). A constant current driving test was carried out by using an ITO electrode as an anode and a magnesium/silver electrode as a cathode to obtain a current density of an initial luminance of 2000 cd/m 2 . The drive test start voltage was 4.25 V, and the time for maintaining the brightness of 90% or more of the initial value was 70 hours.
除了將化合物(1-11-1)換為化合物(1-14-18)以外,藉由依據實例5的方法獲得有機EL元件。以ITO電極作為陽極,以鎂/銀電極作為陰極,藉由用於獲得初始亮度2000cd/m2的電流密度而實施恆定電流驅動試驗。驅動試驗開始電壓為3.75V,保持初始值的90%以上的亮度的時間為125小時。 An organic EL element was obtained by the method according to Example 5 except that the compound (1-11-1) was replaced with the compound (1-14-18). A constant current driving test was carried out by using an ITO electrode as an anode and a magnesium/silver electrode as a cathode to obtain a current density of an initial luminance of 2000 cd/m 2 . The driving test starting voltage was 3.75 V, and the time for maintaining the brightness of 90% or more of the initial value was 125 hours.
除了將化合物(1-11-1)換為化合物(1-14-20)以外,藉由依據實例5的方法獲得有機EL元件。以ITO電極作為陽極,以鎂/銀電極作為陰極,藉由用於獲得初始亮度 2000cd/m2的電流密度而實施恆定電流驅動試驗。驅動試驗開始電壓為4.19V,保持初始值的90%以上的亮度的時間為63小時。 An organic EL element was obtained by the method according to Example 5, except that the compound (1-11-1) was replaced with the compound (1-14-20). A constant current driving test was carried out by using an ITO electrode as an anode and a magnesium/silver electrode as a cathode to obtain a current density of an initial luminance of 2000 cd/m 2 . The drive test start voltage was 4.19 V, and the time to maintain the brightness of 90% or more of the initial value was 63 hours.
除了將化合物(1-11-1)換為化合物(1-11-18)以外,藉由依據實例5的方法獲得有機EL元件。以ITO電極作為陽極,以鎂/銀電極作為陰極,藉由用於獲得初始亮度2000cd/m2的電流密度而實施恆定電流驅動試驗。驅動試驗開始電壓為4.29V,保持初始值的90%以上的亮度的時間為60小時。 An organic EL element was obtained by the method according to Example 5, except that the compound (1-11-1) was replaced with the compound (1-11-18). A constant current driving test was carried out by using an ITO electrode as an anode and a magnesium/silver electrode as a cathode to obtain a current density of an initial luminance of 2000 cd/m 2 . The driving test starting voltage was 4.29 V, and the time for maintaining the brightness of 90% or more of the initial value was 60 hours.
除了將化合物(1-11-1)換為化合物(G)以外,藉由依據實例5的方法獲得有機EL元件。以ITO電極作為陽極,以鎂/銀電極作為陰極,藉由用於獲得初始亮度2000cd/m2的電流密度而實施恆定電流驅動試驗。結果驅動試驗開始電壓為5.36V,保持初始值的90%以上的亮度的時間為2小時。 An organic EL element was obtained by the method according to Example 5, except that the compound (1-11-1) was replaced with the compound (G). A constant current driving test was carried out by using an ITO electrode as an anode and a magnesium/silver electrode as a cathode to obtain a current density of an initial luminance of 2000 cd/m 2 . As a result, the driving test start voltage was 5.36 V, and the time for maintaining the brightness of 90% or more of the initial value was 2 hours.
除了將化合物(1-11-1)換為化合物(H)以外,藉由依據實例5的方法獲得有機EL元件。以ITO電極作為陽極,以鎂/銀電極作為陰極,藉由用於獲得初始亮度2000cd/m2的電流密度而實施恆定電流驅動試驗。結果驅動試驗開始電壓為4.12V,保持初始值的90%以上的亮度的時間為26小時。 An organic EL element was obtained by the method according to Example 5 except that the compound (1-11-1) was replaced with the compound (H). A constant current driving test was carried out by using an ITO electrode as an anode and a magnesium/silver electrode as a cathode to obtain a current density of an initial luminance of 2000 cd/m 2 . As a result, the driving test start voltage was 4.12 V, and the time for maintaining the brightness of 90% or more of the initial value was 26 hours.
除了將化合物(1-11-1)換為化合物(I)以外,藉由依據實例5的方法獲得有機EL元件。以ITO電極作為陽極,以鎂/銀電極作為陰極,藉由用於獲得初始亮度2000cd/m2的電流密度而實施恆定電流驅動試驗。結果驅動試驗開始電壓為4.15V,保持初始值的90%以上的亮度的時間為30小時。 An organic EL element was obtained by the method according to Example 5 except that the compound (1-11-1) was replaced with the compound (I). A constant current driving test was carried out by using an ITO electrode as an anode and a magnesium/silver electrode as a cathode to obtain a current density of an initial luminance of 2000 cd/m 2 . As a result, the driving test start voltage was 4.15 V, and the time for maintaining the brightness of 90% or more of the initial value was 30 hours.
將以上結果匯總於表4。 The above results are summarized in Table 4.
根據本發明的較佳型態,可提供一種尤其提昇發光元件的壽命,與驅動電壓的平衡性亦優異的有機電激發光元件、具備其的顯示裝置及具備其的照明裝置等。 According to a preferred embodiment of the present invention, it is possible to provide an organic electroluminescence device which is excellent in balance between the driving voltage and the display device, and an illumination device including the same, which is excellent in the balance between the driving voltage and the driving voltage.
Claims (18)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2010247332 | 2010-11-04 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TW201226394A TW201226394A (en) | 2012-07-01 |
| TWI508949B true TWI508949B (en) | 2015-11-21 |
Family
ID=46024488
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW100140164A TWI508949B (en) | 2010-11-04 | 2011-11-03 | Electron transport material and organic electroluminescent device using the same |
Country Status (5)
| Country | Link |
|---|---|
| JP (1) | JP5737294B2 (en) |
| KR (1) | KR101835020B1 (en) |
| CN (2) | CN104744349B (en) |
| TW (1) | TWI508949B (en) |
| WO (1) | WO2012060374A1 (en) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5799772B2 (en) * | 2010-11-25 | 2015-10-28 | Jnc株式会社 | Electron transport material and organic electroluminescent device using the same |
| CN103958471B (en) * | 2012-02-03 | 2016-08-17 | 捷恩智株式会社 | Anthracene derivant and use its organic electric field luminescence assembly, electron transport material, display device and lighting device |
| JP6136311B2 (en) * | 2012-02-06 | 2017-05-31 | Jnc株式会社 | Electron transport material and organic electroluminescent device using the same |
| KR102030584B1 (en) * | 2013-01-08 | 2019-10-10 | 에스에프씨주식회사 | Antracene derivatives having heteroaryl substituted phenyl group and organic light-emitting diode including the same |
| KR102051952B1 (en) * | 2013-01-08 | 2019-12-04 | 에스에프씨주식회사 | Antracene derivatives having heteroaryl substituted naphthyl group and organic light-emitting diode including the same |
| KR101492523B1 (en) * | 2013-01-25 | 2015-02-12 | 에스에프씨 주식회사 | Organic light-emitting diode including aryl substituted antracene derivatives |
| WO2014204234A1 (en) * | 2013-06-19 | 2014-12-24 | 경상대학교산학협력단 | Phenylanthracene derivative and organic light emitting device containing same |
| TWI632140B (en) * | 2013-08-07 | 2018-08-11 | 捷恩智股份有限公司 | Compound for electron transport materials,electron transport materials and organic electroluminescent elements using the same |
| WO2015064560A1 (en) * | 2013-10-29 | 2015-05-07 | Jnc株式会社 | Anthracene compound; light-emitting-layer material; and organic electroluminescent element, display device, and illumination device using same |
| KR20180108604A (en) * | 2016-02-10 | 2018-10-04 | 가꼬우 호징 관세이 가쿠잉 | Retarded fluorescent organic electroluminescent device |
| KR20240095561A (en) * | 2022-12-06 | 2024-06-26 | 삼성디스플레이 주식회사 | Electron transport layer comprising mixed composition, method of manufacturing light-emitting device, light-emitting device and electronic apparatus using the same |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060014046A1 (en) * | 2004-07-09 | 2006-01-19 | Guofang Wang | Luminescent material and organic electroluminescent device using the same |
| US20090166670A1 (en) * | 2007-10-30 | 2009-07-02 | Sang-Hoon Park | Anthracene-based compound and organic light emitting device employing the same |
| TW200948782A (en) * | 2008-04-15 | 2009-12-01 | Samsung Mobile Display Co Ltd | Bipyridine-based compound and organic light emitting diode employing organic layer comprising the same |
| TW201022406A (en) * | 2008-12-08 | 2010-06-16 | Lg Display Co Ltd | Blue light emitting compound and organic light emitting diode device comprising the same |
| TW201202199A (en) * | 2010-07-05 | 2012-01-16 | Jnc Corp | Electron transportation material and organic electroluminescent device using the same |
| TW201213503A (en) * | 2010-08-26 | 2012-04-01 | Jnc Corp | Anthracene derivative and organic electroluminescence element using the same, display device and lighting device |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4646494B2 (en) | 2002-04-11 | 2011-03-09 | 出光興産株式会社 | Novel nitrogen-containing heterocyclic derivative and organic electroluminescence device using the same |
| CN101407492A (en) * | 2003-01-10 | 2009-04-15 | 出光兴产株式会社 | Nitrogen-containing heterocyclic derivative and organic electroluminescent device using the same |
| US8674138B2 (en) * | 2005-10-21 | 2014-03-18 | Lg Chem. Ltd. | Binaphthalene derivatives, preparation method thereof and organic electronic device using the same |
| JP5353233B2 (en) * | 2007-12-27 | 2013-11-27 | Jnc株式会社 | Anthracene derivative compound having pyridylphenyl group and organic electroluminescence device |
| CN101570536B (en) * | 2008-04-28 | 2014-08-20 | 三星显示有限公司 | Anthracene-based compound and organic light emitting device employing the same |
| KR100974125B1 (en) * | 2008-05-14 | 2010-08-04 | 주식회사 두산 | Preparation of Asymmetric Anthracene Derivatives and Organic Electroluminescent Device Using the Same |
| EP2372803A4 (en) * | 2008-12-26 | 2012-07-04 | Idemitsu Kosan Co | MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, AND ORGANIC ELECTROLUMINESCENT ELEMENT |
| JP5210187B2 (en) * | 2009-01-22 | 2013-06-12 | ユー・ディー・シー アイルランド リミテッド | Organic electroluminescence device |
| KR101789339B1 (en) * | 2009-05-29 | 2017-10-23 | 제이엔씨 주식회사 | Electron transporting material and organic electroluminescent device using same |
| CN101597259B (en) * | 2009-07-07 | 2012-11-07 | 清华大学 | Organic material and application thereof in organic electroluminescence device (OELD) |
-
2011
- 2011-11-01 KR KR1020137011642A patent/KR101835020B1/en active Active
- 2011-11-01 CN CN201510107860.XA patent/CN104744349B/en active Active
- 2011-11-01 CN CN201180052069.3A patent/CN103189355B/en active Active
- 2011-11-01 JP JP2012541874A patent/JP5737294B2/en active Active
- 2011-11-01 WO PCT/JP2011/075179 patent/WO2012060374A1/en not_active Ceased
- 2011-11-03 TW TW100140164A patent/TWI508949B/en not_active IP Right Cessation
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060014046A1 (en) * | 2004-07-09 | 2006-01-19 | Guofang Wang | Luminescent material and organic electroluminescent device using the same |
| US20090166670A1 (en) * | 2007-10-30 | 2009-07-02 | Sang-Hoon Park | Anthracene-based compound and organic light emitting device employing the same |
| TW200948782A (en) * | 2008-04-15 | 2009-12-01 | Samsung Mobile Display Co Ltd | Bipyridine-based compound and organic light emitting diode employing organic layer comprising the same |
| TW201022406A (en) * | 2008-12-08 | 2010-06-16 | Lg Display Co Ltd | Blue light emitting compound and organic light emitting diode device comprising the same |
| TW201202199A (en) * | 2010-07-05 | 2012-01-16 | Jnc Corp | Electron transportation material and organic electroluminescent device using the same |
| TW201213503A (en) * | 2010-08-26 | 2012-04-01 | Jnc Corp | Anthracene derivative and organic electroluminescence element using the same, display device and lighting device |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103189355B (en) | 2015-08-26 |
| TW201226394A (en) | 2012-07-01 |
| KR20130140709A (en) | 2013-12-24 |
| JPWO2012060374A1 (en) | 2014-05-12 |
| JP5737294B2 (en) | 2015-06-17 |
| CN103189355A (en) | 2013-07-03 |
| CN104744349B (en) | 2017-09-22 |
| WO2012060374A1 (en) | 2012-05-10 |
| KR101835020B1 (en) | 2018-03-06 |
| CN104744349A (en) | 2015-07-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI508949B (en) | Electron transport material and organic electroluminescent device using the same | |
| CN102414179B (en) | Compound for electron transport material, electron transport material, and organic electroluminescence element using same | |
| TWI491602B (en) | Benzo(c)carbazole compound having substituent including pyridine and organic electroluminescent device | |
| TWI498321B (en) | Electron transport material and organic electroluminescent element using same | |
| TWI475091B (en) | Electron transport material and organic electroluminescent device using same | |
| WO2011105373A1 (en) | Substituted pyridyl compound and organic electroluminescent element | |
| TWI570095B (en) | Benzofluorene compound, material for light-emitting layer using the same, and organic electroluminescent element | |
| JP5799772B2 (en) | Electron transport material and organic electroluminescent device using the same | |
| CN103958471B (en) | Anthracene derivant and use its organic electric field luminescence assembly, electron transport material, display device and lighting device | |
| TWI542586B (en) | Compound having substituted bipyridyl group and pyridoindole ring structure and organic electroluminescence device | |
| TWI632140B (en) | Compound for electron transport materials,electron transport materials and organic electroluminescent elements using the same | |
| CN104040747A (en) | Material for light-emitting layer and organic electroluminescent device using same | |
| JP6136311B2 (en) | Electron transport material and organic electroluminescent device using the same | |
| JP6428762B2 (en) | Electron transport material and organic electroluminescent device using the same | |
| JP2013227251A (en) | Electron transport material and organic electroluminescent element using the same | |
| JP6070047B2 (en) | Electron transport material and organic electroluminescent device using the same | |
| CN103917516B (en) | Benzofluorene compound, material for light-emitting layer using same, organic electroluminescent element, display device, and lighting device | |
| JP2016074623A (en) | Compound having alkyl-substituted azole, electron transport material including the compound and organic electroluminescent element using the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Annulment or lapse of patent due to non-payment of fees |